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Introduction	Infectious	Bronchitis	is	a	ubiquitous,	highly	contagious	viral	disease	of	chickens.		It	is	caused	by	the	Infectious	Bronchitis	virus	(IBV).	While	the	virus	has	an	initial	respiratory	tropism,	it	can	also	affect	the	female	reproductive	tract,	causing	loss	of	production	and	poor	egg	quality.	Some	 strains	 have	 predilection	 for	 the	 kidney	 of	 young	 chickens,	 resulting	 in	 nephritis	associated	 with	 significant	 mortality.	 Control	 is	 attempted	 using	 live	 attenuated	 and	inactivated	vaccines.	 IBV	 is	able	 to	genetically	mutate	and	recombine,	 resulting	 in	antigenic	shift	 and	 drift.	 This	 means	 that	 vaccination	 programmes	 are	 constantly	 being	 challenged.	Thus,	 even	 though	 the	 disease	was	 first	 reported	more	 than	 60	 years	 ago,	 control	 is	 never	complete	even	today,	because	new	strains	emerge	continuously	(Cook	et	al.,	2012).	The	aim	of	this	thesis	was	to	analyze	the	full-length	genome	sequences	of	different	strains	of	IBV.	 In	 the	 first	 part	 of	 the	 project,	we	 obtained	 and	 analyzed	 the	 sequence	 of	 a	 Q1	 strain	isolated	in	Italy	in	2013	in	order	to	have	more	information	on	the	genetic	characteristics	and	the	origin	of	this	strain.	The	Q1	genotype	was	for	the	first	time	isolated	in	China	in	1996	and	then	have	spread	in	Far	East,	Middle	East,	Europe	and	South	America.	In	Italy,	it	was	isolated	for	the	first	time	in	2011	and	is	still	circulating.	The	results	of	this	study	led	to	the	hypothesis	that	the	Q1	genotype	was	genetically	related	to	the	624I	genotype,	circulating	in	Italy	from	the	1960s.	So,	the	full-length	analysis	of	a	624I	IBV	strain	isolated	in	Italy	in	1996	was	carried	out	and	 the	 genetic	 correlation	 between	 Q1	 and	 624I	 genotypes	 was	 assessed	 in	 order	 to	understand	 the	 evolutionary	 scenario.	 IBV	 QX	 genotype	 was	 detected	 for	 the	 first	 time	 in	China	in	1996	and	then	spread	worldwide	becoming	one	of	the	most	commonly	encountered	genotypes.	 IBV	 QX	 genotype	 causes	 sufficient	 disease	 in	 Europe	 for	 several	 commercial	companies	 to	 have	 started	 developing	 live	 attenuated	 vaccines.	 Effective	 knowledge	 of	 the	prevalence	and	circulation	of	different	IBV	genotypes	in	any	area	is	not	straightforward.	One	complication	can	be	 the	presence	of	 the	 live	vaccines	previously	applied	 for	disease	control	and	 the	 inability	 to	 distinguish	 between	 the	 field	 viruses	 and	 vaccines.	 The	 possibility	 to	analyze	field	strain	(progenitor)	used	to	make	any	particular	vaccine	 is	vital	 in	tracking	IBV	vaccines.	This	 is	because	comparison	of	the	full	sequences	of	progenitor	and	vaccine	strains	reveals	 the	 changes	 which	 occurred	 in	 the	 attenuation	 process,	 and	 those	 changes	 are	generally	unique	to	that	particular	vaccine.	In	the	second	part	of	the	study,	the	full	genome	of	an	 IBV	 QX	 vaccine	 (L1148	 strain)	 was	 consensus	 sequenced	 alongside	 its	 progenitor	 field	strain	(1148-A	strain)	to	determine	vaccine	markers,	thereby	enabling	detection	on	farms	and	to	investigate	the	changes	occurred	during	the	attenuation	process.		
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1.	Infectious	Bronchitis	Literature	Review	
1.1	Aetiology		
1.1.1	Taxonomy	
	 Infectious	bronchitis	(IB)	is	caused	by	a	virus	traditionally	named	IBV	which	has	been	recently	 included	 in	 the	 species	 Avian	 coronavirus	 (AvCoV)	 belonging	 to	 the	 genus	
Gammacoronavirus	in	the	family	Coronaviridae	(order	Nidovirales).		The	Coronaviridae	family	includes	two	subfamilies,	Coronavirinae	and	Torovirinae	and	within	the	subfamily	Coronavirinae	 there	are	4	genera:	Alpha-,	Beta-,	Gamma-	and	Deltacoronavirus.	The	 genus	 Gammacoronavirus	 includes	 two	 species:	 Avian	 coronavirus	 and	 Beluga	Whale	
coronavirus	 SW1	 (https://talk.ictvonline.org/taxonomy/).	 Alphacoronavirus	 (α-CoV)	 and	
Betacoronavirus	 (β-CoV)	 infect	 many	 mammalian	 species	 ranging	 from	 bats	 to	 humans,	whereas	Gammacoronavirus	 (γ-CoV)	and	Deltacoronavirus	 (δ-CoV)	are	 largely	established	in	birds	and	to	a	lesser	degree	in	mammals.	It	has	been	hypothesized	a	model	of	CoV	evolution,	in	 which	 a	 Coronavirus	 ancestor	 has	 evolved	 separately	 in	 bats	 in	 Alphacoronavirus	 and	
Betacoronavirus	and	 in	birds	 in	Gammacoronavirus	and	Deltacoronavirus	(Fig.1)	 (Woo	et	al.,	2012).	The	classification	of	the	family	Coronaviridae	has	been	reviewed	in	2009	by	the	International	Committee	 on	 Taxonomy	 of	 Viruses.	 	 The	 strains	 showing	 a	 90%	 pair-wise	 amino	 acid	sequence	 identity	 in	 seven	 conserved	 replicase	 domains,	 are	 now	 classified	 in	 the	 same	species.	Therefore,	all	the	different	species	of	avian	Gammacoronaviruses	previously	existing,	including	 IBV,	 IBV-like	 isolated	 from	 different	 avian	 species	 and	 the	 Turkey	 coronavirus	(TCoV)	have	been	grouped	together	in	the	AvCoV	species.						
		
Fig.1		A	model	of	CoV	evolution	(Woo	et	al.,	2012).		
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1.1.2	Avian	coronavirus	nomenclature	
Many	 different	 antigenic	 forms,	 serotypes	 or	 variants	 of	 AvCoV	 exist	 worldwide	 and	 this	variability	 results	 in	 an	 inconsistent	 nomenclature.	 For	 this	 reason,	 a	 new	 nomenclature	“CoVGenus/AvCov/host/country/specimen	id/year”	has	been	recently	proposed	to	refer	the	AvCoV	strains	(Ducatez	et	al.,	2016).		
1.1.3	Morphology	
IBV	 is	 an	 enveloped	 virus	 with	 a	 round	 to	 pleomorphic	 shape.	 The	 virus	 particles,	 of	approximately	120nm	in	diameter,	are	covered	by	club-shaped	surface	projections	(spikes),	formed	by	the	Spike	(S)	proteins,	of	about	20nm	in	length	which	gives	to	the	virus	a	crown-like	 appearance	 and	 hence	 the	 name	 “corona”	 (latin	 for	 crown),	 (Fig.	 2).	 IBV,	 like	 other	coronaviruses	has	a	helical	nucleocapsid	that	enclose	the	genetic	material	and	is	surrounded	by	membrane	proteins	(M)	and,	in	a	smaller	number	by	envelope	proteins	(E),	all	of	which	are	embedded	in	a	lipid	membrane	(Fig.	3),	(Becker	et	al.,	1967;	Jackwood	and	de	Wit	2013).		
	
	 	
	
	
	
	 	1.1.4	Genome	organization	and	replication	
	 IBV	has	a	single	strand	(ss)	RNA	positive	sense	(ps)	genome	of	approximately	27.5	to	28	kb.	The	genome	of	IBV	is	typical	of	other	coronaviruses	and	comprises	the	following	genes:	gene	 1,	 encoding	 for	 the	 polyproteins	 1a-1ab,	 spike	 gene	 (S),	 accessory	 genes	 3a	 and	 3b,	envelope	gene	(E),	membrane	gene	(M),	5a	and	5b	accessory	genes	and	the	nucleocapsid	gene	(N)	(Jackwood	and	de	Wit,	2013).	Additionally,	either	for	IBV	and	the	closely	related	Turkey	CoV,	there	is	a	region	located	between	the	membrane	(M)	gene	and	the	group-specific	gene	5	referred	to	the	intergenic	region	(IR),	also	known	as	Open	Reading	Frame	(ORF)	4b	or	10,	and	
Fig.	 2	 Electron	 micrograph	 of	
Infectious	 Bronchitis	 virus	 particles	
(Cook	et	al.,	1983)	
Fig.	3	Coronavirus	virion	structure	
(Ujike	and	Taguchi	2015)	
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recently	for	some	strains	also	ORFs	4c	and	6b	have	been	described	(Cao	et	al.,	2008;	Hewson	
et	al.,	2011,	Bentley	et	al.,	2013,	Albonik,	2015).	In	the	figure	4	the	most	common	IBV	genome	organization:	5’UTR-1a/1ab-S-3a-3b-E-M-4b-5a-5b-N-3’UTR	is	reported	(Cavanagh,	2005).	
	
The	5’	end	of	the	genome	is	capped,	although	the	exact	structure	of	the	capped	5’end	has	not	been	determined.	The	3’	end	is	polyadenilated	(poly-(A)).	At	the	5’end	there	is	an	untraslated	region	(5’	UTR)	of	approximately	500	nucleotides	(nts).	At	the	end	of	the	genome	there	is	an	untraslated	 region	 (3’-UTR)	 of	 approximately	 300	 nts,	 before	 the	 poly-(A),	 (Cavanagh	 and	Britton	2008).	
Gene	1	occupies	the	first	two-thirds	of	the	entire	genome	and	consists	of	two	large	ORFs	1a,	and	1ab.	ORF	1a	 and	1ab	overlap	 slightly	 and	are	 translated	by	 a	 -1	 frameshift	mechanism	into	 two	 long	 polyproteins:	 pp1a	 and	 pp1ab	 (Namy	 et	 al.,	 2006).	 Both	 proteins	 are	proteolytically	 cleaved	 by	 two	 virus-encoded	 proteases	 (Ziebhur	 et	 al.,	 2000)	 in	 15	 non-structural	proteins	(nsp).	Nsp	2	to	11	are	encoded	in	ORF	1a	(most	coronaviruses	have	16	nsp	but	 IBV	 lack	 the	 nsp	 1)	 and	 nsp	 12	 to	 16	 are	 encoded	 in	 ORF	 1ab.	 The	 nsps	make	 up	 the	replication-transcription	complex	(RTC).	
The	remaining	one	 third	of	 the	genome	encodes	 for	structural	and	group-specific	accessory	proteins.		
Transcription	Regulatory	Sequences	(TRS),	consisting	 in	short,	repeated,	AT-rich	sequences,	are	found	upstream	the	5’	end	of	each	gene	(TRS-B)	and	at	the	3’	end	of	the	leader	sequence	(TRS-L).		
Fig.	4	IBV	genome	organization	
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The	genome	replication	strategy	of	coronaviruses	was	originally	proposed	 in	1995	(Sawicki	and	Sawicki,	1995).	The	ORF	1	is	directly	translated	to	form	the	polyproteins	1a	and	1ab	that	are	 then	 cleaved	 to	 form	 the	 replication-transcription	 complex	 (RTC).	 The	 RNA	 dependent	RNA	 polimerase	 (RdRp)	 copies	 the	 genome	 continuously	 from	 the	 3’	 end	 to	 produce	 a	complementary	negative	sense	(ns)	copy	of	the	genome,	that	serves	in	turn	to	be	copied	into	more	genomes	(genome	replication).	Furthermore,	the	RdRp	generate	a	series	of	subgenomic	ns	genomes	for	each	gene	or	group	specific	genes	by	a	process	of	discontinuous	transcription	that	 is	 typical	of	 the	 coronaviruses	 replication	 (Fig	5).	The	RdRp	starts	 the	 synthesis	of	 the	subgenomic	 ns	 genomes	 from	 the	 3’	 end	 of	 the	 genomic	 RNA.	 Elongation	 of	 the	 nascent	subgenomic	ns	genome	continues	until	the	first	functional	TRS-B	motif	is	encountered.	After	the	 copy	 of	 the	 TRS-B,	 the	 RdRp	 will	 either	 disregard	 the	 TRS-B	 motif	 and	 continue	 to	elongate	the	nascent	strand,	or	stop	the	elongation	of	the	nascent	ns	genome	and	relocate	and	complete	its	synthesis.	This	relocation	will	be	guided	by	complementary	between	the	3’end	of	the	 nascent	 ns	 strand	 (TRS-B)	 and	 the	 TRS-L.	 Then	 the	 translocated	 ns	 strand	 will	 be	extended	by	coping	the	5’end	of	the	genome	(Fig.	5).		Because	of	this	discontinuous	event,	the	subgenomic	ns	templates	and	the	genomic	ns	template,	all	have	the	same	3’	end	and	would	be	equally	recognized	and	copied	into	subgenomic	or	genomic	mRNAs	respectively,	by	the	viral	transcriptase.	 	Furthermore,	both	the	genomic	and	the	subgenomic	mRNAs	could	be	used	to	produce	the	new	proteins,	because	they	have	the	same	5’end	which	would	give	each	the	same	ribosome	recognition	signal	(Sawicki	et	al.,	2007;	Sawicki,	2009).		
	
	
	
	
	
	
	
	 Fig.5	Schematic	view	of	Coronavirus	replication	and	transcription	(Posthuma	et	al.,	2017)	
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1.1.5	Proteins	characteristics	and	roles	
1.1.5.1	Non	structural	proteins	
The	 nsps	 have	 at	 least	 eight	 enzymatic	 activity	 and	 are	 involved	 in	 the	 replication-transcription	process	(Sawicki	et	al.,	2007;	Snijdr	et	al.,	2003).		
The	 nsp	 11	 and	 12	 form	 the	 RNA	 dependent	 RNA	 polimerase.	 In	 the	 nsp	 3	 resides	 a	proteolitically	 active	 domain	 PLpro	 for	 the	 cleavage	 of	 the	 polyproteins	 1a-1ab	 in	 sites	between	 nsp	 2	 and	 3,	 and	 nsp	 3	 and	 4	 (Lim	 and	 Liu	 1998;	 Lim	 et	al.,	 2000;	 Ziebuhr	 et	al.,	2001).	The	Nsp	5	contains	the	Main	protease	Mpro	responsible	for	cleaving	nsp	4	through	16	(Jackwood	et	al.,	2012).		The	CoV	nsps	assemble	themselves	together	with	the	N	protein	into	the	RTC,	forming	double-membrane	vescicles	(DMV)	in	which	viral	RNA	synthesis	occurs	(Gosert	et	al.,	2002).	The	nsp	4,	 for	 its	 multiple	 highly	 hydrophobic	 stretches	 of	 amino	 acids,	 is	 predicted	 to	 span	intracellular	 membranes	 (Bonilla	 et	al.,	 1994).	 Together,	 nsps	 3,	 4,	 and	 6	 are	 predicted	 to	anchor	viral	RTC	on	double-membrane	vesicles	 in	the	cytoplasm	(Graham	et	al.,	2008).	Also	nsp	 2	 has	 been	 shown	 to	 be	 recruited	 to	 RTCs	 and	 no	 exchange	 of	 nsp	 2	 between	 the	cytoplasm	or	other	DMVs	occurs	(Hagemeijer	et	al.,	2010).		
Nsp	 7	 and	nsp	 8	 form	 a	 super-complex	 that	may	 act	 as	 a	 cofactor	 to	 the	RdRp	 (Zhai	 et	al.,	2005).	The	nsp	9	is	a	ss	RNA	binding	protein	and	interacts	with	the	super-complex	(Sutton	et	
al.,	2004;	Egloff	et	al.,	2004).	Nsp	8	and	nsp	9,	also	bind	 the	RNA,	and	 this	possibly	suggest	their	 ability	 to	 interfere	 with	 host-cell	 translation	 (Ponnusamy	 et	 al.,	 2006).	 Nsp	 10	 is	involved	 in	 RNA	 synthesis	 (Donaldson	 et	 al.,	 2006).	 Nsp	 14	 has	 3’-5’	 exonuclease	 activity	(Minskaia	 et	 al.,	 2006).	 Nsp	 15	 is	 an	 endoribonuclease	 and	 nsp	 16	 is	 an	 RNA	methyltransferase	(Eckerle	et	al.,	2006).		
1.1.5.2	Spike	protein	
The	 Spike	 protein	 is	 the	 largest	 structural	 protein	 of	 coronaviruses	 and	 forms	 the	characteristic	 club-like	 or	 petal-shaped	 protrusions	 that	 emerge	 from	 the	 virion	 surface	(reviewed	in	Wickramasinghe	et	al.,	2014).	The	S	protein	of	IBV	is	cleaved	by	a	furin-like	host	cell	protease	at	the	highly	basic	pentapeptide	motif	RRFRR,	generating	the	subunits	S1	and	S2	of	 about	 500	 and	 600	 amino	 acids	 in	 size,	 respectively	 (Cavanagh	 et	 al.,	 1986a).	 The	 N	
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terminal	 S1	 subunit	 is	 part	 of	 the	 large	 ectodomain	 and	 forms	 the	bulb	of	 the	oligomeric	 S	protein.	 The	 C-terminal	 S2	 subunit	 comprises	 the	 other	 part	 of	 the	 ectodomain	 forming	 a	narrow	 stalk,	 the	 short	 transmembrane	 (TM)	 and	 the	 endodomain	 (Cyto)	 of	 the	 protein	(Fig.6),	(rewieved	in	Wickramasinghe	et	al.,	2014).	
	
	
	
	
	
	
	
The	 coronaviruses	 spike	 protein	 is	 a	 class	 I	 viral	 fusion	 peptide,	 in	 which	 the	 variable	 S1	domain	 is	 involved	 in	 host	 cell	 receptor	 binding.	 The	 conserved	 S2	 domain	 mediates	 the	anchor	and	the	 fusion	of	 the	virion	to	 the	cellular	membranes	and	the	releasing	of	 the	viral	ribonucleoprotein	in	the	cytosol	of	the	infected	cell	(Bosch	et	al.,	2003).	All	mapped	receptor-binding	domains	(RBD)	are	located	at	various	positions	within	the	S1	domain	(Promkuntod	et	
al.,	 2014).	 The	 S2	 membrane	 fusion	 unit	 of	 the	 ectodomain	 contains	 two	 heptad	 repeat	regions	(HR1	and	HR2),	which	interact	to	form	the	coiled-coil	structure	of	the	stalk	(de	Groot	
et	al.,	1987),	and	a	putative	fusion	peptide.	After	endocytosis,	conformational	changes	in	the	S	protein	are	 trigged	by	exposure	to	acid	pH	 in	endosomes	(Chu	et	al.,	2006),	resulting	 in	 the	fusion	of	viral	envelope	with	the	cellular	membrane.	Although	the	S2	domain	is	not	principally	involved	 in	 binding	 to	 host	 cell	 receptors,	 the	 interplay	 between	 S1	 and	 S2	 domains	might	synergically	 influence	 the	 avidity	 and	 specificity	 of	 virus	 attachment	 (de	Haan	 et	al.,	 2006;	Promkuntod	et	al.,	2013).	The	S	protein	is	the	main	antigenic	viral	protein	containing	epitopes	for	 virus	 neutralization.	 Using	 monoclonal	 antibodies,	 five	 conformation-dependent	neutralizing	antigenic	sites	have	been	mapped	on	S1	(Cavanagh	et	al.,	1984,	Cavanagh	et	al.,	1986b;	 Kant	 et	al.,	 1992;	 Koch	 et	al.,	 1990;	Mockett	 et	al.,	 1984;	 Niesters	 et	al.,	 1987),	 and			another	immunodominant	region	in	the	N-terminal	region	of	the	S2	(Koch	et	al.	1990;	Kusters	
Fig.	6	Schematic	representation	of	the	S	gene	coding	regions	(Armesto	et	al.	2012,	slightly	
modified)	
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et	al.,	 1989;	 Lenstra	et	al.,	 1989).	The	 five	neutralizing	 antigenic	 sites	 found	 in	 S1	 co-locate	within	 three	hypervariable	regions	(HVRs)	(Cavanagh	et	al.,	1988,	1992;	Moore	et	al.,	1997;	Niesters	et	al.,	1987),	suggesting	HVRs	to	be	involved	in	antigenicity	variation.	Within	the	IBV	strains,	variation	in	the	S1	domain	in	amino	acid	sequence,	ranges	from	2-3%	to	50%	with	an	average	of	20-25%,	while	identity,	for	the	conserved	S2	domain,	is	usually	>90%	(Britton	and	Cavanagh	2007).	It	has	been	demonstrated	that	the	S	protein	is	a	determinant	of	cell	tropism	(Casais	et	al.,	2003).	Alpha2,3-linked	sialic	acid	have	been	identified	as	a	receptor	determinant	in	cells	for	primary	attachment	of	IBV	(Winter	et	al.,	2006,	2008).	
1.1.5.3	Membrane	protein	
The	M	protein	is	a	type	III	membrane	protein,	it	is	the	most	abundant	structural	glycoprotein	in	 the	virus	particles	and	plays	an	essential	role	 in	virion	assembly	and	budding	(Stern	and	Sefton.,	1982;	Sturman	et	al.,	1980).	It	spans	the	membrane	bilaterally	three	times,	leaving	a	short	N-terminal	ectdomain	and	a	long	C-terminus	inside	the	virion	(Armstrong	et	al.,	1984).	The	M	protein	is	essential	for	coronavirus	envelope	formation.	It	has	been	demonstrated	that	Virus	Like	Particles	(VLPs),	with	similarity	in	size	and	shape	to	the	authentic	virions,	can	be	formed	 from	 cells	 that	 express	 both	 E	 and	M	 proteins	 (Vannema	 et	al.,	 1996).	 It	 has	 been	proposed	that	the	envelope	formation	is	mediated	by	lateral	interaction	between	M	molecules	that	form	a	two-dimensional	lattice	in	intracellular	membranes	(Opstelten	et	al.,	1995).	 	The	M	protein	 interacts	 also	with	 the	 viral	 nucleocapsid	 and	with	 the	 S	 protein	 (McBride	et	al.,	2007),	for	virus	particles	assembling	(Sturman	et	al.,	1980;	Narayanan	et	al.,	2000).		
1.1.5.4	Envelope	protein	
The	membrane	topology	of	E	protein	is	not	completely	resolved	but	most	data	suggest	that	it	is	 a	 transmembrane	 protein.	 The	 E	 protein	 has	 a	 N-terminal	 ectodomain	 and	 a	 C-terminal	endodomain	and	has	 ion	channel	activity.	While	 the	M	protein	 is	 relatively	abundant,	 the	E	protein	 is	 only	 present	 in	 small	 quantities	 in	 the	 virion	 (Fehr	 and	 Perlman,	 2015).	 It	 is	unknown	how	E	protein	assists	M	protein	in	assembly	of	the	virion,	and	several	possibilities	have	 been	 suggested.	 Some	 works	 have	 indicated	 a	 role	 for	 the	 E	 protein	 in	 inducing	membrane	 curvature	 (Raamsman	 et	 al.,	 2000;	 Corse	 et	 al.,	 2000;	 Fischer	 et	 al.,	 1998),	although	other	authors	have	suggested	that	E	protein	prevents	the	aggregation	of	M	proteins	(Boscarino	 et	 al.,	 2008).	 The	 E	 protein	 may	 also	 have	 a	 separate	 role	 in	 promoting	 viral	release	by	altering	 the	host	 secretory	pathway	(Ye	et	al.,	2007).	Furthermore,	 the	E	protein	
	 9	
forms	cation-selective	ion	channels	in	the	lipid	envelope,	enhancing	membrane	permeability	(Wilson	et	al.,	2004).		
1.1.5.5	Nucleocapsid	protein	
The	N	protein	is	the	only	protein	present	in	the	nucleocapsid.	It	is	composed	by	two	separate	domains,	 an	 N-terminal	 domain	 and	 a	 C-terminal	 domain,	 both	 capable	 of	 binding	 RNA	 in	
vitro.	 It	 has	 been	 suggested	 that	 optimal	 RNA	 binding	 requires	 contribution	 from	 both	domains	(Chang	et	al.,	2006;	Hurst	et	al.,	2009).	N	protein	also	binds	nsp	3,	(Hurst	et	al.,	2009;	2013)	a	key	component	of	the	RTC,	and	the	M	protein	(Sturman	et	al.,	1980).	These	proteins	interactions	likely	help	to	tether	the	viral	genome	to	the	RTC,	and	subsequently	the	packaging	of	the	genome	into	viral	particles.		
1.1.5.6	Accessory	proteins	
It	has	been	demonstrated	that	the	accessory	proteins	3a,	3b,	5a	and	5b	are	not	essential	for	virus	 replication.	 They	 have	 accessory	 functions,	 possibly	 associated	 with	 the	 virus-host	interaction	(Casais	et	al.,	2005;	de	Haan	et	al.,	2002;	Hodgson	et	al.,	2006;	Yount	et	al.,	2005;	Cavanagh,	2007).	For	example,	it	has	been	demonstrated	that	accessory	protein	5b	is	required	for	the	inhibition	of	IFN	production	by	blocking	host	translation,	better	known	as	host	shutoff,	(Kint	et	al.,	2016).			
1.1.6	Cell	infection	and	virus	replication	
The	attachment	of	the	virion	to	the	host	cells	is	initiated	by	the	interaction	between	the	S	protein	and	its	receptor.	Following	receptor	binding,	the	virus	must	next	gain	access	to	the	host	cell	cytosol	by	fusion	of	the	viral	and	cellular	membranes	and	release	of	the	viral	genome	into	 the	 cytoplasm.	The	next	 step,	 in	 the	 coronaviruses	 lifecycle,	 is	 the	 translation	 from	 the	virion	genomic	RNA	of	the	replicase	gene,	which	origins	the	nsps.	They	assemble	into	the	RTC	to	 create	 an	 environment	 suitable	 for	 RNA	 synthesis.	 The	 nsps	 are	 also	 responsible	 for	genomic	RNA	 replication	 and	 transcription	 of	 the	 sub-genomic	RNAs.	 Following	 replication	and	 subgenomic	RNA	synthesis,	 the	viral	 structural	proteins	 S,	E,	 and	M	are	 translated	and	inserted	 into	 the	 endoplasmic	 reticulum	 (ER).	 These	 proteins	 move	 along	 the	 secretory	pathway	 into	 the	 endoplasmic	 reticulum-Golgi	 intermediate	 compartment	 (ERGIC).	 Viral	genomes,	encapsidated	by	N	protein,	bud	 into	the	membranes	of	 the	ERGIC	containing	viral	
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structural	 proteins,	 forming	mature	 virions.	 Following	 assembly,	 virions	 are	 transported	 to	the	cell	surface	in	vesicles	and	released	by	exocytosis	(Fig.	7)	(Fehr	and	Perlman,	2015).		
	
	
	
	
	
	
		1.1.7	Susceptibility	to	Chemical	and	physical	agents	
Coronaviruses	are	heat	liable,	being	inactivated	after	15	minutes	at	56°C,	but	samples	containing	proteins	should	be	treated	at	60°C	 for	at	 least	30	minutes	 to	 inactivate	 the	virus	(Rabenau	 et	al.,	 2005).	 Long	 term	 storage	 of	 IBV	 is	 recommended	 at	 -80°C.	 Survival	 of	 the	virus	up	to	12	days	in	spring,	and	56	days	at	temperatures	below	freezing,	has	been	reported.	Cold	chain	should	be	maintained	for	samples	sent	to	the	laboratory	for	diagnosis	(Jackwood	and	de	Wit,	2013).	Infectious	allantoic	fluid	lyophilized,	sealed	under	vacuum,	and	stored	in	a	refrigerator	 might	 remain	 viable	 for	 at	 least	 30	 years	 (Cavanagh	 and	 Jelb,	 2008).	 	 The	reduction	 in	 titre	 following	 extremes	 of	 pH,	 is	 variable	 depending	 on	 virus	 strain.	 A	 pH	 3	treatment,	at	room	temperature	for	4	hours,	results	in	reduction	of	titre	of	1-2	log10	for	most	isolates,	 but	 up	 to	 5	 log10	 for	 others	 (Cavangh	 and	 Jelb,	 2008).	 IBV	 in	 cell	 cultures	 is	more	stable	in	medium	at	pH	6.0	and	6.5	than	pH	7.0	to	8	(Alexander	and	Collins,	1975).	IBV,	being	an	enveloped	virus,	is	sensitive	to	either	50%	chloroform,	and	0.01%	sodium	dexycholate	at	4°C	for	18	hours.	Most	common	disinfectants	used	in	poultry	houses	inactivate	IBV.	The	area	to	 be	 disinfected	 should	 be	 free	 of	 organic	material.	 Treatment	 with	 0.05%	 or	 0.1%	 beta-propriolactone	(BPL)	or	0.1%	formalin	eliminates	IBV	infectivity.	Only	BPL	treatment	had	no	adverse	effect	on	IBV	hemoagglutination	(HA)	activity,	making	it	a	good	choice	for	creating	HA	antigen	and	killed	vaccine	(Jackwood	and	de	Wit,	2013).			
Fig	7	Coronavirus	replication	in	host	cells	(Bergmann	et	al.,	2006	slightly	modified)	
Receptor 
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1.1.8	IBV	typing	
The	 preferred	 IBV	 typing	 system	 depends	 on	 the	 goal	 (e.g.	 selection	 of	 vaccination	programmes,	or	epidemiological	studies),	available	techniques,	experience,	field	situation	and	costs.	Classification	systems	are	divided	into	two	major	groups:	functional	tests,	which	regard	the	biological	 function	of	a	virus;	and	non-functional	tests,	which	examine	the	viral	genome.	Typing	 by	 functional	 tests	 results	 in	 protectotypes	 and	 serotypes.	 Tests	 which	 look	 at	 the	genome	result	in	genotypes	(de	Wit	2000;	de	Wit	et	al.,	2011a).			 1.1.8.1	 Genotypes:	 Grouping	 strains	 based	 on	 genetic	 characterization	 provide	essential	information	for	epidemiological	studies.	Most	used	for	genotyping	is	the	part	of	the	genome	that	encodes	for	the	S1	subunit	of	the	spike	glycoprotein,	which	is	the	major	inducer	of	 the	 virus-neutralizing	 epitopes,	 including	 serotype-specific	 epitopes	 which	 are	 usually	conformation	dependent	(Mockett	et	al.,	1984;	Cavanagh	and	Davis,	1986;	Koch	et	al.,	1990;	Cavanagh	 et	al.,	 1992).	 	 A	 new	 classification	 of	 IBV	 based	 on	 the	 phylogenetic	 analysis	 of	complete	 S1	 nucleotide	 sequences	 has	 been	 recently	 proposed	 (Valastro	 et	al.,	 2016).	 	 Six	genotypes	 have	 been	 defined	 that	 together	 comprise	 32	 distinct	 viral	 lineages.	 The	 IBV	lineages,	on	the	new	classification	scheme,	exhibit	a	pairwise	distances	of	13%	and	14%	for	nucleotide	and	amino	acid	respectively.	Similarly,	viral	genotypes	differ	at	least	of	30%	in	the	nucleotide,	or	31%	in	amino	acid	sequences.	Twenty-seven	 lineages	cluster	 into	genotype	1	(GI),	 which	 includes	 the	 majority	 of	 the	 IBV	 strains,	 whereas	 the	 remaining	 5	 genotypes	contain	only	one	lineage	each.		1.1.8.2	 Serotypes:	 Two	 IBV	 strains	 (e.g.	 A	 and	 B)	 are	 considered	 to	 be	 of	 the	 same	serotype	 when	 two-way	 heterologous	 neutralization	 titers	 (antiserum	 A	 with	 virus	 B,	 and	antiserum	B	with	virus	A)	differ	 less	 than	20-fold	 from	the	homologous	 titers	 (antiserum	A	with	virus	A,	and	antiserum	B	with	virus	B)	in	both	directions	(Hesselink,	1991).	Serotyping	became	less	practical	as	more	IBV	types	are	detected	in	a	certain	area,	since	every	serotype	need	its	own	neutralization	test,	and	for	new	strains	that	appear	to	be	different,	an	antiserum	has	to	be	raised	in	specific	pathogens	free	(SPF)	birds.	More	and	more	countries	have	to	deal	with	an	 increasing	number	of	 variants,	which	decreases	 the	practicability	of	 serotyping	 (de	Wit	et	al.,	2011a).		1.1.8.3	Protectotypes:	 For	 the	 field,	 grouping	 of	 IBV	 strains	 into	protectotypes	 is	 the	most	important	system	from	a	practical	point	of	view,	because	it	provides	direct	information	
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about	the	efficacy	of	a	vaccine.	Strains	that	 induce	protection	against	each	other	in	chickens	belong	to	the	same	protectotype	(Lohr,	1988;	Cook	et	al.,	1999).	However,	protectotyping	 is	laborious	 and	 expensive	 and	 required	 both	 SPF	 chickens	 and	 high-level	 facilities	 for	performing	vaccination	challenge	studies.		1.1.8.4	Relationship	between	genotype,	serotype	and	protectotype	A	complicating	factor	with	regard	to	genotyping	of	IBV	is	that	a	change	of	only	a	small	percentage	of	amino	acids	in	the	S1	protein	can	result	in	a	change	of	serotype	(Cavanagh	et	al.,	1992)	due	to	a	change	in	virus	neutralizing	epitopes,	whereas	mutations	in	other	parts	of	S1	might	not	result	 in	a	relevant	change	in	antigenicity	of	the	virus.	On	the	other	hand,	IBVs	of	different	 serotypes	 and	 genotypes	 not	 only	 have	 different	 epitopes	 but	 also	 share	 common	epitopes	 that	 are	 of	 importance	 in	 cross-immunity	 (Cavanagh	 et	al.,	 1992;	 1997)	 and	 cell	mediated	 immune	 responses	 (Boots	 et	al.,	 1992;	 Ignjatovic	 and	 Galli,	 1995).	 Despite	 these	limitations,	 S1	 gene	 sequence	 comparison	 is	 reported	 as	 a	 better	 predictor	 of	 immunity	 in	chickens	 than	 serotyping	 by	 virus	 neutralization	 (Ladman	 et	al.,	 2006).	 In	 general,	 a	 lower	homology	 in	 the	 sequences	 of	 the	 S1	 subunit	 of	 two	 strains	 means	 greater	 chance	 that	relevant	mutations	have	occurred,	which	might	result	 in	a	lower	cross-protection	(de	Wit	et	
al.,	 2011a).	 	 Genotyping	 is	 an	 excellent,	 convenient	 and	 practical	 tool	 for	 epidemiological	studies,	and	it	can	be	used	best	as	a	means	of	screening	to	select	potentially	important	strains.	In	 field	situations,	where	 there	 is	suspicion	that	 the	genotyping	of	a	recent	 IBV	 isolate	does	not	 provide	 accurate	 information	 about	 the	 true	 antigenic	 nature	 of	 the	 virus,	 then	conventional	 testing	 (serotyping)	 and	 especially	 in	vivo	 protection	 studies	 are	 required	 (de	Wit	et	al.,	2011a).			
1.1.9	IBV	mutation	and	recombination	
Genetic	diversity	in	coronaviruses	is	due	to	adaptive	evolution	driven	by	high	mutation	rates	and	genetic	recombination	(Holmes	et	al.,	2009).	Mutations	includes	substitutions,	which	are	the	result	of	high	error	rate	and	limited	proofreading	capability	of	the	viral	RdRp,	as	well	as	insertions	and	deletions,	caused	by	recombination	events	or	by	RdRp	stuttering	or	slippage	(Jackwood	 and	 de	 Wit,	 2013).	 Although	 IBV	 (and	 other	 coronaviruses)	 has	 a	 3’-5’	exoribonuclease	 (ExoN)	 domain	 in	 nsp	 14	 that	 is	 involved	 in	 proofreading	 and	 repair	(Minskaia	et	al.,	2006),	the	average	rate	of	synonymous	mutations	is	approximately	1.2	X	10-3	
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substitutions/site/year,	that	is	still	high	(Hanada	et	al.,	2004,	Holmes,	2009).	Recombination	has	been	associated	with	the	expansion	of	viral	host	range	(Brown	et	al.,	1997;	Gibbs	and	Weiller.,	1999),	 increases	 in	virulence	 (Khatchikian	et	al.,	1989),	evasions	of	host	immunity	(Malim	et	al.,	2001)	and	evolution	of	resistance	to	antivirals	(Nora	et	al.,	2007).		The	process	of	recombination,	that	takes	place	in	RNA	viruses,	corresponds	to	the	formation	of	chimeric	molecules	 from	parental	genomes	of	mixed	origin.	 In	the	 family	Coronaviridae	it	has	been	well	documented	and	 is	 thought	 to	be	a	 contributing	 factor	 in	 the	emergence	and	evolution	of	different	IBV	genotypes	as	well	as	different	species	of	coronaviruses	(Thor	et	al.,	2011).	 In	 these	viruses,	 recombination	 is	 thought	 to	be	due	 to	a	unique	 template	 switching	“copy-choice”	mechanism	during	RNA	replication	(Lai	et	al.,	1992).	The	RdRp	switches	from	one	RNA	molecule	(the	donor	template)	to	another	(the	acceptor	template)	during	synthesis,	while	remaining	bound	to	the	nascent	nucleic	acid	chain,	thereby	generating	an	RNA	molecule	with	mixed	ancestry	 (Aaziz	 and	Tepfer,	 1999;	Breyer	et	al.,	 2001;	Von	Hippen	et	al.,	 1994),	(Fig.8).	It	is	common	opinion	that	the	emergence	of	new	strains	and	serotypes	of	IBV	is	largely	due	 to	 the	accumulation	of	mutations	 in	 the	S	gene	over	 time	rather	 than	 to	recombination	events	(Jackwood,	2012).	
	
	
	
	
	
	
	
	
 
Fig.8	Schematic	view	of	recombinant	virus	
generation	by	Copy-Choice	recombination	
mechanism	(Simon-Loriere	and	Holmes,	2011). 
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1.2	Epidemiology															1.2.1	IBV	world	distribution		Infectious	bronchitis	virus	is	worldwide	distributed	and	many	serotypes	and	genotypes	have	been	 detected	 in	 all	 continents,	 except	 Antarctica.	 While	 the	 vast	 majority	 of	 variants	remained	confined	in	time	and	space,	some	of	them	have	managed	to	invade	broader	regions	or	even	to	emerge	as	a	worldwide	threat	(de	Wit	et	al.,	2011a).	IBV	was	reported	for	the	first	time	in	USA	in	1931	(Schalk	and	Hawn,	1931)	and	the	first	IBV	variants	were	detected	in	the	early	 1950s	 (Jungherr	 et	 al.,	 1956).	 Since	 then,	 in	 USA	 numerous	 IBV	 strains	 have	 been	identified,	of	which	the	Massachusetts	or	‘Mass’	serotype	become	dominant	(Jackwood	et	al.,	2005).	Recently	it	has	been	reported	that	the	most	commonly	isolated	types	of	IBV	in	the	USA	are	Arkansas	and	Ark-like	strains.	Other	IBV	types	reported	in	the	USA	are	the	California-type	viruses,	nephropathogenic	strains	identified	in	Pennsylvania,	strains	GA07	and	GA08	detected	in	Georgia	and	South	Carolina,	SE17,	Connecticut	and	Delaware	strains	(Jackwood	et	al.,	2005;	Jackwood,	2012).		IBV	had	appeared	in	Latin	America	by	the	1950s	and	the	first	reported	isolate	in	Brazil	was	of	the	Mass	serotype	(Hipolito,	1957).	About	10	years	later,	the	Ark	type	emerged,	causing	huge	economic	 losses	 in	Brazilian	poultry	 industry	 (Branden	and	De	Silva,	1986).	Recently	 it	has	been	shown	that	a	Brazilian	cluster	of	viruses	subdivided	in	three	subclusters	(Brazil	01,	02,	and	 03)	 as	 the	Mass	 and	 793B	 genotype	 currently	 co-exist	 in	 that	 country	 (Villareal	 et	al.,	2010).	 Most	 recent	 works	 conducted	 in	 Perù,	 Colombia,	 Argentina,	 Chile	 and	 Uruguay	revealed	 the	 circulation	 of	 the	 Q1,	 South	 America	 I	 (SAI),	 and	 Mass	 genotype	 in	 those	countries	(Sesti	et	al.,	2014a,b;	Marandino	et	al.,	2015).	In	Colombia,	 in	addition,	three	other	variant	 strains	 have	 been	 reported	 (Sesti	 et	 al.,	 2016).	 	 The	 Ark	 type	 has	 been	 recently	identified	 in	Mexico	 (Jackwood,	 2012).	 In	 Cuba	 three	 isolates	 have	 been	 characterized,	 and	respectively	shown	to	be	similar	to	Mass	type,	Belgian	and	Californian	strains	(Acevedo	et	al.,	2012).	
In	 Europe,	 the	 Mass	 serotype	 was	 detected	 for	 the	 first	 time	 in	 the	 1940s	 (Cavanagh	 and	Davis,	 1993).	 Variant	 IBVs	 were	 first	 reported	 in	 early	 1970s	 (Dawson	 and	 Gough,	 1971).		These	 IBVs	 belonged	 to	 four	 novel	 serotypes:	 D207	 (also	 known	 as	 D274),	 D212	 (better	known	as	D1466),	D3896	and	D3128.	Vaccines	were	developed	using	some	of	these	variants,	of	which	 several	 are	 still	 in	 use	 today.	 The	 variant	D1648	was	 able	 to	 cause	major	 disease	outbreaks	 for	 a	 relatively	 short	 period	 of	 time	 in	 the	 1990s,	 mainly	 associated	 with	 renal	
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problems	in	flocks	in	Belgium	and	in	the	neighboring	countries.	The	variant	called	793B	(also	known	 as	 4/91	 or	 CR88)	 emerged	 in	 the	 1990s	 (Gough	 et	 al.,	 1992)	 and	 had	 the	 major	importance	 internationally.	 This	 variant	 caused	 major	 welfare	 and	 economic	 problems	 in	apparently	well	vaccinated	 flocks.	 IBV	793B	quickly	 spread	 to	many	parts	of	 the	world	and	necessitated	 the	 development	 of	 homologous	 live-attenuated	 IB	 vaccines	 to	 control	 it.	 This	genotype	continues	to	be	a	major	concern	in	poultry	of	all	ages	in	many	parts	of	the	world,	but	interestingly	has	not	been	reported	in	the	USA	(de	Wit	et	al.,	2011a).	In	Italy,	a	recent	study	showed	that	the	793B	strains	circulating	are	only	of	vaccine	origin	(Franzo	et	al.,	2014)	
	The	 genotype	 Italy-02	was	 detected	 in	Germany	 for	 the	 first	 time	 in	 2000,	 then	 in	 Italy	 in	2002,	 and	 then	 spread	 in	 many	 European	 countries	 (Jones	 et	 al.,	 2005).	 	 After	 2004,	 its	prevalence	declined	 in	all	countries	except	Spain	(Worthington	et	al.,	2008),	but	also	 in	 this	Country	has	 recently	been	 replaced	by	other	genotypes	as	 the	QX	and	793B	 (Moreno	et	al.,	2017).	IBV	624I	has	been	reported	for	the	first	time	in	Italy	in	1993	(Capua	et	al.,	1994,	Capua	et	al.,	1999),	but	a	retrospective	study	demonstrated	its	circulation	from	1965	(Taddei	et	al.,	2012).	This	genotype	had	largely	circulated	in	the	Country	until	2004;	then	it	seemed	to	have	disappeared	up	to	2010	when	again	viruses	belonging	to	624I	genotype	were	detected;	in	the	two	 following	 years	 the	 number	 of	 detections	 increased	 (Massi,	 2013).	 After	 2013,	 624I	genotype	has	not	been	reported	anymore	(Massi,	2015).		
Because	 of	 its	 pathogenicity,	 the	 most	 important	 IBV	 type	 which	 become	 widespread	 in	Europe	 in	 recent	years	 is	 the	QX	genotype	 (Beato	et	al.,	 2005),	 isolated	 for	 the	 first	 time	 in	China	in	1996	(Wang	et	al.,	1998).	The	Q1	genotype,	after	its	first	detection	in	China	in	1996	(Yu	et	al.,	2001),	was	detected	in	Europe	for	the	first	time	in	2011,	where	spread	in	most	of	the	EU	countries	(Toffan	et	al.,	2011).		
Early	isolations	from	Russia	and	neighboring	countries	were	closely	related	to	the	Mass	type,	whereas	isolation	from	the	late	1990s	up	to	2002	were	recognized	to	be	related	to	European	types	793B,	D274,	B1648,	624/I	and	Italy-02	(Bochkov	et	al.,	2006).	A	more	recent	extensive	epidemiological	study	performed	in	Russia,	Ukraine	and	Kazakhstan	revealed	the	prevalence	also	of	QX	and	Italy-02	genotypes,	Ark	variants	and	local	strains	(Ovchinnikova	et	al.,	2011)	
The	prevalence	of	 IBV	 strains	 in	 the	Middle	East	 varied	 from	Country	 to	Country.	 In	 Israel,	Mass	was	 the	only	genotype	detected	 for	many	years	until	793B	genotype	was	 identified	 in	1996	 (Meir	 et	 al.,	 1998).	 Few	 years	 later	 a	 new	 variant,	 Israel/Variant-2/98	 (Var2),	 was	
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reported	 (Callison	et	al.,	 2001)	 along	with	 another	 variant	named	 IS720;	 it	 spread	 in	 Israel	and	also	 in	other	countries	 like	 Iraq	and	Egypt,	where	also	793B	and	D274	genotypes	were	reported	(Jackwood	2012).	In	Iraq,	a	recent	study	revealed	the	presence	of	the	Israel/Variant-2/98,	793B,	QX	genotypes	and	 the	DY	12-2-like	strain,	 that	 is	a	Chinese	recombinant	strain	reported	for	the	first	time	in	Middle	East	(Seger	et	al.,	2016).	In	Iran,	Var2,	793B,	QX,	IS720,	Mass	and	IR-1	type	have	been	detected	(Najafi	et	al.,	2016).		
The	Var2	has	been	recently	detected	and	characterized	in	Poland,	revealing	that	this	genotype	that	 have	 circulated	 only	 in	 Middle	 East,	 for	 more	 than	 20	 years,	 spread	 in	 a	 European	Country	becoming	one	of	the	predominant	genotype	circulating	in	that	Country	(Lisowska	et	
al.,	2017).	
It	has	been	speculated	that	the	IBVs	have	long	been	in	existence	in	Asia.	In	China	IBV	was	first	reported	 in	 the	 mid	 1980s	 and	 showed	 great	 diversity,	 although	 several	 Mass	 and	 793B	isolates	were	reported	(Bande	et	al.,	2017).	Recently,	nine	different	genetic	groups	have	been	recognized	 in	 China:	 LX4,	 LDT3,	 LHLJ,	 BJ,	 LDL,	 N1/62	 and	 LSC,	 as	 well	 as	 Mass	 and	 793B	genotypes	 (Han	 et	al.,	 2011).	 Possibly	 the	most	 significant	 IBV	 variant	worldwide	 emerged	from	China,	 is	 the	QX	genotype,	 reported	 for	 the	 first	 time	by	YuDong	et	al.	 (1998)	 in	birds	affected	by	proventriculitis	and	kidney	lesions	and	later	classified	in	the	LX4	group	(Han	et	al.,	2011).	 Another	 IBV	 genotype,	 the	 Q1,	 also	 associated	 with	 proventriculitis,	 have	 emerged	from	China	(Yu	et	al.,	2001).	It	was	later	included	in	the	LDL	group	(Han	et	al.,	2011).		In	 the	 early	 1990s	 a	 nephropathogenic	 strain	 designated	KM91	was	 identified	 and	 became	widespread	 in	Korea	 (Lee	et	al.,	 2004).	Ten	years	 later,	 strains	similar	 to	 that	 circulating	 in	China	(including	the	QX	genotype)	were	identified	in	Korea	(Liu	et	al.,	2006).	Characterization	of	IBV	isolates	between	2003	and	2006	identified	three	genetic	groups,	designated	Korea	(K)-I,	K-II	(LX4-type),	and	K-III	(LDL-type)	(Lee	et	al.,	2008).	More	recently,	strains	that	appear	to	be	recombinants	of	KM91	and	QX	were	detected	(Lim	et	al.,	2011).		Since	1995	in	Japan,	four	different	genetic	groups	have	been	identified:	Japan	(JP)-I,	JP-II,	JP-III	 (LX4),	 and	 JP-IV	 (Ariyoshi	et	al.,	 2010;	Mase	et	al.,	 2004).	The	 JP-	 III	 group	 falls	 into	 the	China	LX4	group	 (QX	 IBV),	whereas	 JP-I,	 JP-	 II,	 and	 JP-IV	appear	 to	be	unique	variants.	The	793B	 type,	 as	 well	 as	 Mass	 and,	 interestingly,	 Gray	 genotypes	 have	 also	 been	 reported	(Ariyoshi	et	al.,	2010;	Mase	et	al.,	2010).			In	 Thailand,	 a	 recent	 molecular	 study	 based	 on	 phylogenetic	 analysis	 of	 the	 S1	 gene,	 has	
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identified	two	groups	of	IBV	variants:	Group	I	appeared	to	be	unique	to	that	Country,	whilst	Group	 II	 showed	 a	 close	 relationship	 to	 Chinese	 IBVs	 (Pohuang	 et	al.,	 2009).	 	 IBV	 variants	have	been	recognized	in	Taiwan	since	the	mid-1960s.	Local	strains	divided	into	two	distinct	lineages	 (TWI	 and	 TWII)	 have	 been	 identified,	 as	well	 as	Mass	 and	 IBVs	 related	 to	 the	 Q1	genotype	 (Wang	&	 Tsai,	 1996;	Wang	&	Huang,	 2000;	 Huang	 et	al.,	 2004).	 However,	 recent	data	have	suggested	that	the	currently	dominant	IBV	variant	in	Taiwan	may	have	arisen	as	a	result	of	recombination	in	the	5’	end	of	the	N	gene	between	Taiwanese,	Chinese	and	US	IBVs	(Kuo	et	al.,	2010)		In	 Africa	 IBV	 was	 reported	 for	 the	 first	 time	 in	 the	middle	 80s	 in	 South	 Africa	 (Morley	 &	Thomson	1984).	 In	 the	early	1980s	 the	unusual	enterotropic	variant,	known	as	 IB	 ‘‘G’’,	was	isolated	 in	 Morocco	 (El-Houadfi	 &	 Jones,	 1985;	 El-Houadfi	 et	 al.,	 1986).	 Interestingly,	 S1	sequence	 data	 have	 shown	 that	 IBV	 G	 and	 4/91	 are	 very	 closely	 related,	 possibly	 with	 a	common	origin	(Jones	et	al.,	2004).		Recent	studies	report	in	this	Country	the	presence	of	the	genotypes	Mass,	Italy	02	and	793B	and	the	emergence	of	a	new	Moroccan	genotype	(Fellahi	et	
al.,	2015	a,b)	
An	epidemiological	survey	conducted	in	Nigeria	and	Niger	between	2006	and	2007	identify	a	unique	African	cluster	of	viruses	for	which	no	clinical	signs	were	recorded.	These	local	strains	were	grouped	into	a	novel	IBV	genotype	designated	as	IBADAN,	referring	to	the	name	of	the	city	(in	Nigeria)	where	the	viruses	were	first	detected,	and	were	described	to	be	genetically	and	antigenically	 clearly	distinct	 from	all	other	known	 IBV	strains	 (Ducatez	et	al.,	 2009).	 In	Tunisia,	many	strains	have	been	 isolated	 forming	a	new	genotype,	being	genetically	distinct	from	the	other	genotypes	and	are	serologically	related	to	the	793B	and	D274	genotypes,	also	the	 Italy-02	 genotype	 has	 been	 reported	 (Borugaa	 et	 al.,	 2009;	 2012).	 In	 Libya	 strains	clustering	with	Egyptian	and	Israeli	genotypes	have	been	recently	characterized	(Awad	et	al.,	2014).	In	Algeria,	strains	genetically	related	to	the	Mass	genotype	have	been	detected	(Sid	et	
al.,	2015).	In	the	“Horn	of	Africa”,	in	Ethiopia	recently	IBV	793B	has	been	reported	(Hutton	et	
al.,	 2016).	 In	 Sudan,	 strains	 belonging	 to	 the	 793B	 and	Mass	 genotype	 have	 been	 reported	(Ballal	 et	al.,	 2005).	More	 recently	 an	 epidemiological	 survey	 revealed	 the	 presence	 in	 this	Country	of	strains	similar	to	Korean	and	Russian	strains	and	QX	genotype,	and	recombinant	strains	that	could	have	likewise	risen	from	H120,	4/91	and	an	Italian	QX	strain	(Naguib	et	al.,	2016).	
In	Australia	 IBV	has	 always	 evolved	 independently	 from	 the	 rest	 of	 the	world.	 IBV	 isolates	
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have	 been	 separated	 into	 subgroup	 1	 (classical	 strains),	 and	 subgroups	 2	 and	 3	 (novel	strains).	 Subgroup	1	 viruses	 include,	 among	 others,	 the	 nephropathogenic	Australia/N1/62	strain,	 the	 first	 isolate	 of	 IBV	 in	 Australia,	 and	 the	 vaccine	 strain	 Australia/VicS/62.	 The	subgroup	 2	 viruses	 were	 identified	 in	 1988	 and	 include	 Australia/	 subgroup	 2/N1/88,	Australia/subgroup	 2/Q3/88,	 and	 Australia/	 subgroup	 2/V18/91	 (Ignjatovic	 et	 al.,	 1997).	The	subgroup	3	strains	were	first	identified	around	2002	(Ignjatovic	et	al.,	2006)	and	appear	to	be	chimeras	resulting	from	recombination	between	subgroup	1	and	2	viruses	(Mardani	et	
al.,	2010).	Both	subgroup	2	and	3	viruses	are	respiratory	pathogens,	and	to	date,	none	have	been	found	to	be	nephropathogenic,	like	the	classical	strains	in	subgroup	1.		12.2	IBV	in	Italy	In	 Italy,	 a	 recent	 epidemiological	 study	 conducted	 mainly	 in	 the	 Emilia	 Romagna	region,	 but	 also	 in	 other	 Italian	 regions,	 revealed	 that,	 currently,	 the	 main	 genotype	circulating	 in	 the	 Country	 is	 the	QX	 (28,6%)	 followed	by	 the	 793B	 (28%),	M41	 (9,3%),	Q1	(7,8%)	and	D274	(1,4%),	(Massi	2017).	It	has	been	hypotized	that	the	793B	strains	circulating	are	of	vaccine	origin	(Franzo	et	al.,	2014),	so	it	is	reasonable	to	assert	that	the	vast	majority	of	the	 field	 strains	 circulating	 belonging	 to	 the	 QX	 genotype.	 Another	 genotype	 circulating	 in	Italy	is	the	recombinant	Guandong/Xindadi	(4,1%)	resulted	from	the	recombination	between	QX	and	793B	genotypes,	that	probably	co-infect	frequently	the	birds	(Moreno	et	al.,	2017).			
1.2.3	Natural	and	experimental	hosts	of	Avian	coronaviruses		
It	is	no	longer	accepted	that	the	chicken	is	the	only	host	for	IBV,	although	it	is	possible	that	 IBV	 only	 causes	 disease	 in	 the	 chicken.	 IBV	 has	 been	 detected	 in	 many	 species	 of	gallinaceous	and	non-gallinaceous	and	some	of	them	could	be	considered	a	reservoir	 for	IBV	(Liu	et	al.,	2005).	 IBV	strains	with	high	genetic	 identity	 in	S1	gene	with	Mass-type	vaccines,	has	 been	 recovered	 from	 peafowl	 (Pavo	cristatus)	 (Liu	 et	al.,	 2005).	 Ito	 and	 colleagues,	 in	1991	 (Ito	et	al.,	 1991)	 have	 isolated	 from	guinea	 fowls	 (Numida	meleagridis)	 a	 coronavirus	antigenically	 related	 to	 IBV.	 The	 affected	 birds	 had	 been	 suffering	 high	mortality,	 low	 feed	consumption	 and	 enteritis.	 Whether	 the	 guinea	 fowl	 virus	 was	 a	 ‘‘genuine’’	 guinea	 fowl	coronavirus	 (i.e.	a	 separate	species)	or	an	 IBV	 that	had	spread	 from	nearby	chickens	 to	 the	guinea	fowl	is	not	known	(Cavanagh,	2005).		
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In	China,	a	Gammacoronavirus	has	been	isolated	from	a	teal	(Anas	crecca)	kept	domestically	near	chickens.	The	isolate	had	a	spike	protein	with/90%	identity	with	some	known	field	IBV	strains,	including	a	nephropathogenic	one.	When	this	isolate	was	inoculated	into	chickens,	it	caused	 disease,	 including	 kidney	 involvement.	 This,	 plus	 the	 very	 high	 relationship	 found	between	the	genes	of	the	teal	isolate	and	of	IBV,	including	the	S	gene,	makes	probable	that	the	teal	isolate	was	actually	an	IBV	strain	that	had	spread	to	the	teal	from	nearby	chickens	(Liu	et	
al.,	2005).		During	 a	 recent	 epidemiological	 investigation	 in	 northern	 Italy,	 IBV	 strains	with	 very	 high	percentages	 of	 identity	with	 IBV	 vaccine	 strains,	 applied	 in	 the	 neighboring	 chicken	 flocks,	have	been	detected	in	quails	(Coturnix	Coturnix)	and	pheasants	(Phasianus	Colchicus)	(Torres	
et	al.,	2016)	Virus	similar	to	IBV	(IBV-like),	have	been	isolated	from	different	avian	species.	The	Turkey	coronavirus	 (TCoV)	is	associated	with	highly	contagious	gastroenteritis	 in	young	poults	 (Barnes	 et	al.,	 2000)	 and	was	 first	 identified	 in	 1951	 (Peterson	 and	Hymass,	 1951).	Experimental	inoculation	of	TCoV	into	chickens	resulted	in	replication	in	the	alimentary	tract,	although	 asymptomatically	 (Ismail	 et	al.,	 2003).	 The	 sequences	 of	 the	 genes	 of	 the	 Turkey	coronaviruses	 in	the	US,	and	those	subsequently	detected	 in	the	UK	(Cavanagh	et	al.,	2001),	had	85	to	90%	identity	with	those	of	 IBV,	which	is	high	given	that	strains	of	 IBV	commonly	differ	from	each	other	by	this	amount.	The	exception	was	in	the	spike	protein;	a	research	has	revealed	that	there	is	only	approximately	34%	identity	between	the	spike	protein	of	the	TCoV	isolates	and	those	of	IBVs,	a	lower	identity	than	the	lowest	yet	seen	between	IBV	strains.	The	emergence	 of	 coronaviruses	 in	 turkeys	 in	 the	 USA	 was	 proposed	 to	 have	 resulted	 from	recombination	events	involving	IBVs	and	an	as-yet-unidentified	coronavirus	donating	a	spike	(S)	gene	(Lin	et	al.,	2004).	This	is	suspected	to	have	resulted	from	a	host	shift	from	chickens	to	turkeys	 and	 the	 virus	 has	 altered	 the	 tissue	 tropism	 from	 upper	 respiratory	 to	 intestinal.	Recombination	has	been	proposed	in	preference	to	evolution	or	selection	of	a	subpopulation	of	 viruses	owing	 to	 this	 low	S	protein	amino	acid	 identity	 and	because	under	experimental	conditions	 exposure/passage	 of	 TCoVs	 in	 chickens	 did	 not	 result	 in	 selection	 for	 genetic	changes	that	were	sufficient	to	maintain	infection	and	replication	in	chickens	(Jackwood	et	al.,	2010).	A	recent	analysis	on	the	complete	genome	sequence	of	a	European	TCoV	demonstrated	that	European	turkey	and	guinea	fowl	coronaviruses	share	a	common	genetic	backbone	and	suggests	 that	 these	recombined	 in	 two	separate	events	with	different,	yet	related,	unknown	
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Avian	 coronaviruses,	 acquiring	 their	 S-3a	 genes.	 The	 study	 also	 showed	 that	 the	 North	American	viruses	do	not	 share	a	 common	backbone	with	European	 turkey	and	guinea	 fowl	viruses;	 however,	 they	 do	 share	 similar	 S-3a	 genes	 with	 guinea	 fowl	 virus	 (Brown	 et	 al.,	2016).	Pheasants	were	 infected	 by	 a	 coronavirus	 (PhCoV),	 sometimes	 associated	with	 respiratory	disease	and	sometimes	associated	with	kidney	disease	(Spackman	&	Cameron,	1983;	Lister	et	
al.,	1985;	Gough	et	al.,	1996;	Pennycott,	2000).	 Inoculation	of	chickens	with	several	PhCoVs	resulted	in	production	of	antibodies,	 indicative	of	replication,	but	without	disease	(Gough	et	
al.,	1996).	A	molecular	investigation	of	coronaviruses	isolated	from	pheasants	showed	a	high	genetic	 similarity	 of	 these	 strain	 with	 IBV	 (Cavanagh	 et	 al.,	 2002).	 The	 degree	 of	 genetic	relatedness	 to	 IBV	 is	 the	 same	 as	 that	 between	 IBV	 and	 TCoV	 except	with	 regard	 to	 the	 S	protein,	in	which	PhCoV	and	IBV	are	more	closely	related	to	each	other	than	to	TCoV.		Recently	 a	Gammacoronavirus	 has	 been	 isolated	 from	quails	 showing	 an	 enteric	 syndrome.	The	amino	acid	 (aa)	 sequence	 identity	 in	 the	S1	gene	with	 IBVs	was	of	16-18%,	 suggesting	that	Quail	coronavirus	(QCoV)	is	not	an	IBV	variant.	In	contrast,	the	S1	of	QCoV	displayed	79-81%	aa	identity	with	TCoV	strains	suggesting	that	the	QCoV	is	a	TCoV-like	virus	(Circella	et	
al.,	2007).	
Gammacoronaviruses,	 genetically	 different	 from	 IBV	 and	 other	 IBV-like	 viruses,	 have	 been	detected	 in	 fecal	samples	or	cloacal	swabs	of	graylag	geese	(Anser	anser),	pigeons	(Columba	
livia)	and	mallard	ducks	(Anas	platyrhynchos),	(Jonassen	et	al.,	2005).	The	 relatedness	 at	 the	 genetic	 level	 and	 the	 capacity	 of	 IBV,	 TCoV	 and	 PhCoV	 to	 infect	chickens,	raised	the	question	as	to	whether	these	three	viruses	should	be	considered	as	three	distinct	 species	 or	 as	 one	 species	 (Cavanagh,	 2005).	 For	 these	 reasons,	 to	 overcome	 a	classification	problem,	 the	new	nomenclature	 of	 the	 coronaviruses	 includes	 all	 the	 IBV-like	viruses	 and	 the	 Gammacoronaviruses	 isolated	 in	 avian	 species	 within	 IBV	 in	 the	 Avian	
Coronaviruses	species.	The	 presence	 of	 IBV	 and	 other	 Gammacoronaviruses	 in	 the	 same	 host	 could	 determine	recombination	between	them.	
1.2.4	Transmission	
IBV	is	highly	contagious	and	spreads	rapidly	among	chickens	in	a	flock.	Transmission	may	 occur	 by	 either	 inhalation,	 thought	 oculo-nasal	 route,	 or	 ingestion	 of	 infectious	 virus	
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particles	by	direct	contact	between	infected	and	susceptible	birds;	by	indirect	contact	trough	aerosol	droplets	of	 faeces;	and	by	exposure	to	virus-contaminated	fomites,	such	as	clothing,	shoes,	 tools	 etc.	 Aerosol	 generation	 from	 the	 respiratory	 tract	 is	 a	 significant	 mode	 of	transmission	 because	 of	 high	 virus	 concentration	 in	 the	 respiratory	 tract	 during	 the	 acute	stage	of	 the	 infection.	Most	 likely,	 transmission	by	 aerosol	 is	 especially	 effective	over	 short	distances,	 such	 as	 within	 a	 flock	 or	 premises,	 because	 the	 enveloped	 virion	 is	 inactivated	relatively	quickly	in	the	environment	(Jackwood	and	De	Wit	2013).	The	virus	is	also	excreted	by	 faeces	 and	 urine.	 A	 long-term	 recovery	 (2-7	 months)	 of	 IBV	 has	 been	 reported	 from	infected	 or	 vaccinated	 flocks	 (Naqi	 et	al.,	 2003).	 Vertical	 transmission	 does	 not	 seem	 to	 be	relevant	 for	 IBV,	 although	 Cook	 and	 colleagues	 could	 re-isolate	 the	 challenge	 virus	 after	infection	 in	 laying	SPF	hens	and	cockerels	 from	 the	vitelline	membrane	of	 the	eggs,	 for	1-7	weeks,	and	from	semen	of	cockerels	for	two	weeks;	virus	could	be	isolated	even	from	a	small	number	of	hatched	chicks.	However,	the	implication	for	the	field	of	this	 last	finding	remains	unclear,	because	 these	chicks	developed	no	clinical	signs,	did	not	seroconvert	and	were	not	protected	against	challenge	(Cook	et	al.,	1971).			
	
1.3	Pathogenesis	
The	 incubation	 period	 of	 IBV	 is	 dose	 dependent	 and	 can	 be	 as	 short	 as	 18	 hours	 for	intratracheal	 inoculation	 and	 up	 to	 36	 hours	 for	 ocular	 application	 (Jackwood	 and	 de	Wit,	2013).	 Generally,	 the	 disease	 has	 a	 short	 incubation	 period:	 susceptible	 birds	 placed	 with	recently	infected	chickens	usually	develop	clinical	signs	within	24-48	hours.	
IBV	initially	infects	the	upper	respiratory	tract	where	infection	is	restricted	to	the	ciliated	and	mucus	 secreting	 cells.	 This	 is	 the	 main	 site	 of	 IBV	 replication,	 following	 which	 a	 viraemia	occurs	 and	 the	 virus	 gets	 widely	 disseminated	 to	 other	 tissues	 (Mc	 Martin,	 1993).	 IBV	 is	epitheliotropic	 and	 is	 able	 to	 replicate	 in	 different	 tissues	 depending	 on	 the	 tropism	of	 the	strain.	In	the	trachea,	the	virus	causes	the	stasis	of	cilia,	both	in	vivo	and	in	vitro	and	damages	of	 the	 respiratory	 epithelium	 often	 predisposing	 chickens	 to	 secondary	 infections	 such	 as	
E.coli,	 which	 can	 be	 the	 main	 cause	 of	 most	 debilitating	 disease,	 including	 mortality	(Peighambari	et	al.,	2000;	Matthijs	et	al.,	2005).	Titers	of	 live	virus	are	maximal	 in	 the	nose	and	 trachea	within	 three	days	and	 they	 remain	so	 for	 two	 to	 five	days	 further	 (Ambali	 and	Jones,	 1990).	 After	 this	 period,	 virus	 titres	 in	 the	 respiratory	 tract	 drop	 rapidly	 and	 in	 the	
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second	week	p.i.	can	be	below	the	level	of	detection.	It	has	been	suggested	that	the	tracheal	damage	in	terms	of	ciliary	activity	is	variable	since	it	depends	on	the	virulence	of	IBV	strains	for	 the	 trachea	 (Otsuki	 et	 al.,	 1990;	 Dhinakar	 Raj	 and	 Jones,	 1997).	 Tissue	 recovery	 is	normally	seen	after	10	to	14	days	(Cook	et	al.,	2012).		
IBV	 is	 able	 to	 replicate	 also	 in	 the	 epithelial	 cells	 of	 the	 lungs	 (Janse,	 1994)	 and	 airsacs	(Nauwync	and	Pensaert,	1988).	High	virus	titer	has	been	seen	in	these	tissues	between	4	to	11	days	p.i.	Some	strains	of	IBV	are	intrinsically	nephropathogenic	i.e.	they	cause	nephritis	when	inoculated	 experimentally	 into	 specific	 pathogen	 free	 chickens,	 causing	mortality	 (Pensaert	and	Lambrechts,	1994;	Cook	et	al.,	1996).	IBV	infects	mainly	the	lower	nephron	down	to	the	collecting	 duct	 epithelial	 cells	 and	 replicate	 in	 all	 segments	 of	 tubules	 and	 ducts,	 but	more	frequently	 in	 the	epithelial	 cells	of	 the	 collecting	ducts,	 collecting	 tubules,	distal	 convoluted	tubules	and	Henle’s	loops	(Chen	and	Itakura,	1996;	Chen	et	al.,	1996).	Structural	alterations	in	the	 tubular	 epithelial	 cells	 (Condron	 and	 Marshall,	 1986)	 causes	 impaired	 fluid	 and	electrolyte	transport	leading	to	acute	renal	failure.	It	has	been	hypothesized	that	the	kidney	is	the	site	of	persistence	of	IBV	(Dhinakar	Raj	and	Jones,	1996),	and	is	an	immunoprivileged	site	where	virus	could	survive	away	from	the	immune	response	(Cook	et	al.,	2012).	Modest	to	high	titer	of	IBV	in	the	kidney	do	not	necessarily	correlate	with	overt	kidney	disease.	For	example,	in	 an	 experimental	 study,	 the	Moroccan	 G	 strain	 replicated	 to	 similar	 titer	 in	 kidney	 as	 in	trachea,	though	no	gross	kidney	changes	were	observed	(Ambali	and	Jones,	1990).		
Some	IBV	strains	are	able	to	replicate	and	cause	lesions	in	the	reproductive	tract.	It	has	been	demonstrated	 that	 the	 ciliated	 and	 granular	 cells	 of	 the	 surface	 epithelia	 and	 secretory	epithelial	cells	of	the	tubular	glands	of	the	infundibulum	and	magnum	are	the	target	cells	for	the	 virus	 (Chousalkar	 et	al.,	 2007).	 Furthermore,	 there	 are	 IBV	 strains	 able	 to	 cause	 cystic	lesions	 of	 the	 oviduct	 when	 layers	 hens	 are	 infected	 in	 the	 first	 days	 of	 life	 (Crinion	 and	Hofstad,	 1972;	Landman	et	al.,	 2005;	Benyeda	et	al.,	 2009).	These	viruses	 cause	permanent	damage	of	 the	oviduct	 that	 could	be	evident	only	 several	weeks	after	 infection,	when	birds	come	into	lay	leading	to	reduced	egg	production	and	quality,	and	increasing	the	incidence	of	“false	layers”	in	the	flock	(De	Wit,	2006).	Within	a	few	weeks,	the	susceptibility	of	the	young	chicks	 to	 develop	 damage	 of	 the	 oviduct	 that	 leads	 to	 the	 false	 layers	 syndrome	 has	 been	shown	to	drop	dramatically	(de	Wit	et	al.,	2011b).	The	pathogenesis	of	this	syndrome	has	not	been	 elucidated.	 In	 hens,	 experimentally	 infected	 with	 the	 QX	 genotype,	 the	 absence	 of	obvious	 histological	 changes	 and	measurable	 replication	 of	 IBV	 in	 the	 oviduct	 point	 to	 the	
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presumption	that	 the	dilatated	 lumen	and	the	accumulation	of	serous	 fluid	 in	 the	oviduct	 is	not	 the	 direct	 effect	 of	 the	 virus.	 It	 is	 likely	 that	 infection	during	 the	 first	week	 of	 life	may	affect	 the	 last	 step	 of	 the	 post-embryo	 development	 of	 the	 oviduct,	 which	 enables	 the	Mullerian	duct	 (developing	 oviduct)	 to	 open	 into	 the	 lumen	of	 the	 cloaca.	 An	 inflammation	and	the	subsequent	stricture	of	the	wall	of	the	cloaca	or	of	the	entry	of	the	oviduct	might	let	to	the	 obstruction	 of	 the	 posterior	 part	 of	 the	 oviduct	 resulting	 in	 fluid	 accumulation	 and	dilatation.	 This	 hypothesis	 explains	 the	 occurrence	 of	 false	 layer	 syndrome	 only	 following	early	IBV	infection	(Benyeda	et	al.,	2010).		It	has	been	suggested	that	IBV	is	implicated	in	the	formation	of	epydidimal	stones,	in	rooster	epidydimis,	that	has	detrimental	effects	on	sperm	production	and	fertility	(Boltz	et	al.,	2004).	
IBV	have	been	 isolated	 from	cloacal	swabs,	 faeces	and	caecal	 tonsils	 (Alexander	and	Gough,	1977;	Alexander	et	al,	1978;	Cook,	1984;	Lucio	and	Fabricant,	1990).	In	vitro	explants	of	gut	tissues	 have	 been	 shown	 to	 support	 the	 growth	 of	 IBV	 (Bhattacharjee	 and	 Jones,	 1997;	Darbyshire	 et	al.,	1976).	 IBV	 has	 been	 isolated	 also	 from	 oesophagus	 (Lucio	 and	 Fabricant,	1990;	 Dhinakar	 Raj	 and	 Jones,	 1996).	 However,	 because	 of	 the	method	 used	 for	 the	 virus	detection,	 it	 is	not	clear	whether	the	virus	actually	multiplies	 in	the	oesophagus	or	whether	virus	 is	 swallowed	 after	 being	 expelled	 from	 the	 trachea.	 IBV	 has	 also	 been	 isolated	 from	proventriculus,	duodenum	and	jejunum	(Ambali	and	Jones,	1990;	Lucio	and	Fabricant,	1990).	Darbyshire	 and	 colleagues	have	 shown	 that	proventriculus	was	 inferior	 only	 to	 respiratory	tissues	and	oviduct	in	supporting	virus	multiplication	in	vitro	(Darbyshire	et	al.,	1976).		
IBV	replication	has	been	described	 in	cells	 resembling	histiocytes	and	 lymphoid	cells	of	 the	caecal	tonsils	(Owen	et	al.,	1991)	and	demonstrated	by	IF	in	apical	epithelial	cells	of	the	villi	in	ileum	and	rectum	(Ambali	and	Jones,	1990;	Dhinakar	Raj	and	Jones,	1996).	Despite	IBV	has	a	wide	 tropism	 for	 gut	 tissues,	 gross	 and	 histological	 changes	 have	 been	 described	 only	 in	proventriculus,	 following	Q1	and	QX	genotypes	 infection	 (Wang	et	al.,	 1998;	Yu	et	al.	 2001,	Toffan	et	al.,	2013).		
Gross	 pectoral	 muscle	 lesions	 have	 been	 observed	 in	 chickens	 infected	 with	 the	 793B	genotype.	 The	 genesis	 of	 these	 lesions	 has	 not	 been	 elucidated,	 it	 has	 been	 tempted	 to	speculate	that	it	could	have	been	a	result	of	immune	complex	deposition	in	the	capillary	walls	of	the	muscles	(Gough	et	al.,	1992;	Dhinakar	Raj	and	Jones	1996).		
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There	 is	 evidence	 of	 replication	 of	 the	 virus	 also	 in	 lymphoid	 tissues	 including	 harderian	glands	and	bursa	of	Fabricius,	it	might	be	reasonable	to	suppose	that	infection	could	result	in	immunosuppression	(Dhinakar	Raj	and	Jones,	1996).		
	
1.5	Clinical	signs	
The	clinical	outcome	of	an	infection	in	chickens,	and	occurrence	of	mortality	depend	on	many	variables	 such	 as	 the	 virus	 strain,	 sex,	 age	 and	 immune	 status	 (vaccination,	 immune	suppression,	 and	 maternally	 derived	 antibodies)	 of	 chickens,	 co-infections,	 environmental	factors	such	as	climate,	dust,	ammonia,	and	cold	stress	(Jackwood	and	de	Wit,	2013).		Usually	all	birds	 in	the	flock	became	infected.	Mortality	may	be	as	high	as	25%	or	more	 in	chickens	less	 than	 6	weeks	 of	 age	 and	 usually	 is	 negligible	 in	 chickens	 greater	 than	 6	weeks	 of	 age	(Cavanagh	and	Naqi,	2008).		
IB	 respiratory	 signs	 in	 chicks	 are:	 gasping,	 coughing,	 sneezing,	 tracheal	 rales,	 and	 nasal	discharge;	wet	eyes	and	swollen	sinuses	may	be	observed	(Fig.9).	
	
	
	
	
	
	
	
The	 chicks	 appear	 depressed	 and	 may	 be	 seen	 huddled	 under	 a	 heat	 source.	 Feed	consumption	and	weight	gain	are	significantly	reduced.	 In	chickens	greater	than	6	weeks	of	age	and	 in	adult	birds,	 the	signs	are	similar	 to	 those	 in	chicks,	but	nasal	discharge	does	not	occur	as	frequently,	and	the	disease	may	go	unnoticed	unless	the	flock	is	examined	carefully	by	handling	the	birds	or	listening	to	them	at	night	when	the	birds	are	normally	quiet	(Hofstad,	
Fig.	9	IBV	Infected	chick	showing	gasping	and	respiratory	
distress	(https://partnersah.vet.cornell.edu/avian-atlas/#/)	
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1984).	 Broiler	 chickens	 infected	 with	 a	 nephropathic	 strain	 may	 appear	 to	 recover	 from	respiratory	 phase	 and	 then	 show	 depression,	 ruffled	 feathers,	wet	 dropping	 and	 increased	water	intake	(Jackwood	and	de	Wit,	2013).		
In	laying	flocks,	decline	in	egg	production	and	quality	are	seen	in	addition	to	respiratory	signs.	The	severity	of	the	production	declines	might	vary	with	the	period	of	lay	(Eck,	1983)	and	with	the	causative	virus	strain.	Six	to	eight	weeks	may	elapse	before	production	returns	to	the	pre-infection	 level,	but	 in	most	 cases,	 this	 is	never	attained.	 Soft-shelled,	misshapen	and	 rough-shelled	eggs	are	produced	(Fig.10)	and	the	 internal	quality	of	 the	eggs	may	be	 inferior.	The	albumen	may	be	 thin	 and	watery	without	 definite	 demarcation	between	 the	 thick	 and	 thin	albumen	 of	 the	 normal	 fresh	 egg	 (Cavanagh	 and	 Naqi,	 2008).	 In	 addition	 to	 production	declines,	 for	 the	 breeders,	 the	 number	 of	 eggs	 unacceptable	 for	 setting	 is	 increased	 and	hatchability	is	reduced	(Crinion	and	Hofstad,	1972).		
	
	
	
	
 
 
 
	Flocks	with	false	 layers	fail	 to	reach	the	normal	rate	of	 lay,	whereas	the	flock	 looks	healthy,	and	behaves	normally.	The	peak	of	production	can	be	as	low	as	35%	of	expected	production	values	(Cavanagh,	2000).		The	large	cysts	can	distend	the	hen’s	abdomen	and	the	hens	stands	like	penguins	(de	Wit,	2006)	(Fig.	11).	
 
	
Fig.10	Soft	shelled	and	misshaped	eggs	from	IB	affected	hens;	(“Atlante	di	anatomia	patologica	della	gallina	ovaiola”,	Elanco)	
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1.4	Macroscopic	and	microscopic	lesions	
The	 post	 mortem	 examination	 of	 the	 respiratory	 tract	 in	 affected	 chickens	 shows,	macroscopically,	 serous,	 catarrhal,	 or	 caseous	 exudate	 in	 the	 trachea,	 nasal	 passages	 and	sinuses.	The	mucosa	of	the	trachea	is	edematous	and	congested	(Fig.12).	A	caseous	plug	may	be	 found	 in	 the	 lower	 trachea	or	bronchi	of	 chicks	 that	are	 found	died	 (Cavanagh	and	Naqi	2008,	Benyeda	et	al.,	2010).	
	
	
	
	
	
	
Within	18	hours	of	infection,	histological	exam	shows	loss	of	cilia,	rounding	and	sloughing	of	epithelial	 cells,	 and	minor	 infiltration	 of	 heterophils	 and	 lymphocytes.	 Regeneration	 of	 the	epithelium	 starts	 within	 48	 hours.	 Hyperplasia	 is	 followed	 by	 massive	 infiltration	 of	 the	
lamina	propria	 by	 lymphoid	 cells	 and	 the	 formation	of	 a	 large	number	 of	 germinal	 centers,	which	may	be	present	after	seven	days.		
Fig.	 12	 Post	 mortem	 examination	 of	 IBV	
infected	 chicken	 showing	 oedema	 and	
congestion	 of	 the	 proximal	 trachea		
(https://partnersah.vet.cornell.edu/avian-
atlas/#/)	
Fig.	11	Hen	affected	by	false	layer	sindrome,	standing	like	penguin	
(“Atlante	di	anatomia	patologica	della	gallina	ovaiola”,	Elanco)	
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Air	 sacs	 may	 appear	 macroscopically	 cloudy	 or	 contain	 a	 yellow	 caseous	 exudate.	Microscopically	there	is	oedema,	epithelial	cells	desquamation,	and	some	fibrinous	exudation	within	24	hours,	 lymphoid	nodules,	 increased	heterophils,	 fibroblast	proliferation,	and	 later	regeneration	 by	 cuboidal	 epithelial	 cells	 (Riddell,	 1987).	 Small	 areas	 of	 pneumonia	may	 be	observed	around	the	large	bronchi	(Jackwood	and	de	Wit	2013).		
In	the	Harderian	gland	the	presence	of	IBV	can	be	characterized	microscopically	by	a	sharpe	increase	in	the	number	of	plasma	cells,	hyperemia,	and	exstensive	lymphoid	follicle	formation	(Toro	et	al.,	1996).	
Nephropatic	 infections	 produce	macroscopically	 swollen	 and	pale	 kidneys	with	 the	 tubules	and	ureters	often	distended	with	urates	(Fig.13)	(Cumming	et	al.,	1969;	Gillette	et	al.,	1973).		
	
	
	
	
	
	
	
	
	
The	 microscopic	 kidney	 lesions	 of	 IB	 are	 principally	 those	 of	 an	 interstitial	 nephritis.	 The	virus	causes	granular	degeneration,	vacuolation	and	desquamation	of	the	tubular	epithelium,	and	massive	infiltration	of	heterophils	in	the	interstitium	in	acute	stage	of	the	disease.		
The	lesions	in	tubules	are	most	prominent	in	the	medulla.	Focal	area	of	necrosis	may	be	seen	as	well	as	indications	of	attempted	regeneration	of	the	tubular	epithelium.		
Fig.13	 IBV	 infected	 chicken,	 pale	 kidneys	
distended	 with	 urates	 (Avian	 Pathology	
Service-University	of	Bologna,	Photo	Archive)	
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During	recovery,	the	inflammatory	cell	population	changes	to	lymphocytes	and	plasma	cells.	In	some	cases,	degenerative	changes	may	persist	and	result	in	severe	atrophy	of	one	or	all	of	the	divisions	of	 the	nephrons.	 In	urolithiasis,	 the	ureters	associated	with	atrophied	kidneys	are	distended	with	urates	and	often	contain	large	calculi	composed	mainly	of	urates	(Riddell,	1987).		
When	the	reproductive	system	is	affected,	large	accumulation	of	yolk	fluid	may	be	seen	in	the	abdominal	cavity,	often	associated	with	bacterial	infection	in	laying	hens.	The	infection	of	the	reproductive	 tract	of	hens	determines	microscopically	patchy	 loss	of	 cilia	 from	 the	anterior	segment	 as	well	 as	 the	 posterior	 segment	 of	 the	 infundibulum,	 that	 could	 be	 seen	 even	 30	days	 after	 infection,	 and	 plasma	 cells	 and	 lymphocytes	 infiltration	 in	 the	 lamina	 propria.	Lymphoid	 nodules	 have	 been	 recorded	 in	 the	 lamina	propria	 and	muscularis	 region	 of	 the	infundibulum	(Chousalkar	and	Roberts,	2007).	
In	 the	 magnum	 IBV	 causes	 microscopically	 loss	 of	 cilia	 and	 patchy	 loss	 of	mucopolysaccharides	 of	 the	 epithelial	 cells,	 loss	 of	 cilia	 and	 lymphocyte	 and	 plasma	 cell	infiltration	in	both	the	tubular	shell	gland	and	shell	gland	pouch,	and	a	persistent	lymphocytic	and	plasma	cell	 infiltration	in	the	subepithelial	space.	The	lymphocytes	surround	also	blood	vessels	in	the	muscularis	area	(Chousalkar	et	al.,	2007)	
Few	strains	of	IBV	such	as	those	of	QX	genotype,	when	infects	hens	in	the	first	days	of	age,	are	able	to	cause	the	false	layer	syndrome	macroscopically	characterized	by	permanent	damage	of	 the	 oviduct,	 causing	 dilatation	 of	 the	 oviduct	 with	 serum-like	 fluid	 accumulation,	accompanied	 by	 very	 few	 microscopic	 changes.	 In	 the	 dilated	 oviducts,	 flattening	 of	 the	developing	 folds	 and	 thinning	 of	 the	 walls	 could	 be	 seen,	 with	 focal	 mononuclear	 cell	infiltration	beneath	the	epithelial	layer	or	the	serosal	lining	(Fig.14).		
 
 
 
Fig.14	 Post	 mortem	 examination	 of	 hens	 affected	 by	
false	 layer	 syndrome	 showing	 oviduct	 serum-like	 fluid	
accumulation	 in	 the	 oviduct	 (Avian	 Pathology	 Service-
University	of	Bologna,	Photo	Archive) 
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In	 the	 bursa	 of	 Fabricius	 it	 has	 been	 described	macroscopically	 the	 presence	 of	 yellowish	brown	material	 filling	 the	 serrated	 lumen	 of	 the	 bursa	 and	microscopically	 the	 necrosis	 of	lymphocytes	 in	 the	 follicles	 with	 the	 presence	 of	 numerous	 heterophils	 in	 the	 bursal	secretion.	 The	 surface	 epithelium	 of	 the	 plicae	 lining	 the	 lumen	 of	 the	 bursa	 shows	 mild	hyperplasia	 and	 forms	 a	 series	 of	 cystic	 cavities.	 The	 follicles	 could	 be	 repopulated	 with	lymphocytes	but	 the	 lymphocytolysis	and	cystic	hyperplasia	of	 the	epithelium	could	persist	21	 days	 p.i.	 It	 has	 been	 observed	 also	 proliferation	 of	 fibrous	 tissue	 between	 the	 follicles	accompanied	atrophy	of	these	structures	and	resulted	in	shrinkage	of	the	bursa	(Mac	Donald	and	Mc	Martin,	1976).	
It	has	been	observed	that	the	myopathy	affecting	both	deep	and	superficial	pectoral	muscles	associated	to	IBV	(Gough	et	al.,	1992)	is	characterized	by	marked	swelling	and	pallor	of	deep	pectoral	muscles	together	with	the	presence	of	occasional	fascial	hemorrhages	and	a	layer	of	gelatinous	oedema	over	its	surface.	
Lesions	 of	 the	 proventriculus	 are	 characterized	 by	 thickening	 of	 the	 wall,	 proventricular	congestion	at	the	point	of	emergence	of	the	glandular	ducts	(papilla),	(Fig.15).		
 
 
 
 		
		Histologically,	the	proventriculus	is	affected	by	mild	to	severe	proventriculitis,	characterized	by	multifocal	erosion	and	necrosis	of	the	tunica	mucosa	and	glandular	epithelium,	associated	with	 infiltration	 of	 lymphocytes,	 plasma	 cells	 and	 heterophils,	 as	well	 as	 fibroplasia	 in	 the	lamina	propria	(Toffan	et	al.,	2013).		Except	 for	 the	 proventriculus,	 although	 IBV	 has	 a	wide	 tropism	 for	 gut	 tissues	 no	 gross	 or	
Fig.	 15	 Post	 mortem	 examination	 of	 Q1	 IBV	 infected	 chicken,	
showing	 thickening	 of	 proventricular	 wall	 with	 prominence	 of	
papilla	(Toffan	et	al.,	2013)	
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histological	changes	have	been	reported.			
1.6	Immunity	
The	 immune	 system	 works	 through	 a	 complex	 interplay	 of	 several	 cell	 types	 and	proteins	that	protect	the	host	from	invading	pathogens.	The	first	line	of	defence	for	IBV	is	the	mucous	membranes	of	 the	respiratory	tract,	and	of	 the	gut.	The	tracheal	mucosa	 is	 lined	by	ciliated	epithelium	that	contains	mucus	producing	goblet	cells.		
The	innate	immune	system	represents	the	second	line	of	defence	consisting	of	proteins	and	different	cell	types.	
Finally,	 T	 and	 B	 cells,	 cells	 of	 the	 adaptive	 immune	 system	 are	 activated	 by	 antigen	presenting	 cells	 (APC)	 to	 exert	 their	 effector	 functions.	 Chickens	 have	 a	 well-developed	mucosal	 immune	system,	with	several	organised	mucosa-associated	 lymphoid	 tissues	 in	 the	respiratory	tract,	eye/head	region	(that	are	very	important	in	the	response	to	IBV	infection)	and	intestinal	tract.	In	the	respiratory	tract,	lymphoid	tissues	are	located	in	Harderian	Gland	(HG),	conjunctiva	(conjunctiva	associated	lymphoid	tissue;	CALT),	and	nose	(nasal-associated	lymphoid	tissue;	NALT).	Lymphoid	follicles	and	scattered	lymphoid	cells	found	in	the	lamina	
propria	 consist	 of	 APC,	 CD4+	 and	 CD8+	 lymphoid	 cells.	 In	 the	 lung,	 there	 is	 the	 bronchus	associated	lymphoid	tissue	(BALT)	(Vervelde	and	de	Wit,	2014).			
1.6.1	Innate	immunity	The	 innate	 and	 the	 adaptive	 immune	 responses	 to	 IBV	 are	 highly	 integrated.	 The	 innate	immune	system	is	involved	in	directing	the	adaptive	response	and	can	also	act	as	expresser	of	the	 adaptive	 immunity	 (Juul-Madsen	 et	 al.,	 2011).	 IBV	 induces	 a	 diversity	 of	 local	 innate	effectors.	The	type	I	Interferon	(IFN),	produced	in	the	early	phase	of	infection,	has	an	antiviral	activity	against	IBV	(Wang	et	al.,	2006;	Pei	et	al.,	2001)	and	could	induce	an	up-regulation	of	the	expression	of	 the	Toll	 like	 receptors	 (TLR)	2	and	3.	 It	has	been	demonstrated	 that	 also	Interleukin-1,	 macrophage	 colony-stimulating	 factor	 I	 receptor	 precursor	 (CSF-1-R),	chemokine	 ah294,	 and	 common	 cytokine	 receptor	 chain,	 all	 significantly	 increased	 their	transcription	 during	 the	 early	 phase	 of	 infection	 (Wang	 et	 al.,	 2006).	 IBV	 induces	 the	activation	of	Natural	killer	cells	(NK)	producing	IFN-g,	able	to	kill	the	virus-infected	cells	at	1	
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day	p.i.	in	the	lung	and	in	the	blood	(Vervelde	et	al.,	2013).	Mannose-binding	lectin	(MBL),	an	innate	 pathogen	 pattern-recognition	molecule,	 is	 involved	 in	 the	 regulation	 of	 the	 adaptive	immune	response	to	IBV	(Juul-Madsen	et	al.,	2011).	1.6.2	Active	Immunity	1.6.2.1	Cell-mediated	immunity	
The	Cytotoxic	T	Lymphocytes	(CTL)	response	of	chicks	to	IBV	infection	plays	a	critical	role	in	the	 elimination	 of	 virus	 during	 acute	 infection	 (Collison	 et	 al.,	 2000).	 It	 has	 also	 been	demonstrated	 that	 adoptive	 transfer	 of	 CTLs	with	 alpha/beta	 T	 cell	 receptor	 (TCR2)	 could	protect	 chicks	 from	 acute	 infection	 of	 IBV	 in	 the	 respiratory	 tract	 (Seo	 et	 al.,	 2000).	 IBV	specific	 CTL	 epitopes	 were	 mapped	 within	 the	 carboxy-terminal	 120	 amino	 acids	 of	 the	nucleic	 capsid	 protein	 (Timms	 and	 Bracewell,	 1983).	 Furthermore,	 during	 a	 primary	 IBV-specific	immune	response,	induced	by	ocular	inoculation	of	attenuated	IBV,	only	the	HG	and	the	 CALT	 exhibit	 a	 response	 with	 a	 noticeable	 change	 in	 CD3+	 and	 CD44+	 T	 cells,	 IFN-g,	granzyme	A	and	perforin	mRNA	expression	while	 little	change	is	noticed	in	the	spleen.	This	observation	is	consistent	with	the	observation	that	HG	is	the	initial	site	of	replication	for	IBV	after	ocular	inoculation	(Gujar	et	al.,	2013).		
1.6.2.2	Humoral	immunity	
	 The	protective	effect	of	antibodies	is	not	only	achieved	by	neutralising	the	free	virus.	Virus	 specific	 antibodies	 lead	 to	 a	 plethora	 of	 antiviral	 activities.	 Coating	 of	 virus	 with	antibodies	 can	 result	 in	 virolysis	 by	 complement	 activation	 and	 enhance	 phagocytosis	(Vervelde	and	de	Wit,	2014).		
Usually	 the	 first	 antibodies	 can	 be	 detected	 in	 serum	 and	 lacrimal	 fluid	 between	 1	 and	 2	weeks	p.i.:	 IgA,	 IgG,	 and	 IgM	 can	be	detected	 in	 serum;	while	 in	 lacrimal	 fluid	 and	 tracheal	washing,	IgA	and	IgG	are	the	commonly	detected	antibody	classes	(reviewed	in	Jackwood	and	de	Wit,	2013).	An	important	part	of	the	IgA	in	the	lacrimal	fluid	originated	from	the	HG	(Baba	
et	al.,	1988;	Develaar	et	al.,	1982),	while	the	IgG	concentration	is	largely	the	result	of	passive	transport	of	IgG	from	the	serum	(Develaar	et	al.,	1982;	Toro	et	al.,	1993).	IgM	is	only	present	for	a	few	weeks	after	vaccination	or	infection;	therefore,	its	detection	is	indicative	of	a	recent	vaccination	 or	 infection.	 Serotype	 specific	 virus	 neutralizing	 antibodies	 are	 induced	 by	 the	amino-terminal	S1	subunit	of	the	S	glycoprotein	(Cavanagh	et	al.,	1992).	The	protective	role	of	
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antibodies	 has	 been	 shown	 by	 the	 significantly	 longer	 period	 of	 virus	 persistence	 p.i.	 in	chickens	 that	 were	 immunocompromised	 by	 Infectious	 Bursal	 Disease	 virus	 infection	(Rosemberg	and	Gelb,	1978).	A	similar	effect	was	reported	after	in-ovo	bursectomy	in	white	leghorn	chickens	(Cook	et	al.,	1991).	The	IBV	ELISA	and	Virus	Neutralization	(VN)	antibodies	levels	 in	 tears	are	not	accurate	 indicators	of	 IBV	 immunity	 (Gelb	et	al.,	 1998),	moreover	no	correlation	 was	 found	 between	 the	 serum	 ELISA	 antibody	 titres	 and	 the	 degree	 of	 kidney	protection	 against	 a	 nephropathogenic	 strain	 (Pensaert	 and	 Lambrechts,	 1994).	 In	 another	study,	 no	 antibodies	 were	 detectable	 after	 vaccination	 in	 post-hatch	 cyclophosphamide	bursectomized	chickens	that	still	resisted	to	challenge	(Chubb,	1974).	In	laying	birds,	a	clear	correlation	was	found	between	the	level	of	antibodies	against	the	challenge	virus	and	the	level	of	protection	against	egg	drop	(Finney	et	al.,	1990).	
1.6.3	Maternally	derived	immunity	
High	levels	of	maternally	derived	antibodies	(MDA)	significantly	reduced	the	extent	of	clinical	signs	or	damage	to	trachea,	kidneys	and	oviduct	due	to	IBV	infection	in	chicks	during	the	first	days	of	life	(reviewed	in	Jackwood	and	de	Wit,	2013).	An	experimental	study	conducted	by	de	Wit	 and	 colleagues	 in	 2009	 showed	 that	 a	 higher	 level	 of	 neutralizing	 antibodies	 in	 the	breeders,	 for	 the	 strain	 used	 in	 that	 study,	 is	 correlated	 with	 a	 higher	 level	 of	 protection	against	early	challenge	in	the	progeny,	giving	to	unvaccinated	and	challenged	birds	ciliostasis	protection	 ranging	 between	 50%	 to	 100%,	 at	 6	 days	 of	 age	 (de	Wit	 et	al.,	 2009).	 A	 recent	study	on	 the	protection	of	birds	against	a	QX	strain	 (D388)	suggests	 that	virus	neutralizing	MDA	 are	 important	 for	 the	 early	 protection	 of	 birds	 against	 the	 false	 layers	 syndrome,	especially	associated	with	the	use	of	a	heterologous	vaccine	at	one	day	of	age	(De	Wit	et	al.,	2011b).		
1.7	Diagnosis	
Diagnosis	of	 IB	 is	based	on	 clinical	 signs,	 lesions,	detection	of	 IBV	RNA,	 virus	 isolation,	 IBV	antigen	detection	and	seroconversion	(Gelb	and	Jackwood,	2008).	
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1.7.1	Factors	influencing	IBV	detection	and	isolation	
One	of	the	most	important	factor	for	a	successful	detection	of	IBV	is	the	time	of	sampling.	All	the	IBV	strains	can	be	isolated	from	the	respiratory	tract	during	the	first	3	to	5	days	p.i.,	after	this	 period	 the	 virus	 titre	 drop	 rapidly	 (de	Wit,	 2000).	When	 chickens	 are	 sampled	 in	 the	chronic	 stage	 of	 an	 IBV	 infection,	 the	 value	 of	 sampling	 intestinal	 tract	 and	 associated	lymphoid	 tissues	 (e.g.	 cecal	 tonsils)	 is	 higher	 than	 sampling	 tracheas	 (reviewed	 in	 de	Wit,	2000).	The	level	of	immunity	of	the	chicken	at	the	moment	of	infection	has	a	major	influence	on	the	amount	of	IBV	that	can	be	detected.	When	collecting	samples	from	a	large	flock,	both	healthy	birds	and	those	with	clinical	signs	should	be	sampled.	Typically,	clinical	signs	begin	3-5	days	post	infection,	when	the	virus	is	no	longer	at	the	peak	titre	in	the	trachea.	In	mild	cases	of	the	disease,	clinical	signs	may	go	unnoticed	until	secondary	pathogens	become	involved,	at	which	time	IBV	is	no	longer	present	(Jackwood	and	de	Wit,	2013).		
Samples	 for	 IBV	 isolation	 must	 be	 chilled	 at	 0°	 to	 4°	 as	 soon	 as	 possible	 to	 preserve	 the	viability	 of	 the	 virus.	 If	 virus	 isolation	 is	 to	 be	 attempted	 within	 1	 day,	 no	 other	 storage	precaution	 is	necessary.	For	 longer	storage,	 the	samples	should	be	frozen	at	below	-20°C	as	soon	as	possible.	 Swabs	 should	be	placed	 in	 cold	 sterile	media	with	antibiotics	 to	 suppress	bacterial	and	fungal	growth	(Gelb,	1989;	de	Wit,	2000).	In	case	of	identification	by	molecular	techniques,	 swabs	 from	 respiratory	 tract	 or	 cloaca	 may	 also	 be	 submitted	 without	 being	placed	in	liquid	transport	media	(Cavanagh	et	al.,	1999).			
1.7.2	Virus	Isolation	and	serotyping		
Virus	 isolation	 (VI)	 can	 be	 laborious,	 time	 consuming	 and	 costly.	 The	 isolation	 has	 to	 be	confirmed	using	a	second	technique,	such	as	retro-trascription	polimerase	chian	reaction	(RT-PCR),	immunofluorescence	assay	(IFA)	or	antigen	ELISA,	for	genome	or	antigen	detection.	IBV	can	 be	 isolated	 using	 different	 biological	 systems:	 embryonated	 chicken	 specific	 pathogen	free	 (SPF)	eggs,	 chicken	embryo	 tracheal	organ	cultures	 (TOC)	and	cell	 cultures	 (McMartin,	1993).		IBV	 grows	 well	 in	 embryonated	 chicken	 eggs.	 The	 eggs	 are	 inoculated	 at	 9-11	 days	 of	incubation	by	corion-allantoic	route	(Gelb	and	Jackwood	2008).	The	maximum	virus	titre	 in	allantoic	 fluids	 can	 be	 reached	 1	 to	 2	 days	 post-inoculation	 (Hitchner	 and	 White,	 1955),	although	this	peak	can	be	delayed	for	non-egg-adapted	field	strains.	For	isolation	of	non-egg-
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adapted	field	strains	several	sequential	passages	can	be	given	to	increase	the	amount	of	virus	before	 performing	 the	 antigen	 detection	 method.	 The	 extent	 of	 changes	 to	 the	 infected	embryos	 that	 are	 induced	 by	 IBV	 vary	 greatly.	 IBV	 produces	 embryo	 stunting,	 dwarfing,	curling,	clubbing	of	the	down,	or	urea	deposit	in	the	mesonephros.	Especially	for	field	strains,	the	 visible	 changes	 in	 the	 embryos	 in	 the	 first	 passage	 can	 be	 minimal.	 Usually,	 embryo	mortality	and	dwarfing	increase	as	the	number	of	serial	passages	increases.		In	 general,	 adaptation	 of	 IBV	 strains	 is	 necessary	 for	 fluent	 replication	 and	 induction	 of	cytopathic	effect	(CPE)	in	cell	cultures	(Gillette,	1973).	Chick	embryo	kidney	(CEK)	cells	and	chicken	kidney	cells	show	the	highest	sensitivity	for	adapted	IBV	strains	(Otsuki	et	al.,	1979).		TOCs,	usually	prepared	from	20-day-	old	(SPF)	embryos,	have	proved	very	successful	for	the	isolation,	titration	and	serotyping	of	IBV	(Cook,	1984)	because	no	adaptation	of	field	strains	is	required	 for	 growth	 and	 induction	 of	 ciliostasis.	 Ciliostasis,	 easily	 observed	 by	 low-power	microscopy,	 usually	 occurs	 within	 3	 to	 4	 days	 after	 inoculation,	 but	 this	 period	 can	 differ	between	 strains,	 inoculation	dose	 (Colwell	&	Lukert,	 1969)	 and,	 possibly,	 genetic	 factors	of	the	host	(Otsuki	et	al.,	1990).	The	presence	of	IBV	has	to	be	confirmed	by	an	IBV-specific	test,	since	ciliostasis	can	also	be	induced	by	many	other	agents.		Serotyping	of	 IBV	 isolates	and	strains	can	be	done	using	haemoagglutination	 inhibition	 test	(HI)	 (Alexander	et	al.,	1983;	King	and	Hopkins,	1984)	and	virus	neutralization	(VN)	 tests	 in	chicken	embryos	(Dawson	and	Gough,	1971),	TOCs	(Darbyshire	et	al.,	1979)	and	cell	cultures	(Hopkins,	1974).		Monoclonal	 antibodies	 (MAbs),	 usually	 employed	 in	 ELISA,	 have	 proven	 useful	 in	 grouping	and	 differentiating	 strains	 of	 IBV	 (Ignjatovic	 and	 McWater,	 1991;	 Koch	 et	 al.,	 1986).	 The	limitation	of	MAb	analysis	for	IB	serotype	definition	are	the	lack	of	availability	of	MAbs	and	the	 need	 to	 produce	 new	 MAbs,	 with	 appropriate	 specificity,	 to	 keep	 pace	 with	 the	 ever-growing	number	of	emerging	IB-variant	serotypes	(Karaca	et	al.,	1992).		
1.7.3	Detection	of	IBV	genome	
A	wide	range	of	genetically	distinct	IBV	genotypes	exists	and	novel	variants	continue	to	emerge.	With	the	advent	of	molecular	biology	technique,	many	different	protocols	of	RT-PCR,	RT-Nested	PCR	and	Real	Time	RT-PCR	have	been	developed,	for	detection	and	typing	of	IBV.		
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Protocols	direct	on	conservative	regions	of	the	viral	genome,	such	as	the	3’UTR	(Adzhar	et	al.,	1996),	 the	 5’	UTR	 (Callison	et	al.,	 2006)	 and	 the	RdRp	 (Poon	et	al.,	 2005)	 are	 used	 for	 IBV	detection.	 Protocols	 targeting	part	 of	 the	 S1	 gene	 (Cavanagh	et	al.,	 1999;	 Jones	et	al.,	 2005;	Valastro	 et	al.,	 2010)	 are	 typically	 used	 for	 genotyping.	 However,	 due	 to	 the	 availability	 of	different	 protocols	 for	 IBV	 genotyping,	 in	 the	 online	 databases	 are	 present	 sequences	 of	different	 parts	 of	 the	 S1	 gene.	 In	 order	 to	 standardize	 all	 the	 available	 data,	 it	 has	 been	recently	proposed	to	use	only	the	sequencing	of	the	complete	S1	gene	for	the	genotypization	(Valastro	 et	 al.,	 2016).	 An	 issue	 that	 make	 difficult	 the	 diagnostic	 of	 IBV	 is	 the	 frequent	presence	in	the	same	host	of	different	IBV	strains,	including	vaccine	strains,	and	the	inability	to	 unequivocally	 distinguish	 between	 them	 (Franzo	 et	 al.,	 2014).	 Although	 universal	oligonucleotides	are	adequate	for	the	detection	of	most	known	IBV	strains,	emerging	variants	or	 some	 strains	 in	 a	 mixed	 sample	 may	 be	 missed.	 In	 many	 laboratories,	 after	 the	 IBV	detection	using	universal	primers,	genotype	specific	protocols	are	used	for	the	identification	of	different	genotypes	co-infecting	the	same	host.	The	traditional	molecular	diagnostic	 tools	applied	 to	genotype	 identification	are	 relatively	 laborious	and	 frequently	 require	additional	analyses	 procedure	 to	 ensure	 unambiguous	 identification	 of	 IBV	 strains,	 and	 to	 type	 all	 IB	variants	potentially	co-infecting	the	same	host.	As	consequence,	new	molecular	methods	for	genotype	characterization	are	needed	and	have	been	investigated	as	the	use	of	microsphere-based	assay	(Valastro	et	al.,	2014).	1.7.4	Antigen	detection	methods	
All	 the	 technique	 used	 for	 identification	 of	 IBV-specific	 antigen	 employ	 IBV-specific	antibodies.	These	antibodies	are	either	 in	 form	of	antisera	or	MAbs.	 	Agar	Gel	precipitation	test	 (AGPT),	 IFA,	 Immunoperoxidase	 assay	 (IPA)	 and	 antigen	 ELISA	 could	 be	 used	 for	detecting	IBV	antigen	directly	in	tracheal	exudate	(Lohr,	1981)	or	to	confirm	the	presence	of	IBV	in	inoculated	embrionated	chicken	eggs	(Alexander	and	Gough,	1977,	reviewed	in	de	Wit,	2011).	
1.7.5	Serology	
A	number	of	 serological	 tests	have	been	described,	 including	VN,	 agar	 gel	 immunodiffusion	(AGID),	HI	 and	 ELISA.	 Each	 test	 has	 advantages	 and	 disadvantages	 in	 terms	 of	 practicality,	specificity,	 sensitivity	 and	 cost.	 In	 general,	 for	 routine	 serological	 testing	 VN	 tests	 are	 too	expensive	 and	 impractical,	 while	 AGID	 tests	 lack	 sensitivity.	 ELISA	 and	 HI	 tests	 are	 most	
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suitable	 for	 routine	serology.	ELISAs	are	useful	 for	general	monitoring	of	 IBV	exposure	and	can	 detect	 antibody	 responses	 to	 all	 serotypes.	 Strains	 and	 isolates	 of	 IBV	will	 agglutinate	chicken	 red	 blood	 cells	 after	 neuraminidase	 treatment.	 HI	 when	 used	 on	 serial	 sera	 from	young	 growing	 chickens	 such	 as	pullets	 and	broilers	 can	 give	 information	on	 the	 serotype-specific	antibody	status	of	a	 flock.	Because	chicken	sera	from	older	birds	contain	antibodies	that	 are	 highly	 cross-reactive	 against	 antigenically	 unrelated	 strains,	 serodiagnosis	 of	suspected	disease	outbreaks	of	 IB	cannot	be	used	with	a	high	degree	of	confidence.	Regular	monitoring	of	sera	from	flocks	for	IB	antibody	titres	may	help	to	indicate	the	level	of	vaccine	or	field	challenge	responses	(OIE,	2017).			1.8	Control	1.8.1	Biosecurity	and	traditional	vaccines	IBV	 is	ubiquitous	 in	most	parts	of	 the	world	where	poultry	are	reared	and	 is	able	 to	spread	very	rapidly	 in	non-protected	birds	 (De	Wit	et	al.,	1998).	Although	strict	biosecurity	and	working	with	a	one-age	system	are	essential	control	measures,	vaccination	is	normally	an	essential	 tool	 to	 increase	 the	 resistance	 of	 the	 chickens	 against	 challenge	 with	 IBV	 (Cook,	2008).		For	 vaccination	 of	 chickens	 against	 IBV,	 both	 live	 attenuated	 and	 inactivated	 (usually	 oil-adjuvanted)	 vaccines	 are	 used.	 Live	 vaccines	 are	 especially	 used	 in	 young	 birds	 to	 achieve	early	protection	and	also	for	priming	of	future	layers	and	breeders	that	will	be	boosted	with	the	 inactivated	 vaccines.	 Live	 attenuated	 vaccines	 are	 important	 for	 the	 stimulation	 of	 the	local	protection,	but	the	protection	last	not	very	long	in	the	field.		In	areas	with	an	increased	level	of	 field	challenge,	 live	attenuated	vaccines	are	also	used	periodically	during	 the	 laying	period	with	 the	 intention	 of	 keeping	 the	 local	 protection	 of	 the	 respiratory	 tract	 at	 a	 high	level.		The	vaccines	of	Mass	serotype	are	the	most	used	in	the	world.	In	several	parts	of	the	world,	Mass	vaccines	are	the	only	allowed	vaccines,	but	elsewhere,	vaccines	of	other	serotypes	are	permitted.	 In	 Europe,	 vaccine	 strains	 of	 the	 793B	 and	 QX	 genotype	 are	 commonly	 used.	Depending	on	the	epidemiological	situation	of	the	area,	also	other	genotypes	are	used.		Vaccines	of	a	certain	serotype	(or	genotype)	are	normally	able	to	protect	the	well-vaccinated	
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chicken	against	a	homologous	challenge.	Often	there	is	a	partial	protection	against	strains	of	other	 serotypes	 or	 genotypes,	 that	 can	 vary	 from	 low	 to	 high	 (Bijlenga	 et	 al.,	 2004).	 The	magnitude	 and	 duration	 of	 the	 response	 to	 vaccination	 is	 dependent	 on	 many	 factors,	including	 age	 of	 the	 chick,	 levels	 of	 maternal	 immunity,	 immunogenicity	 of	 the	 vaccine,	method	 of	 vaccine	 application,	 virulence	 of	 the	 field	 strain	 challenge,	 interval	 between	vaccination	and	challenge	and	immunocompetency	of	the	host.	Chickens	live	vaccinated	under	optimal	conditions	may	have	immunity	lasting	many	months	and	for	broilers,	this	may	be	life-long	(Bijlenga	et	al.,	2004).		It	 has	 been	 shown	 that	 vaccination	with	 two	 antigenically	 distinct	 live-attenuated	 vaccines	such	 as	 Mass	 and	 793B	 can	 result	 in	 a	 broad	 cross-protection	 against	 many	 different	 IBV	types	(Cook	et	al.,	1999;	Terregino	et	al.,	2008).	The	cross-protection	was	broader	when	these	vaccines	were	applied	with	a	2-week	interval	than	when	the	vaccines	were	combined	on	the	same	day.	Whatever	live	vaccine	is	used,	the	application	is	a	very	critical	step.	IBV	virus	is	a	sensitive	virus	 that	 can	be	 inactivated	easily	 (Cavanagh	&	Gelb,	 2008),	which	may	 result	 in	inadequate	efficacy	of	the	vaccination	under	field	conditions	(Jackwood	et	al.,	2009;	De	Wit	et	
al.,	 2010).	 Live	 attenuated	 vaccines	 may	 be	 applied	 by	 eye	 drop	 or	 nasal	 drop,	 spray	 or	drinking	water	routes	and	it	is	essential	that	a	high	percentage	of	the	birds	receive	a	required	dose	of	the	vaccine	in	the	right	tissue.	Inadequate	‘‘take’’	of	the	vaccine	may	result	in	no	or	a	decreased	 level	 of	 protection,	 delayed	 protection,	 or	 prolonged	 presence/circulation	 of	 the	vaccine	virus	in	the	flock,	that	could	result	 in	reversion	to	virulence	of	the	virus	(Hopkins	&	Yoder,	1986).		Commonly,	broilers	are	vaccinated	in	the	hatchery	at	one	day	of	age	by	coarse	spray	using	a	live	attenuated	M41	vaccine	strain.		A	booster	vaccination	at	10-15	days	with	a	live	attenuated	vaccine	of	a	different	genotype,	depending	on	the	epidemiological	situation	of	the	 area,	 is	 used	 to	 give	 broad	 protection	 to	 the	 vaccinated	 birds.	 In	 Italy,	 usually,	 for	 the	booster	vaccination	a	793B	or	a	QX	vaccine	strain	is	used.		It	is	also	possible	to	combine	at	one	day	of	age	different	vaccine	strains	in	the	hatchery	(Pascucci,	2015).	Inactivated	oil-emulsion	vaccines	are	administered	to	breeders	and	layers	prior	to	the	onset	of	egg	production.	Pullets	may	be	vaccinated	between	10	and	18	weeks	of	age	depending	on	the	immunization	program.	The	 effects	 of	 inactivated	 vaccines	 depend	 heavily	 on	 proper	 priming	 with	 live	 vaccines.	Inactivated	 vaccines	 must	 be	 administered	 to	 birds	 individually,	 by	 intramuscular	 or	subcutaneous	 injection.	 Inactivated	 vaccines	 induce	 high	 level	 of	 serum	 antibodies	 and	provide	 protection	 to	 internal	 tissues,	 kidney,	 and	 reproductive	 tract	 (de	Wit	 et	al.,	 2011a;	Landman	 et	 al.,	 2002).	 In	 contrast	 to	 live	 vaccines,	 inactivated	 vaccines	 are	 not	 nearly	 as	
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effective	at	preventing	infection	of	the	respiratory	tract	following	challenge	with	homologous	virulent	virus	(Cook	et	al.,	1986).	To	achieve	an	early	post	hatch	protection	against	IBV,	Avian	metapneumovirus	 (AMPV)	 and	 a	 Newcastle	 disease	 virus	 (NDV),	 it	 is	 possible	 to	 apply	simultaneously	 different	 live	 attenuated	 vaccines	 in	 the	 hatchery.	 Different	 studies	demonstrated	 that	 the	 simultaneously	 application	 of	 an	 IBV,	 an	 AMPV	 and	 a	 NDV	 live	attenuated	 vaccine	 in	 dual	 or	 triple	 combination	 did	 not	 interfere	 in	 the	 production	 of	 IBV	humoral	antibody	responses,	neither	 in	the	 level	of	protection	against	 IB	challenge	(Cook	et	
al.,	2001;	Tarpey	et	al.,	2007;	Awad	et	al.,	2015).	1.8.2	New	generation	Vaccines		
Molecular	vaccines,	 including	subunit	vaccines,	DNA	vaccines,	virus-like	particles	 (VLP)	and	recombinant	vector	vaccines	have	all	been	developed	and	tested	for	their	efficacy	against	IBV	(Cook	et	al.,	2012).	Already	 in	1994,	 Ignjatovic	and	Galli	produced	S1,	N,	and	M	proteins	by	immunoaffinity	purification	of	IBV	strain	N1/62	and	used	them	for	immunization	of	chickens.	Multiple	immunizations	were	necessary	for	induction	of	an	antibody	response.	Neither	the	N	nor	the	M	antigen	induced	protection	to	a	virulent	challenge	after	4	immunizations.	
	A	recombinant	CVI1988/Rispens	Marek’s	disease	virus	(MDV)	vaccine	(rMDV-S1)	expressing	the	S1	gene	of	a	QX	IBV	inserted	into	the	genome	of	virus	has	been	developed.	SPF	chickens	that	were	 vaccinated	 at	 day	 old	with	 rMDV-S1	were	 found	 to	 have	 a	 low-level	 of	 antibody	response	until	4	weeks	post-vaccination,	but	after	IBV	challenge,	performed	at	4	weeks	of	age,	the	antibody	level	increased	more	rapidly	when	compared	to	the	control	group.	The	chickens	were	 protected	 when	 challenged	 with	 the	 QX-like	 IBV	 (Zhang	 et	 al.,	 2012).	 Falchieri	 et	colleagues	in	2013	developed	a	recombinant	vaccine	expressing	either	S1	or	N	genes,	or	both,	of	 IBV	 in	 AMPV	 vector.	 Day-old	 chicks	 were	 vaccinated	 by	 eye-drop.	 The	 vaccine	 induced	partial	 protection	 against	 virulent	 IBV	 QX	 challenge	 3	weeks	 later,	 as	 assessed	 by	 tracheal	ciliar	activity	test.	Nonetheless	no	sero-conversion	nor	major	tracheal	rAMPV/IBV	replication	(assessed	 by	 real	 time	 RT-PCR)	 in	 vaccinated	 chicks	 was	 observed	 (Falchieri	 et	al.,	 2013).	Toro	 and	 colleagues	 in	 2014	 developed	 a	 recombinant	 vaccine	 using	 a	 Newcastle	 disease	virus	 (LaSota)	 expressing	 IBV	 S2	 gene.	 IBV	 heterotypic	 protection	 was	 assessed	 using	 a	prime–boost	approach	along	with	a	commercial	attenuated	Mass	 type	vaccine.	Their	results	demonstrated	 that	 priming	 the	 birds	 with	 IBV	 S2,	 which	 overexpose	 the	 chicken	 immune	system	to	S2,	 followed	by	boost	with	whole	virus	protects	chickens	against	 IBV	(Toro	et	al.,	2014a).	Different	research	groups	have	used	Adenovirus	as	vector	for	the	expression	of	IBV	
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proteins.	A	recombinant	Fowl	Adenovirus	(FAV)	that	expresses	the	S1	from	IBV	Vic	S	strain	has	been	developed	and	tested	in	birds	at	day	six,	90–100%	protection	was	induced	against	either	 homologous	 or	 heterologous	 challenge,	 demonstrating	 that	 the	 recombinant	 FAV/S1	IBV	vaccine	could	be	a	potential	alternative	vaccination	strategy	against	 IBV	(Johnson	et	al.,	2003).		
Toro	 and	 colleagues	developed	a	 recombinant	Adenovirus	 vaccine	 expressing	 S1	protein	of	Ark	 genotype	 IBV;	 one	 of	 the	 vaccine	 developed	 caused,	 after	 a	 single	 vaccination	 dose,	 an	effective	protection	of	 chickens	 from	clinical	 signs	and	significantly	 reduced	viral	 load	after	IBV	Ark	virulent	challenge;	moreover,	the	number	of	both	IgA	and	IgG	IBV	specific	antibody	secreting	 lymphocytes	 in	 the	 spleen	 increased	 after	 challenge	 (Toro	 et	al.,	 2014b).	 Liu	 and	colleagues,	 in	2013,	 produced	and	assembled	 a	 IBV	VLPs	 vaccine	by	 inserting	 and	M	and	S	proteins	 in	 baculovirus	 grown	 in	 Sf9	 cells.	 The	 generated	 VLPs	 induced,	 28	 days	 post	vaccination	 humoral	 immune	 responses	 in	 a	 level	 comparable	 to	 that	 of	 inactivated	 IBV	vaccine	 and	 elicited	 significantly	 higher	 cellular	 immune	 responses	 than	 the	 inactivated	vaccine	(Liu	et	al.,	2013).		In	the	2014	a	modified	baculovirus	expressing	the	S1	glycoprotein	of	 a	M41	 strain	was	 produced.	 This	 vaccine	was	 able	 to	 generate	 strong	 humoral	 and	 cell-mediated	immune	responses,	and	showed	good	induction	of	cytotoxic	T	lymphocyte	response,	giving	to	the	vaccinated	birds	a	good	protection	following	challenge	with	a	virulent	IBV	M41,	almost	comparable	to	an	inactivated	IBV	vaccine	(Zhang	et	al.,	2014).	In	the	same	year,	Lv	et	colleagues	(2014)	developed	a	chimeric	virus-like	particle	(VLP).	The	VLP	was	composed	of	matrix	and	neuraminidase	proteins	of	avian	 influenza	(AI)	(H5N1)	and	of	protein	S1	of	 IBV.	The	chimeric	VLPs	induced	in	SPF	chickens	a	significantly	higher	neutralization	antibody	level	when	compared	 to	an	 inactivated	H120	virus.	A	 recombinant	S-ectodomain	protein	subunit	vaccine	has	recently	been	developed	and	tested	in	experimental	trial.	This	vaccine	showed	a	reduced	viral	 loads	5	days	post-challenge	 in	both	 tears	and	 tracheas	 statistically	 significant	different	 from	 chickens	 immunized	 with	a	 recombinant	S1	 protein.	 Consistent	 with	 viral	loads,	 significantly	 reduced	 tracheal	mucosal	 thickness	 and	 tracheal	 lesion	 scores	 revealed	that	recombinant	S-ectodomain	 protein	 provided	 improved	 protection	 of	 tracheal	 integrity	compared	to	S1	protein.	These	results	 indicate	 that	 the	S2	domain	has	an	 important	role	 in	inducing	 protective	 immunity.	 Thus,	 including	 the	 S2	 domain	 in	 IBV	 recombinant	 vaccine	might	be	promising	 for	better	viral	vectored	and/or	subunit	vaccine	strategies	(Eldemery	et	
al.,	 2017).	 Different	 research	 groups	 have	 developed	 a	 reverse	 genetic	 system	 for	manipulation	 of	 IBV	 genome	 in	 order	 to	 develop	 of	 rationally	 designed	 live-attenuated	 IBV	
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vaccines	 (Casais	 et	 al.,	 2001;	 Fang	 et	 al.,	 2007;	 Youn	 et	 al.,	 2005;	 Zhou	 et	 al.,	 2013;	 van	Beurden	et	al.,	2017).		
To	date	only	 traditional	 live	attenuated	and	 inactivated	vaccines	are	commercially	available	for	the	control	of	the	disease.	
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• Bourogâa	H.,	Miled	K.,	Gribâa	L.,	 El	Behi	 I.,	 Ghram	A.	 (2009).	Characterization	of	new	
variants	of	avian	infectious	bronchitis	virus	in	Tunisia.	Avian	Dis	53:	426-433.		
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Abstract	Since	1996	a	new	Infectious	Bronchitis	virus	(IBV)	genotype,	referred	to	as	Q1,	circulated	in	China	 and	 was	 reported	 for	 the	 first	 time	 in	 Italy	 in	 2011,	 associated	 with	 an	 increase	 of	mortality,	kidney	lesions	and	proventriculitis.	During	northern	Italian	outbreak	of	respiratory	disease	in	a	broiler	flock	in	2013,	an	IBV	strain	was	detected	by	RT-PCR	and	characterized	as	Q1-like	 based	 on	 partial	 S1	 sequence.	 The	 virus	 was	 isolated	 and	 named	γCoV/Ck/Italy/I2022/13.	 All	 coding	 regions	 of	 the	 isolate	 were	 sequenced	 and	 compared	with	130	complete	genome	sequences	of	IBV	and	TCoV,	downloaded	from	ViPR.	This		showed	the	 highest	 identity	 with	 a	 Chinese	 strain	 CK/CH/LDL/97I	 (p-distance=0.044).	 To	 identify	potential	 recombination	 events	 a	 complete	 genome	SimPlot	 analysis	was	 carried	out	which	revealed	the	presence	of	possible	multiple	recombination	events,	but	the	minor	parent	strains	remained	unknown.	A	phylogenetic	analysis	of	the	complete	S1	gene	was	performed	using	all	complete	 S1	 sequences	 available	 on	ViPR	and	 showed	 the	 isolate	 clustered	with	 an	Q1-like	strain	 isolated	 in	 Italy	 in	 2011	 (p-distance=0.004)	 and	 a	 group	 of	 Chinese	 Q1-like	 strains	
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isolated	from	the	mid	90’s	(p-distance	equal	or	higher	than	0.001).	It	could	be	hypothesized	that	the	isolate	descended	from	the	Italian	2011	Q1-like	strain	or	was	the	result	of	a	separate	introduction	from	China	through	commercial	trade	or	migratory	birds;	but	the	data	currently	available	does	not	distinguish	between	these	possibilities.			
Main	text	
Infectious	 bronchitis	 virus	 (IBV),	belonging	 to	 family	 Coronaviridae,	 genus	 Coronavirus,	 is	 a	positive-sense,	 single-stranded	RNA	virus	 of	 about	27.6	 kb	 (5-UTR-1a/1ab-S-3a-3b-E-M-5a-5b-N-3	UTR)	 causing	major	 economic	 losses	 in	 the	poultry	 industry	 (Jackwood	and	de	Wit,	2013).	 Currently,	 control	 strategies	 are	 mainly	 based	 on	 widespread	 use	 of	 vaccination.	Nevertheless,	vaccine-induced	immunity	 is	generally	poorly	protective	between	strains	 	due	to	 limited	 cross	 protection	 afforded	 between	 strains	 (Cook	 et	 al.,	 2012;	 Sjaak	 de	Wit	 et	 al.,	2011b)	and	this	 is	currently	considered	to	result	 from	antigenic	diversity	due	 to	S1	protein	variability.	The	viral	genome	can	mutate	rapidly	 through	substitutions,	 insertions,	deletions	and	 recombinations	 and	 this	 results	 in	 the	 emergence	 of	 a	 large	 number	 of	 IBV	 variants,	characterized	by	little	or	negligible	cross	protection	(Jackwood	et	al.,	2012;	Thor	et	al.,	2011).	In	recent	times,	different	genotypes	of	apparent	Asian	origin,	have	spread	to	other	countries	and	 continents,	 sometimes	 with	 economic	 consequences	 (De	 Wit	 et	 al.,	 2011a).	 Different	strains	closely	related	to	the	proposed	Q1	genotype,	isolated	for	the	first	time	in	the	mid	90’s	(Yu	et	al.,	2001a;	Yu	et	al.,	2001b),	have	more	recently	been	described	in	Italy	(Franzo	et	al.,	2014;	Toffan	et	al.,	2011;	Toffan	et	al.,	2013)	in	association	with	respiratory	disease.	However,	little	 sequence	 information	 is	 available	 about	 this	 genotype	 despite	 its	 presence	 in	 Asia,	Middle	East,	Europe	and	South	America	(Ababneh	et	al.,	2012;	Alvarado,	2012;	de	Wit	et	al.,	2012;	Huang	et	al.,	2004;	Jackwood,	2012a;	Jackwood,	2012b;	Rimondi	et	al.,	2009;	Sesti	et	al.,	2014a;	Sesti	et	al.,	2014b).	This	is	the	first	report	of	a	full	genome	sequence	of	a	Q1	like	isolate	together	 with	 its	 comparison	 to	 currently	 available	 full	 length	 IBV	 genomes	 on	 world	databases.	Additionally,	a	comparison	with	a	broader	S1	protein	database,	typically	used	for	classification	purposes,	was	performed.		To	 this	 end,	 10	 swabs	 were	 collected	 (May	 2013)	 from	 35	 days	 old	 chickens	 showing	respiratory	 signs,	 raised	 in	 a	 commercial	 broiler	 farm	 located	 in	 Northern	 Italy.	 Virus	was	isolated	 in	 chicken	 embryo	 tracheal	 organ	 cultures	 (TOC)	 (Cook	 et	 al.,	 1976).	 Ciliostasis	observed	3	days	after	inoculation	was	taken	as	the	indicator	of	the	presence	of	the	virus.	This	was	confirmed	when	RNA	was	extracted	from	the	TOC	medium	and	an	IBV	specific	RT-Nested	PCR	 was	 performed	 (Cavanagh	 et	 al.,	 1999).	 Virus	 recovered	 from	 the	 third	 passage	 was	
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named	 γCoV/Ck/Italy/I2022/13	 (proposed	 classification	 Ducatez,	 2014)	 and	 used	 for	 the	following	steps.	A	two-step	RT-PCR	protocol	was	developed	to	amplify	the	full	genome	of	IBV	through	 several	 overlapping	 amplicons.	 Different	 sets	 of	 primers	 were	 designed	 using	Primer3	on	the	basis	of	the	sequence	already	published.	Reverse	transcription	was	performed	with	 the	 commercial	 kit	 Maxima	 H	 Minus	 Reverse	 Transcriptase	 (ThermoFisher	 Scientific,	Carlsbad,	 CA)	 while	 PCR	 was	 performed	 using	 the	 Phusion	 Hot	 Start	 II	 High-Fidelity	 DNA	Polymerase	 kit	 (ThermoFisher	 Scientific,	 Carlsbad,	 CA).	 Both	 RT	 and	 PCR	 phases	 were	thoroughly	 optimized	 with	 respect	 to	 primers	 (available	 on	 request),	 thermal	 profiles	 and	reagents,	 so	as	 to	achieve	an	acceptable	 final	yield	 in	absence	of	non-specific	products.	The	final	protocol	included	the	following	steps.:	2µL	of	RNA	were	added	to	a	pre-mix	comprising	dNTP	mix	(final	concentration	0,5mM),	15pmol	of	primer	and	water	up	to	a	volume	of	14,5	µL.	After	a	denaturation	step	at	65°C	for	5	minutes	the	pre-mix	was	added	with	5X	RT	Buffer,	20U	 of	 Thermo	 Scientific	 RiboLock	 RNase	 Inhibitor,	 20U	 Maxima	 H	 Minus	ReverseTranscriptase.	Water	was	added	to	reach	final	volume	of	20µL.	Reverse	transcription	was	performed	at	50°C	for	90	minutes	and	terminated	through	a	step	at	85°C	for	5	minutes.	Several	 PCRs	were	 optimized	 to	 cover	 all	 coding	 regions	 of	 IBV	 genome	 using	 overlapping	amplicons	of	approximatively	2kbp.	Four	µL	of	cDNA	were	added	to	a	standard	mix	including	5X	 Phusion	 HF	 buffer,	 200µM	 of	 each	 dNTP,	 0,5	 µM	 of	 forward	 and	 reverse	 primers,	 and	0,02U/µL	 of	 Phusion	 Hot	 Start	 II	 DNA	 polymerase.	 Nanopure	 water	 was	 added	 to	 a	 final	volume	of	50µL	Sequencing	was	performed	at	Macrogen	(Macrogen	Europe).	After	the	initial	activation	at	98°C	for	30s,	40	cycles	were	performed	at	98°C	for	10s,	60°C	for	20s	and	72°C	for	150s.	Each	amplicon	was	sequenced	using	4	primers	 including	those	used	 for	PCR	plus	 two	additional	 internal	 primers.	 The	 list	 of	 primer	 used	 for	 reverse	 transcription,	 PCR	 and	sequencing	is	available	as	Supplementary	material	1.	All	 chromatograms	 were	 visually	 inspected	 using	 FinchTV	(http://www.geospiza.com/Products/finchtv.shtml)	and	sequences	were	trimmed	to	remove	primer	 contamination	 and	 bases	 with	 a	 phred	 score	 lower	 that	 20	 using	 Geneious	 8.0.5	(http://www.geneious.com/).	 Sequences	 were	 aligned	 to	 a	 reference	 IBV-QX	 genotype	sequence	 (Acc.Num.	 JQ088078)	 and	 consensus	 sequences	 was	 generated	 using	 the	 same	software.	Complete	genome	sequences	including	IBV	and	TCoV	(130)	were	downloaded	from	ViPR	(Pickett	et	al.,	2012)	and	aligned	using	MAFFT	version	7(Katoh	and	Standley,	2013).	The		substitution	 model	 was	 selected	 on	 the	 basis	 of	 Bayesian	 information	 criterion	 (BIC)	calculated	using	Jmodeltest	2.1.6	(Darriba	et	al.,	2012).	A	complete	genome	phylogenetic	tree	was	 reconstructed	 using	 the	MaximumLikelihood	 (ML)	method	 implemented	 in	 PhyML	 3.0	
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(Guindon	 et	 al.,	 2010).	 A	 combination	 of	 Nearest	 neighbor	 interchange	 (NNI)	 and	 sub-tree	pruning	and	regrafting	(SPR)	were	selected	as	the	tree	rearrangement	strategy.	To	evaluate	robustness	of	 the	monophyly	of	 the	 taxa	subsets,	a	 fast	non-parametric	version	of	 the	aLRT	(Shimodaira–Hasegawa	 [SH]-aLRT),	 developed	 and	 implemented	 in	 the	 PhyML	 3.0	(Anisimova	et	al.,	2011),	was	used.	A	 NeighborNet	 network	 was	 reconstructed	 using	 SplitsTree4	 v4.12.3	 (Huson	 and	 Bryant,	2010).	 Phylogenetic	 network	 was	 used	 to	 display	 the	 incompatibilities	 and	 ambiguous	phylogenetic	 signals	within	 datasets	 and	 provided	 a	 preliminary	 overview	on	 the	 extent	 of	recombination	phenomenon.	Presence	of	recombination	within	dataset	was	also	tested	using	the	Phi	 test	 implemented	 in	 the	same	software.	Possible	recombinant	nature	of	 the	 isolated	strain	was	also	evaluated	using	SimPlot.	Briefly,	a	sliding	window	of	300nt	was	moved	along	the	 alignment	 20	 nucleotide	 at	 a	 time	 and	 the	 pairwise	 percentage	 of	 identity	 between	γCoV/Ck/Italy/I2022/13	and	each	of	the	130	complete	genome	sequences	was	calculated	for	each	 step.	 When	 the	 percentage	 of	 identity	 was	 lower	 than	 95%	 a	 BLAST	 search	 was	performed	selecting	the	corresponding	region	as	query	in	order	to	obtain	the	closely	related	sequences.	 The	 region	 coding	 for	 S1	 protein	 is	 traditionally	 used	 for	 genotyping	 and	classification	 purpose.	 All	 available	 complete	 or	 nearby	 complete	 S1	 sequences	 (length	 at	least	 1500bp)	 were	 downloaded	 from	 ViPR	(http://www.viprbrc.org/brc/home.spg?decorator=vipr).	This	dataset	was	 reduced	 in	order	to	 reduce	 the	 computational	 load.	 To	 this	 end,	 CD-HIT	 (Li	 and	 Godzik,	 2006)	 was	 used	 to	cluster	sequences	with	identity	over	95%	and	one	sequence	within	each	cluster	was	selected.	After	clustering,	153	sequences	remained	and	substitution	model	and	phylogenetic	tree	were	reconstructed	as	previously	described.	Based	on	these	results,	a	subset	of	sequences	part	of	the	 subtree	 including	 the	 strain	 γCoV/Ck/Italy/I2022/13	 were	 selected.	 This	 dataset	 was	expanded	to	its	original	number	of	taxa	and	a	new	phylogenetic	tree	was	obtained.		This	study	reports,	for	the	first	time,	the	whole	genome	sequence	(coding	regions)	of	a	Q1	like	strain	(γCoV/Ck/Italy/I2022/13)	isolated	in	Italy	from	chickens	with	respiratory	signs.		A	 27403	 nt	 consensus	 sequence	 was	 obtained	 (minimum	 coverage	 2X).	 Gene	 length	 is	reported	 in	 Table	 1.	 The	 phylogenetic	 tree	 based	 on	 complete	 genome	 sequence	demonstrated	 	 that	 strain	 γCoV/Ck/Italy/I2022/13	 clusters	 with	 Chinese	 sequences	JX195177	 and	 JX195178	 	 (p-distance=0.044)	 (Supplementary	 figure	 1).	 The	 high	 IBV	recombination	frequency	(Thor	et	al.,	2011)	was	confirmed	also	in	present	study	(Phi	test	p-value=0.0).	 Phylogenetic	 network,	 confirming	 JX195177	 and	 JX195178	 as	 the	 most	 closely	related	 to	our	 isolate,	was	characterized	by	 the	presence	of	several	 reticulations	 (Figure	1),	
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strongly	 suggestive	 of	 extensive	 recombination	within	 the	 database	 and	 of	 the	 presence	 of	contrasting	phylogenetic	signal	within	the	sequence.	Pairwise	comparison	with	130	available	complete	 genomes	 confirmed	 the	 close	 relationship	 between	 γCoV/Ck/Italy/I2022/13	 and	JX195177/JX195178	along	the	whole	genome	with	the	exception	of	region	841-2812,	3389-9926,	22355-23143	and	25356-26027(data	not	shown),	corresponding	to	the	1ab,	Spike,	5a	and	N	genes.	The	absence	of	double	peaks	in	the	chromatograms	as	well	as	the	location	of	the	recombination	breakpoints	(i.e.	within	PCR	amplicons)	discount	for	mixed	infections,	in	vitro	and	 in	silico	 recombination,	supporting	 the	genuine	nature	of	 the	reported	event.	The	sharp	change	 in	 percentage	 of	 identity	 in	 these	 positions	 strongly	 suggests	 that	γCoV/Ck/Italy/I2022/13	 had	 undergone	 multiple	 recombination	 events.	 A	 BLAST	 search	using	all	publicly	available	sequences,	performed	on	these	regions,	did	not	find	closely	related	sequences	 (no	 identity	 >95%).	 Unfortunately,	 the	 limited	 number	 of	 sequences	 in	 regions	different	 from	 the	 S	 gene	 impedes	 the	 study	 of	 the	 recombination	 patterns	 and	 the	identification	of	the	strains	involved.		Currently,	 the	vast	majority	of	sequencing	efforts	are	 focused	on	S1	gene	(or	part	of	 it)	and	consequently	 few	 sequences	 are	 available	 for	 other	 genome	 regions,	 thus	 currently	precluding	 identification	 of	 the	 minor	 parents.	 Hopefully,	 the	 advent	 of	 next	 generation	sequencing	technologies	might	contribute	to	an	increase	in	availability	of	full	length	genome	sequences,	 hence	 leading	 to	 a	 deeper	 understanding	 of	 the	 evolution	 of	 other,	 currently	neglected,	genes.			Phylogenetic	 trees	 of	 the	 full	 S1	 gene	 confirmed	 γCoV/Ck/Italy/I2022/13	 to	 belong	 to	 the	same	cluster	 as	 JX195177/JX195178.	This	 clade	 comprised	only	Chinese	 isolates	 (Figure	2)	often	 classified	 as	 belonging	 to	 the	 Q1	 genotype.	 However,	 a	 closely	 related	 Italian	 strain	JQ290229	 (p-distance=0.004)	 was	 previously	 sampled	 in	 2011	 (Toffan	 et	 al.,	 2011).	 The	reconstruction	of	 the	actual	origin	of	strain	γCoV/Ck/Italy/I2022/13	is	challenging.	 It	could	be	the	descendant	of	strain	JQ290229	or	occur	as	the	result	of	separate	 introduction	events	from	China.	Even	if	clear	link	are	still	lacking,	several	hypothesis	can	be	advocated,	including	undeclared	 commercial	 trade	 or	 migratory	 birds	 (Cavanagh,	 2005).	 While	 a	 closer	relationship	 with	 Chinese	 strains	 makes	 the	 second	 hypothesis	 more	 likely,	 some	 sort	 of	convergent	 evolution	 affecting	 Italian	 and	 Chinese	 strains	 can’t	 be	 excluded.	 Further	investigation	 based	 on	 the	 comparison	 of	 broader	 regions	 of	 the	 genome	 and	 taking	advantage	of	the	analysis	of	recombination	patterns	could	provide	more	information	on	this	issue.		It	could	also	highlight	introduction	into	Italy	of	one	of	the	most	challenging	diseases	of	
	 72	
commercial	 poultry.	 Interestingly,	 other	 two	 Italian	 sequences	 (JQ901492	 and	 KJ941019)	were	 part	 of	 the	 γCoV/Ck/Italy/I2022/13	 related	 cluster	 (Figure	 2)	 and	 displayed	 a	 p-distance	 of	 0.058	 and	 0.062.	 Isolate	 JQ901492,	 belonging	 to	 the	 genotype	 624I,	 has	 been	previously	hypothesized	as	an	ancestor	of	the	Q1	genotype	(Massi,	2013)	which	was	imported	to	China	in	the	past	and	introduced	again	in	Italy	after	a	period	of	independent	evolution.	The	high	genetic	diversity	of	624I	and	the	first	Q1,	sampled	only	few	years	apart,	hardly	fit	with	this	hypothesis.	Unfortunately,	even	 if	624I	had	been	reported	and	sequenced	 in	 Italy	since	60’s	(Taddei	et	al.,	2012),	JQ901492	is	the	oldest	public	available	624I	sequence.	Such	scarcity	of	data	makes	it	impossible	to	confidently	support	or	refute	this	hypothesis,	highlighting	the	importance	of	the	need	for	further	sequence	data	availability	(Brister	et	al.,	2010;	Scotch	et	al.,	2011).		
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Fig.1	 Phylogenetic	 network	 based	 on	 NeighborNet	 method	 including	 130	 complete	 IBV	 and	 TCoV	genomes.	For	easiness	of	representation,	only	strain	reported	in	the	present	study	and	closely	related	strains	(i.e.,	JX195177	and	JX195178)	are	labelled.	
	
	
Table	1	Gene	and	protein	lengths	of	strain	γCoV/Ck/Italy/I2022/13.		
Gene	 1ab	 Spike	 3a	 3b	 3c	 M	 5a	 5b	 N	
Length	nt	 19893	 3501	 174	 195	 309	 681	 198	 249	 1230	
Length	aa	 6631	 1167	 58	 65	 103	 227	 66	 83	 410		
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Fig.	 2:	 Maximum	 Likelihood	 (ML)	 tree	 obtained	 from	 S1	complete	 sequences	 closely	 related	 to	CoV/Ck/Italy/I2022/13	 (greyrectangle).	 Nodes	 displaying	 a	bootstrap	support	higher	that	70%,	between	70	and	50%	and	lower	 than	 50%	 are	 represented	 as	 black,	 grey	 and	 white	circles,	respectively.	The	corresponding	cluster	is	highlighted	in	 red	 in	 the	 ML	 tree	 based	 on	 the	 whole	 collection	 of	 S1	sequences.	 To	 facilitate	 graphical	 representation	 sequences	were	 clustered	 based	 on	 an	 identity	 threshold	 of	 95%	 and	only	one	sequence	within	each	cluster	was	selected.	
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KJ524585|CK/CH/GX/GL11_2|China|2011
JQ920379|1038|South_Korea|2010
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KC577369|19JSNJ97|China|1997
KF757442|V8|India|2006
NC_010800|MG10|Canada|NA
KJ941019|IZO_28/86|Italy|1986
GU393331|UNKNOWN_GU393331_Cal56b|USA|1991
DQ646406|TW1171/92|Taiwan|NA
DQ490209|Q1_73|Australia|NA
FJ829882|X|China|2001
AF305595|PA/Wolgemuth/98|NA|NA
KC533682|Eg/1265B/2012|Egypt|2012_02_26
JQ693048|K026_10|South_Korea|2010
AF352312|J|China|NA
JF330898|ck/CH/LHB/100801|China|2010
X04723|6/82|NA|NA
JQ920397|11031|South_Korea|2011
JQ764816|GX_G|China|1988
KC577374|30JX_99I|China|1999
KF757456|V39|India|2008
FN182274|NGA/288/2006|Nigeria|2006
DQ490208|N2_75|Australia|NA
JX027069|IB_VAR2|Israel|NA
KC008600|GX_C|China|1985
GQ844989|Guilin_06|China|2006
KF360983|23/B/2008|India|2008
DQ070838|BJS|China|NA
AF250006|A1211|Taiwan|NA
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GQ844988|Guangzhou_06|China|2006
GU393336|UNKNOWN_GU393336_Holte|USA|1954
JN983807|VicS_del|Australia|2010
JF694497|JZ|China|2010
KC577366|16GNIBV98|China|1998
KC577417|95GD_09III|China|2009
DQ075323|SH1|China|NA
EU925393|CA/1737/04|USA|2004
AF510334|AL/10902/97|NA|NA
FN182244|NGA/B407/2006|Nigeria|2006
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GQ906705|THA001|Thailand|1998
JN176213|N1/08|Australia|2008
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DQ386105|Spain/04/5438_Italy_02_|Spain|NA
KC577397|66GD_98VI|China|1998
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KJ524616|CK/CH/GX/GL12_2|China|2012
AY606320|TP/64|Taiwan|NA
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HQ848267|GX_YL5|China|2005_08_15
KC577384|42HLJ_98I|China|1998
DQ490216|V2_71|Australia|NA
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Supplementary	material	1.	Primers	used	for	reverse	transcription,	PCR	and	sequencing.	Primers	are	named	according	to	their	approximate	position	in	the	viral	genome	reported	in	kb	and	rounded	to	two	decimal	digits.	Forward	and	reverse	primers	are	coded	with	“+”	and	“-“	symbols,	respectively.		
	
RT	 Sequence	5’-3’	 PCR	 Sequence	5’-3’	 Seq	 Sequence	5’-3’	
2,06-	 tttagtaaaaagaccacc	 0,06+	 gcgctagatttccaacttaacaaaacg	 0,67+	 cctaaggattacgctgatgcttttgc	
4,26-	 catacttttgcgcatc	 2,03-	 gacttgcgaaacaagatgccaaatgcc	 1,26+	 ttcgcaggaacttgtcttgcaagc	
6,18-	 agaaaacctacaccag	 1,92+	 tggaggcttgcatatggaaaagtgcg	 2,52+	 tagaggaatgtcacagcttggtgc	
8,18-	 gtaaagaatgtactaacc	 4,2-	 ggtataaagaggatttctttatcctcaagatcatg	 3,1+	 ctctcgatgttgtgaatttaccatctgg	
10,1-	 atagtatcaaagactacagg	 4,1+	 cggaggatggtgttaaataccgc	 4,8+	 tgattgtgatgttgtgaatttaccatctgg	
12,1-	 ctccataagaatcctg	 6,08-	 caaataatattagaaagaccaaataaagccaattcc	 5,32+	 ctattagtcttagggcaatatggg	
14,13-	 taaaacttggttgttcc	 5,93+	 gattcttttgatgtgttacgctattgtgcag	 6,53+	 gttaaacctacagcatatgcttacc	
16,1-	 ttcacataaagcatcaac	 8,05-	 cctggtttagtatactcacatacactacc	 7,17+	 aatgctcctccggtagtatggaag	
18,04-	 gtcatactcaaactgc	 7,97+	 cctaatggtgttaggcttatagttcc	 8,6+	 gtatgatggcaacgagtttgttgg	
19,73-	 caaaatgcattactcgc	 10,1-	 gtatcaaagactacaggatcataccattg	 9,26+	 cctgtcactatgcgttctaatggtac	
22,51-	 catatcttctttttgacc	 10,02+	 cagttattattggagtttgtgctgaag	 10,6+	 ggtaaatccacctaaaactgtgtggg	
24,08-	 tttgaatcattaaacagac	 12,08-	 gaatcctgatccggagttggacttggc	 11,13+	 gaagttagatagcatggcagaacg	
26,23-	 accaactttaggtggc	 12,01+	 gtggcagcaggtaatcaacctttagg	 12,64+	 gacttaaagtcagaagtaacagctg	
27,89-	 ttgctctaactctatac	 14,12-	 ataaaacttggttgttccaataactacagg	 13,18+	 gatctcctcaagtatgattatactgagg	
	 	 14,05+	 gtgtctatcctttctactatgactaataggc	 14,69+	 caaggtcttgtagcagatatttctgg	
	 	 16,09-	 cacataaagcatcaacagctgcatgag	 15,25+	 aagtgttgctatgaccatgtcatgc	
	 	 15,99+	 ggcaagcagaagcgtactacagtac	 16,62+	 catgaaagtggctcagcctacaac	
	 	 18,02-	 ctgcttgacattgggtactattggattc	 17,18+	 caacatgttttataacacgtgatgaggc	
	 	 17,94+	 cgttgtctatgatataggcaaccctaaagg	 18,18+	 taacctacctggttgtaatggtgg	
	 	 19,67-	 gtattgacagagttgtgtatactttgcc	 18,71+	 gaagagaaatattcgcacactgcc	
	 	 19,46+	 gtaacagtgtcaattgattaccatagc	 19,97+	 gatagccaataatggcaatgatgacg	
	 	 22,01-	 gaagctgagaaccagtgtcattacg	 20,38+	 gtgtggtaagttactggtaagag	
	 	 22,26-	 tccatacgcgtttgtatgtactcatctg	 21,66-	 gctcttagtaacataaactaacagtccac	
	 	 21,95+	 ccagcagtttgtagtttctggtgg	 22,48+	 ccatttcttagtaatgttagcactgg	
	 	 24,07-	 gaatcattaaacagactttttaggtctg	 22,99+	 ctctagcattacaacaaattcaagatgttg	
	 	 23,99+	 cattatgcctctaatgagtaagtgtgg	 24,55+	 aagcatttgtacaggctgctgatgc	
	 	 26,22-	 aactttaggtggctttggtcctcc	 25,27+	 gacgtaatatctatcgtatggtgcag	
	 	 26,02+	 gaaaagcgcgaatttatctgagagaagg	 26,49+	 gatagccaagatggtatagtgtggg	
	 	 27,83-	 catagccaattaaacttaacttaaactaaaatttagctc	 	
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Chapter	2:	New	findings	on	the	genetic	correlation	between	Q1	and	624I	genotypes	of	
Infectious	Bronchitis	Virus	
	
	
	
Abstract	
	A	new	Infectious	Bronchitis	virus	(IBV)	genotype,	referred	to	as	Q1,	was	detected	for	the	first	time	in	China	in	1996,	and	then	has	spread	worldwide.	The	first	report	of	Q1	genotype	in	Italy	occurred	 in	 2011	 and	 a	 deep	molecular	 investigation	 of	 a	Q1	 IBV	 strain	 isolated	 in	 Italy	 in	2013	has	raised	hypotheses	regarding	the	origin	of	this	genotype.	The	phylogenetic	analysis	of	the	S1	gene	sequence	of	the	Q1	Italian	strain	revealed,	beyond	an	obvious	correlation	with	Q1	 sequences	 available	 in	 web	 databases,	 a	 close	 relationship	 with	 sequences	 of	 the	 624I	strains	circulating	in	Italy	in	the	early	‘90s.	The	close	genetic	correlation	observed	led	to	the	hypothesis	 that	 624I	 was	 an	 ancestor	 of	 the	 Q1	 genotype.	 Despite	 the	 fact	 that	 most	heterogeneity	of	IBVs	occurs	in	the	S1	gene,	the	sequence	analysis	of	this	single	gene	was	not	sufficient	 neither	 to	 confirm	nor	 deny	 this	 hypothesis.	 In	 the	 present	 study	 an	 Italian	 624I	strain	 isolated	 in	 1996	 and	 identified	 as	 gammaCoV/AvCov/Ck/Italy/IP14425/96	was	 fully	sequenced.	 This	 represents	 the	 first	 full	 genome	 sequence	 of	 a	 virus	 belonging	 to	 the	 624I	genotype.	 The	 presence	 of	 potential	 recombination	 events	 was	 evaluated	 not	 only	 for	gammaCoV/AvCov/Ck/Italy/	 IP14425/96	 but	 also	 for	 all	 the	 complete	 Q1	 full	 genome	sequences	 available.	 Recombinant	 nature	 of	 some	 Q1	 viruses	 was	 demonstrated	 and	 the	parental	 strains	 identified.	 IBV	 full	 genome	 sequences	 phylogenetic	 analysis	 confirms	 the	genetic	 correlation	 between	 gammaCoV/AvCov/Ck/Italy/IP14425/96	 and	 Q1	 strains,	suggesting	that	624I	was	introduced	in	China	somewhere	in	the	past	and	there	it	has	evolved	into	the	Q1	genotype,	before	its	global	dissemination.	Taken	as	a	whole	the	results	presented	in	this	study	confirm	the	hypothesis	of	624I	genotype	as	Q1	genotype	ancestor.									
	 79	
Introduction		Infectious	bronchitis	(IB)	is	an	avian	disease	distributed	worldwide	that	represents	one	of	the	most	persistent	health	problems	of	the	commercial	poultry	industry	(Cook	et	al.,	2012,	de	Wit	et	 al.,	 2011a).	 The	 aetiological	 agent	 of	 the	 disease	 is	 a	 virus	 belonging	 to	 the	 genus	Gammacoronavirus,	characterized	by	a	positive	sense	single	stranded	RNA	genome	(27.6kb)	called	Infectious	Bronchitis	Virus	(IBV)	(Jackwood	and	de	Wit,	2013).	IBV	genome	can	evolve	rapidly	by	mutation	and	 recombination	events,	 resulting	 in	 the	 continue	emergence	of	new	IBV	variants,	characterized	by	little	or	negligible	cross	protection.	The	majority	of	the	variants	causes	 a	 transitory	 problem	 and	 then	 disappears	 or	 remains	 confined	 into	 a	 specific	geographical	region,	but	few	variants	are	able	to	persist	for	extend	period	of	time	and	spread	to	new	areas.	Recently,	genotypes	of	Asian	origin	have	spread	worldwide	causing	important	economic	losses	(de	Wit	et	al.,	2011a).	One	of	these	genotypes	is	the	Q1	that	was	detected	for	the	first	time	in	China	in	1996	(Yu	et	al.,	2001)	and	then	reported	in	Asia,	Middle	East,	Europe	and	South	America	(Ababneh	et	al.,	2012,	Huang	et	al.,	2004,	 Jackwood,	2012,	Marandino	et	al.,	 2015,	 Rimondi	 et	 al.,	 2009).	 In	 Italy	 the	Q1	 genotype	was	 reported	 for	 the	 first	 time	 in	2011,	causing	an	outbreak	of	disease	associated	with	respiratory	signs,	 increased	mortality,	kidney	 lesions	 and	 proventriculitis	 (Toffan	 et	 al.,	 2013).	 Since	 then,	 the	 genotype	 has	 been	continuously	detected	in	Italy	(Massi	et	al.,	2015).	Phylogenetic	analysis	performed	using	full	or	 partial	 S1	 sequences	 showed	 a	 high	 similarity	 (>99%)	 between	 Italian	 and	 Chinese	 Q1	isolates	 (Franzo	 et	 al.,	 2015,	 Massi	 et	 al.,	 2015,	 Toffan	 et	 al.,	 2013).	 Interestingly	 a	 high	homology	(94,1%)	between	strains	belonging	to	the	Q1	genotype	and	strains	belonging	to	the	624I	genotype	was	observed	(Franzo	et	al.,	2015,	Massi	et	al.,	2015),	 such	 that	 the	recently	proposed	new	IBV	nomenclature	based	on	the	S1	sequence	placed	them	in	the	same	lineage	(GI-16)	(Valastro	et	al.,	2016).	IBV	624I	has	been	reported	for	the	first	time	in	Italy	in	1993	(Capua	et	al.,	1994,	Capua	et	al.,	1999),	in	outbreaks	of	diseases	associated	with	kidney	lesions	and	drop	 in	 egg	production	 in	 breeders	 and	 layers	 (Capua	 et	 al.,	 1996).	 This	 genotype	had	largely	circulated	in	the	country	until	2004;	then	it	seemed	to	have	disappeared	up	to	2010	when	again	viruses	belonging	to	624I	genotype	were	detected	in	few	broiler	farms	affected	by	respiratory	disease	located	in	different	areas	of	Italy;	in	the	two	following	years	the	number	of	detections	 increased	 (Massi,	 2013).	 After	 2013,	 624I	 genotype	 has	 not	 been	 reported	anymore	 (Massi	 et	 al.,	 2015).	 	 A	 recent	 retrospective	 study	 carried	 out	 on	 123	 IBV	 strains	isolated	in	Italy	between	1963	and	1989	revealed	that	624I	genotype	had	not	only	circulated	long	before	its	first	reporting	in	1993,	but	that	in	fact	it	was	one	of	the	major	IBV	genotypes	
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circulating	in	the	Country	at	that	time	(Taddei	et	al.,	2012).	Evidences	of	the	presence	of	this	genotype	have	also	been	found	in	Slovenia,	where	several	624I	strains	were	isolated	between	1991	 and	 1999	 (Krapez	 et	 al.,	 2010),	 in	 Poland	 and	 South	 Africa	 (Capua	 et	 al.,	 1999)	 and	eventually	in	Russia	where	624I	genotype	was	reported	in	2002	(Bochkov	et	al.,	2006).		The	high	homology	observed	between	Q1	and	624I	genotypes	arose	questions	regarding	their	origin	 and	 evolution.	 In	 particular	 624I	 has	 been	 hypothesized	 as	 an	 ancestor	 of	 the	 Q1	genotype	(Franzo	et	al.,	2015,	Massi,	2013),	but		unfortunately	the	unavailability	of	any	624I	full	genome	sequence	didn’t	allow	to	draw	any	final	conclusions.	With	the	present	study	we	aimed	to	clarify	the	genetic	correlation	between	624I	genotype	and	Q1	 genotype.	 A	 624I	 IBV	 genotype	 strain	 was	 fully	 sequenced	 and	 phylogenetic	 analysis			performed	both	using	a	dataset	based	on	available	IBV	full	length	genome	sequences	and,	due	to	 the	 larger	number	of	published	sequences,	a	dataset	based	on	 full	S1	gene.	Furthermore,	recombination	 analysis	 was	 carried	 out	 along	 the	 whole	 genome	 sequences	 of	 624I	 or	 Q1	strains.			
Materials	and	Methods		
Virus	624I	IBV	strain	was	isolated	in	1996	in	Specific	Pathogens	Free	(SPF)	chicken	eggs	and	the	3th	passage	was	propagated	in	SPF	chicken	embryo	tracheal	organ	coltures	(TOC).	The	virus	will	be	referred	hereafter	as	gammaCoV/AvCov/Ck/Italy/IP14425/96.			
RNA	extraction,	RT-PCR	and	sequencing	The	RNA	was	extracted	using	Qiamp	viral	RNA	mini	kit	(Qiagen,	Hilden,	Germany)	following	the	 manufacture’s	 protocol.	 Viral	 RNA	 was	 firstly	 retro-transcribed	 using	 Super	 Script	 III	enzyme	 (Invitrogen,	 Carlsbad,	 USA)	 and	 then	 amplified	 using	 Ranger	 enzyme	 (Bioline,	London,	UK)	according	to	the	manufacturer’s	 instructions.	Retro-transcription,	amplification	and	 sequencing	 were	 carried	 out	 using	 primers	 previously	 designed	 for	 IBV	 full	 genome	sequencing	 (Franzo	 et	 al.,	 2015,	 Listorti	 et	 al.,	 2017).	Where	 primers	 did	 not	 work	 due	 to	sequence	differences,	new	primers	were	designed	based	on	the	newly	determined	sequences	flanking	 those	 genome	 regions	 (Table	 1).	Sequencing	was	 performed	 by	 Source	 BioScience	(Nottingham,	UK).				
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RT-PCR	of	the	3’	END	of	genome	3’	end	of	the	genome	was	determined	using	a	3’RACE	protocol	previously	described	(Laconi	et	al.,	2016).	Briefly,	RT	was	performed	with	a	primer	containing	20	Ts	followed	by	an	adaptor	sequence	at	its	5’	terminus.	This	was	amplified	by	PCR	using	2	primers,	one	within	the	end	of	the	 genome	 and	 one	matching	 the	 adaptor	 (Table	 1).	 These	 PCR	 products	were	 sequenced	towards	the	polyA	tail.		
Sequences	analysis	and	comparison	Chromatograms	 were	 analysed	 using	 the	 program	 Chromas	(http://technelysium.com.au/wp/chromas/)	 and	 sequences	 aligned	 using	 BioEdit	(http://www.mbio.ncsu.edu/bioedit/bioedit.html).	 Open	 Reading	 Frame	 (ORF)	 prediction	was	carried	out	using	ORFfinder	program	(https://www.ncbi.nlm.nih.gov/orffinder/).				
Complete	genome	sequences	analysis	A	data	set	containing	313	complete	genome	sequences	of	IBV	was	downloaded	from	ViPr,	an	open	bioinformatics	database	and	analysis	resource	for	virology	research.	This	data	set	was	reduced	in	order	to	minimize	the	computational	load.	To	this	end,	cd-hit-est	test	of	the	CD-HIT	Suite	(Li	and	Godzik,	2006)	was	used	to	cluster	sequences	that	shared	over	98%	identity	and	one	 sequence	 within	 each	 cluster	 was	 selected.	 After	 clustering,	 187	 sequences	 remained.	Sequences	 were	 aligned	 using	 ClustaW	method	 and	 phylogenetic	 analysis	 was	 carried	 out	with	MEGA7	software	(Kumar	et	al.,	2016)	using	Maximum	Likelihood	method	with	Tamura-Nei	 substitution	 model	 and	 1,000	 bootstrap	 replicates	 to	 assess	 the	 robustness	 of	 the	branches.	
	
S1	gene	sequences	analysis	A	 data	 set	 containing	 all	 available	 complete	 or	 nearly	 complete	 S1	 sequences	 (at	 least	1000bp)	was	downloaded	from	ViPr.	In	order	to	minimize	the	computation	load	the	data	set	was	 reduced	 as	 described	 in	 the	 previous	 paragraph.	 After	 clustering,	 320	 sequences	remained.	The	sequences	were	aligned	using	ClustalW	method,	and	a	phylogenetic	 tree	was	reconstructed	using	 the	Maximum	Likelihood	method	with	Kimura	2parameter	substitution	model	and	1,000	bootstrap	replicates	 to	assign	confidence	 level	 to	 the	branches	 in	MEGA	7	software.	 Based	 on	 these	 results	 a	 subset	 of	 sequences	 clustering	 with	gammaCoV/AvCov/Ck/Italy/IP14425/96	was	 selected	and	expanded	 to	 its	 original	number	
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of	 taxa.	 Sequences	 belonging	 to	 this	 dataset	 were	 aligned	 with	 ClustalW	 method,	 and	 a	phylogenetic	tree	was	reconstructed	using	the	parameters	previously	described.		
Recombination	event	analysis	Recombinant	nature	of	strain	gammaCoV/AvCov/Ck/Italy/	IP14425/96	was	evaluated	using	RDP4	 software	 (http://web.cbio.uct.ac.za/~darren/rdp.html)(Martin	 et	 al.,	 2017).		Occurrence	 of	 possible	 recombination	 events	 was	 also	 evaluated	 for	 the	 available	 Q1	 full	genome	sequences:	gammaCoV/Ck/Italy/I2022/13	(KP780179),	an	Italian	isolate	from	2013,	CK/CH/LDL/97I	 (JX195177),	a	Chinese	 isolate	 from	1997	and	UY/09/CA/01	(MF421319)	a	Uruguayan	 isolate	 from	 2009.	 The	 Kimura	 2	 parameter	 substitution	model	with	 a	window	size	of	200	nucleotides	and	a	step	size	of	20	nucleotides	was	used	to	calculate	 the	pairwise	percentage	of	identity	between	gammaCoV/AvCov/Ck/Italy/IP14425/96,	the	Q1	strains	and	13	 complete	 genome	 sequences	 of	 relevant	 strains,	 selected	 on	 the	 previous	 phylogenetic	analysis.	 Phylogenetic	 analysis	 was	 performed	 for	 those	 genome	 portions	 where	 a	 sharp	change	 in	 percentage	 of	 identity	 strongly	 suggested	 recombination	 events	 using	 a	 dataset	including	all	the	sequences	available	for	the	given	regions.			
Results	
	
Genome	organization	of	strain	gammaCoV/AvCov/Ck/Italy/	IP14425/96	A	 consensus	 sequence	 of	 27.573bp	was	 obtained	 (minimum	 coverage	 2X),	with	 the	 5’	UTR	incomplete	 by	 approximately	 100nt.	 The	ORF	 analysis	 predicted	 13	ORFs	 and	 revealed	 the	following	 genome	 organization:	 5’UTR-1a-1b-S-3a-3b-E-M-4b-4c-5a-5b-N-6b-3’UTR	 (Table	2).	The	same	genome	organisation	was	observed	for	viruses	gammaCoV/Ck/Italy/I2022/13,	CK/CH/LDL/97I	and	UY/09/CA/01,	all	belonging	to	the	Q1	genotype	(Table	2).		
Accession	number	Sequence	 of	 the	 IBV	 strain	 gammaCoV/AvCov/Ck/Italy/IP14425/96	 was	 submitted	 to	 the	GenBank	database	and	the	following	accession	number	was	assigned:	MG021194.		
Phylogenetic	analysis	of	full	genomes	of	IBV	strains	The	phylogenetic	analysis	of	the	187	representative	full	IBV	genome	sequences	demonstrated	that	 gammaCoV/AvCov/Ck/Italy/IP14425/96	 clustered	 together	 with	 Q1	 strains	gammaCoV/Ck/Italy/I2022/13,	 CK/CH/LDL/97I	 and	 UY/09/CA/01,	 occupying	 a	 basal	
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position	in	the	specific	cluster	(Figure	1).	In	the	same	clade	was	also	present	the	Uruguayan	strain	 	UY/11/CA/18	 (MF421320),	 previously	 ascribed	 to	 the	 SAI	 genotype	 (Lineage	G-11)	(Figure	1)	(Marandino	et	al.,	2015).	GammaCoV/AvCov/Ck/Italy/IP14425/96	 624I	 strain	 showed	 the	 highest	 sequence	 identity	with	 the	 Italian	 Q1	 strain	 gammaCoV/Ck/Italy/I2022/13	 (p-distance	 0.054),	 while	 the	percentage	 of	 identity	 slightly	 decrease	 when	 the	 virus	 was	 compared	 to	 the	 Chinese	 (p-distance	0.058)	and	the	Uruguayan	(p-distance	0.062)	Q1	strains.		
Phylogenetic	analysis	of	full	S1	sequences	Phylogenetic	analysis	using	a	dataset	characterized	by	320	representative	 full	S1	sequences	showed	 that	 gammaCoV/AvCov/Ck/Italy/	 IP14425/96	 clustered	 together	 with	 strains	previously	 identified	 as	 624/I	 genotype	 isolated	 in	 Italy	 in	 the	 late	 ‘80s	 and	 early	 ‘90s	 and	strains	 belonging	 to	 Q1	 genotype,	 isolated	 in	 Italy,	 in	 China,	 in	 Taiwan	 and	 South	 America	(Figure	2A).	The	highest	sequence	identity	was	observed	with	strain	624I/94/JQ901492.1	(p-distance	 =	 0.036)	 while	 the	 identity	 was	 lower	 when	 compared	 to	 Q1	 strains	 (Table	 1	 –	supplementary	material).		The	subtree	obtained	with	the	expanded	dataset	shows	3	clades,	of	which	the	one	comprising	all	 624/I	 strains	 occupies	 a	 basal	 position	 in	 respect	 to	 the	 others.	 In	 the	 remaining	 two	clades,	 Q1	 Italian,	 Chinese	 and	 some	 of	 the	 Taiwanese	 strains,	 cluster	 together,	 while	 the	remaining	 Q1	 Taiwan	 strains	 and	 all	 South	 American	 Q1	 strains	 form	 a	 distinctive	phylogenetic	group	(Figure	2B).		
Recombination	analysis	Recombination	analysis	was	performed	to	assess	the	possible	recombinant	nature	of	the	624I	strain	 gammaCoV/AvCov/Ck/Italy/	 IP14425/96	 and	 the	 Q1	 strains	gammaCoV/Ck/Italy/I2022/13,	CK/CH/LDL/97I	and		UY/09/CA/01.		Possible	 recombination	 events	 were	 identified	 in	 the	 1a	 gene	 sequence	 of	 the	 strain	CK/CH/LDL/97I	 with	 a	 H120	 vaccine	 strain	 (FJ888351)	 (Figure	 3A)	 and	 of	 the	 strain	UY/09/CA/01	 with	 UY/11/CA/18	 strain	 (Figure	 3D).	 	 Nor	 gammaCoV/Ck/Italy/I2022/13	neither	gammaCoV/AvCov/Ck/Italy/IP14425/96	Q1	strains	showed	a	similar	recombination	event	in	the	1a	gene	(Figures	3B	and	3C).	The	analysis	revealed	a	possible	recombination	event	between	Q1	strains	UY/09/CA/01	and	gammaCoV/Ck/Italy/I2022/13	 in	 the	3’	 portion	of	 the	 genome,	 including	 the	whole	 S	 gene	(Figure	3D).	
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A	 phylogenetic	 analysis	 was	 performed	 considering	 the	 merely	 1a	 gene,	 revealing	 that	CK/CH/LDL/97I	 clustered	 with	 H120	 and	 Mass	 strains,	 UY/09/CA/01	 clustered	 with	UY/11/CA/18	(SAI	genotype	-	GI-11	lineage)	and	strains	of	North	American	origin	(California	genotype	–	lineage	GI-17;	Georgia	genotype	–	lineage	GI-8;	Arkansas	genotype	–	lineage	GI-9),	while	 gammaCoV/AvCov/Ck/Italy/IP14425/96	 and	 gammaCoV/Ck/Italy/I2022/13	 form	 a	distinctive	clade	together	with	a	QX-like	Italian	strain	(ITA/90254/2005	-	FN430414)	(Figure	4).		The	 phylogenetic	 analysis	 performed	 using	 a	 dataset	 based	 on	 the	 last	 3’	 7kb	 of	 187	 IBV	genomes	showed	that	UY/09/CA/01	and	gammaCoV/Ck/Italy/I2022/13	clustered	 together,	while	UY/11/CA/18	clustered	with	two	other	viruses	belonging	to	the	SAI	genotype	(lineage	G-11)	(Figure	5).			
Discussion	In	the	present	study	the	genome	of	the	IBV	strain	gammaCoV/AvCov/Ck/Italy/	IP14425/96	isolated	in	Italy	in	1996	was	fully	sequenced.	To	our	knowledge	this	is	the	first	report	of	a	full	genome	 sequence	 of	 a	 virus	 belonging	 to	 the	 624I	 genotype.	 The	 isolate	 shows	 a	 genome	organisation	 slightly	 different	 when	 compared	 to	 the	 genome	 organization	 of	 most	 IBVs	previously	reported	(5’UTR-1a-1b-S-3a-3b-E-M-5a-5b-N-3’UTR)	(Cavanagh,	2005),	since	ORF	analysis	 	 showed	 the	presence	of	 accessory	genes	4b,	4c	 and	6b	already	 reported	 for	TCoV		and	other	IBVs	(Abolnik,	2015,	Hewson	et	al.,	2011).	Full	genomes	of	Q1	IBVs	analysed	in	the	present	paper	showed	the	same	genome	organization	observed	 in	 624I	 strain.	 It	 is	 not	 clear	 whether	 the	 scarcity	 of	 reports	 of	 presence	 of	 the	accessory	genes	4b,	4c	and	6b	in	IBVs	is	due	to	their	absence	in	some	genomes;	or	whether	it	depends	 on	 algorithms	 and	 software	 used	 by	 other	 authors	 for	 the	 ORFs	 detection.	 As	 a	matter	 of	 fact	 a	 recent	 ORF	 analysis	 of	 the	 genome	 of	 the	 Q1	 strain	gammaCoV/Ck/Italy/I2022/13,	(Marandino	et	al.,	2017)	didn’t	support	the	presence	of	ORF	6b	in	the	analysed	virus,	an	outcome	clearly	in	contrast	with	the	results	presented	here.		A	 recent	 study	 confirmed	 the	 expression	 of	 the	 4b	 protein	 after	M41	 IBV	 infection	 in	vitro	(Bentley	et	al.,	2013).	IBV	accessory	genes	3a,	3b,	5a	and	5b	are	known	to	be	not	necessary	for	viral	replication,	but	several	studies	demonstrated	their	 involvement	in	the	pathogenicity	of	the	virus	(Kint	et	al.,	2015a,	Kint	et	al.,	2015b,	Kint	et	al.,	2016,	van	Beurden	et	al.,	2017).	A	similar	function	might	be	hypothesised	also	for	genes	4b,	4c	and	6b,	especially	in	the	light	that	the	 4b	 homologous	 gene	 in	 the	 MERS-CoV	 has	 been	 reported	 as	 an	 antagonist	 of	 type	 I	interferon	response	(Yang	et	al.,	2013)	and	that	the	6b	homolog	in	SARS-CoV	was	shown	to	be	
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able	 to	 induce	 apoptosis	 (Ye	 et	 al.,	 2008).	 More	 studies	 need	 to	 be	 done	 to	 improve	 the	knowledge	 on	 these	 3	 accessory	 genes,	 in	 particular	 whether	 they	 are	 peculiar	 of	 certain	genotypes	 and	whether	 their	 expression	 influences	 the	 pathogenicity	 or	 the	 tropism	of	 the	virus.	Phylogenetic	 analyses	 performed	using	 two	different	 datasets,	 one	 built	with	 IBV	 complete	genome	sequences	and	one	built	with	 IBV	complete	or	nearly	 complete	S1	gene	 sequences,	showed	that	624I	and	Q1	genotypes	clustered	together.	The	basal	location	of	the	624I	strain	in	both	the	phylogenetic	trees	strongly	suggests	that	this	genotype	has	played	an	 important	role	 in	 the	 emergence	of	 the	Q1	genotype	and	 supports	 the	hypothesis	 that	 elects	 the	624I	genotype	as	Q1	genotype	ancestor	formulated	by	Massi	(2013).		Our	 findings,	 coupled	 with	 the	 epidemiological	 data	 available	 on	 624I	 and	 Q1	 genotypes,	strongly	suggest	that	624I	genotype	was	introduced	in	China	somewhere	in	the	past	and	there	has	 evolved	 into	 Q1	 genotype	 before	 its	 global	 dissemination.	 This	 model	 implies	 a	 long-distance	 intercontinental	 dispersion	 of	 624I	 genotype,	 whose	 mechanism	 is	 still	 not	 fully	understood;	 however	 624I	 has	 proven	 its	 ability	 to	 circulate	 for	 extend	 periods	 in	 a	geographical	area	(Taddei	et	al.,	2012)	and	to	spread	outside	of	it		(	Capua	et	al.,	1999,	Krapez	et	 al.,	 2010).	 The	 intercontinental	 dispersion	 of	 624I	 genotype	 is	 further	 supported	 by	 the	detection	of	this	genotype	in	Russia	(Bochkov	et	al.,	2006);	due	to	the	intermediate	position	between	Europe	and	the	far	East	it	is	not	unlikely	that	the	circulation	of	624I	in	this	country	might	have	played	an	important	role	on	its	introduction	in	China.	The	 relatively	 high	 genetic	 diversity	 between	 the	 624I	 strain	 gammaCoV/AvCov/Ck/Italy/	IP14425/96	and	 the	Q1	Chinese	 strain	CK/CH/LDL/97I,	 two	viruses	 isolated	only	one	year	apart,	 seems	 not	 to	 support	 this	 evolutionary	 model.	 However,	 the	 phylogenetic	 analysis	carried	out	using	the	expanded	S1	sequences	database	showed	that	the	sequences	of	Chinese	Q1	 strains	 were	 closely	 related	 with	 the	 oldest	 624I	 sequence	 available	 in	 web	 databases	(KJ941019.1),	obtained	from	a	virus	isolated	in	Italy	in	the	middle	‘80s.	These	results	suggests	that	the	introduction	of	624I	in	China	might	have	occurred	long	before	the	period	of	isolation	of	 gammaCoV/AvCov/Ck/Italy/	 IP14425/96	 and	CK/CH/LDL/97I	 strains.	 To	 further	 assess	the	robustness	of	this	evolutionary	model	the	release	of	the	full	genome	sequences,	or	at	least	the	S1	sequences,	of	624I	strains	isolated	in	Italy	from	the	late	‘80s	backwards	will	be	crucial.		The	relatively	low	identity	between	the	624I	gammaCoV/AvCov/Ck/Italy/	IP14425/96	strain	and	 Q1	 CK/CH/LDL/97I	 strain	 observed	might	 also	 rely	 on	 the	 recombinant	 nature	 of	 the	latter.	 Recombination	 analyses	 revealed	 in	 fact	 that	 strain	 CK/CH/LDL/97I	 potentially	underwent	 recombination	 with	 a	 H120	 vaccine	 strain,	 which	 has	 been	 previously	
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demonstrated	to	be	involved	in	recombination	events	 leading	to	phenomena	of	reversion	to	virulence	and	the	emerge	of	new	genotypes	in	China	(Zhang	et	al.,	2010).		However,	 the	 absence	 of	 such	 recombination	 in	 the	 genome	 of	 Q1	 Italian	 strain	gammaCoV/Ck/Italy/I2022/13	 suggests	 that	 not	 all	 Q1	 strains	 emerged	 as	 a	 result	 of	 a	recombination	 event	 with	 a	 H120	 strain.	 Recombination	 has	 proved	 to	 be	 a	 fundamental	biological	event	behind	the	emerge	of	new	IBV	genotypes	(Jackwood,	2012,	Quinteros	et	al.,	2016),	but	 it’s	 important	 to	keep	 in	mind	 that	 recombination	might	have	high	 fitness	 costs,	because	 of	 the	 decline	 of	 optimal	 intra-	 and	 inter-protein	 interactions	 (Simon-Loriere	 and	Holmes,	 2011),	 therefore	 it’s	 more	 likely	 that	 non-recombinants	 Q1	 strains	 disseminated	worldwide.	 The	 absence	 of	 the	 recombination	 event	 in	 the	 1a	 gene	 of	 Q1	 Italian	 strain	gammaCoV/Ck/Italy/I2022/13	might	also	lead	to	the	hypothesis	that	the	Chinese	and	Italian	Q1	strains	are	the	results	of	an	independent	evolution	from	624I	genotype.	However,	the	huge	differences	in	field	conditions	between	the	two	countries,	causing	a	different	genetic	pressure	on	 IBV	viruses,	 together	with	 the	results	of	 the	phylogenetic	analyses	based	on	 the	S1	gene	sequences	dataset,	in	which	Q1	Italian	strains	didn’t	form	a	distinctive	phylogenetic	clade,	but	clustered	together	with	Chinese	and	Taiwanese	strains,	make	this	hypothesis	highly	unlikely.	A	 further	 evolutionary	 scenario	 might	 be	 that	 Q1	 genotype	 evolved	 in	 Italy	 from	 624I	genotype	 and	 then	 spread	 worldwide.	 However,	 this	 hypothesis	 is	 not	 supported	 by	 the	epidemiological	data;	in	fact	Q1	genotype	was	detected	for	the	first	time	in	China,	in	1996	(Yu	et	al.,	2001),	long	before	its	first	detection	in	Italy	(Toffan	et	al.,	2013).		To	obtain	a	better	understanding	about	the	worldwide	dissemination	of	Q1	genotype,	the	full	genome	 sequence	 of	 Q1	 virus	 UY/09/CA/01	 was	 taken	 into	 account.	 This	 is	 a	 Q1	 strain	isolated	in	Uruguay	in	2009,	which	had	been	proven	to	have	undergone	recombination	with	a	major	genotype	circulating	in	that	area,	SAI	genotype	–	lineage	GI-11	(Marandino	et	al.,	2015,	Marandino	et	al.,	2017).	Full	genome	sequence	comparison	showed	that	UY/09/CA/01	strain	had	higher	identity	with	the	Q1	CK/CH/LDL/97I	Chinese	strain	(p-distance	0.051)	rather	than	with	 the	 Q1	 gammaCoV/Ck/Italy/I2022/13	 Italian	 strain	 (p-distance	 0.053).	 Moreover	 the	recombination	 analysis	 revealed	 that	 UY/09/CA/01	 sequence	 presented	 a	 recombination	event	 in	 the	 1a	 gene,	 as	 it	 has	 occurred	 in	 CK/CH/LDL/97I	 strain.	 However,	 the	 major	parental	sequences	for	the	recombination	event	in	the	1a	gene	of	UY/09/CA/01	strain	were	identified	to	belong	to	UY/11/CA/18	strain	and	to	Arkansas	genotype	viruses	(lineage	GI-9).	This	 finding	 was	 further	 confirmed	 by	 the	 phylogenetic	 analysis	 of	 the	 merely	 1a	 gene	sequence,	 which	 showed	 that	 strain	 UY/09/CA/01	 clustered	 together	 with	 strain	UY/11/CA/18	 and	 North	 American	 strains.	 Interestingly	 the	 recombination	 analysis	
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identified	gammaCoV/Ck/Italy/I2022/13	as	potential	major	parental	strain	in	the	last	third	of	UY/09/CA/01	genome,	as	 further	suggested	by	 the	phylogenetic	analysis	on	 that	portion	of	the	 genome.	 These	 data	 seem	 to	 support	 the	 previously	 suggested	 hypothesis	 that	 Q1	genotype	has	not	been	 introduced	 in	South	America	directly	 from	China,	but	via	an	 indirect	route	 from	 Italy	 (Marandino	 et	 al.,	 2015).	 However,	 the	 scarcity	 of	 South	 American	 Q1	sequences	available	in	this	portion	of	the	genome,	makes	this	hypothesis	not	conclusive.			In	 accordance	with	previous	 studies,	we	observed	 that	 recombination	events	 can	occur	not	only	within	the	Spike	gene,	known	to	generally	lead	to	the	emerge	of	new	genotypes	(Lim	et	al.,	2011,	Moreno	et	al.,	2017),	but	also	in	other	regions	of	the	IBV	genome	(Quinteros	et	al.,	2016,	Zhang	et	al.,	2010)	with	potential	effects	on	the	pathogenicity	of	the	virus	(Armesto	et	al.,	2009).	Taken	 as	 a	 whole,	 the	 data	 presented	 in	 this	 study	 clearly	 support	 the	 hypothesis	 that	identifies	 624I	 genotype	 as	 the	 ancestor	 of	 Q1,	 one	 of	 the	 recently	 emerged	 Asian	 IBV	genotypes.	 An	 evolutionary	 model,	 which	 implies	 the	 introduction	 of	 624I	 in	 China	 and	 a	subsequent	 evolution	 into	 the	 Q1	 genotype	 in	 that	 country	 before	 its	 dissemination	worldwide,	is	proposed.	Unfortunately	the	scarcity	of	availability	of	624I	and	Q1	full	genome	sequences	makes	difficult	 to	 accept	beyond	any	doubts	 the	 evolutionary	 and	dissemination	models	proposed,	remarking	the	urgency	of	increase	sequence	data	availability.																		
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Table	1:	Primers	used	for	reverse	transcription,	PCR	and	sequencing.	
Primer names generally indicate approximate binding positions in the 624I genome.  
Coding and anticoding sense primers are labeled + and neg respectively. 
†		Indicates	primers	designed	for	the	624I	IBV	strain	sequencing	based	on	the	newly	determined	sequences.	
 
 
 
 
RT Sequence 5’-3’ Sequencing Sequences 5’-3’ 
2.06neg tttagtaaaaagaccacc 0.67+ cctaaggattacgctgatgcttttgc 
4.26neg catacttttgcgcatc 1.26+ ttcgcaggaacttgtcttgcaagc 
6.18neg agaaaacctacaccag 2.52+ tagaggaatgtcacagcttggtgc 
8.18neg gtaaagaatgtactaaac 3.04+ tacaccaatgtcacagcttggtgc 
10.10neg cacagttgtgtgcactaactcaaag 3.10+ ctctcgatgttgtgaatttaccatctgg 
12.10neg ctccataagaatcctg IB4.6+† gtacggatgaagtaatagaagcttc 
14.13neg taaaacttggttgttcc 4.80+ tgattgtgatgttgtgaatttaccatctgg 
16.10neg ttcacataaagcatcaac IB5.15neg† catcagtatcaggtgttaacttataag 
QX18.10neg catagaagaagaatggcatagctttc 5.32+ ctattagtcttagggcaatatggg 
19.73neg caaaatgcattactcgc IB5.70+† gtgtggtttatttacacaagtaatccag 
22.51neg catatcttctttttgacc 6.53+ gttaaacctacagcatatgcttacc 
24.08neg tttgaatcattaaacagac IB6.7neg† ctaatcgttctgaaagtgcctgatcaag 
26.24neg ccaagatacatttccag IB7.15+† ctttataacaagatctggtgctaaac 
27.89neg Ttgctctaactctatac 7.17+ aatgctcctccggtagtatggaag 
Dta-Adaptneg gcatctcgaggcttgtggcttttttttttttttttttttta IB8.2neg† caacccaaactagcattattgtaaacac 
Dtc-Adaptneg gcatctcgaggcttgtggctttttttttttttttttttttc 8.60+ gtatgatggcaacgagtttgttgg 
Dtg-Adaptneg gcatctcgaggcttgtggctttttttttttttttttttttg IB8.61neg† taccaacaaactcgttgccatc 
PCR Sequence 5’-3’ 9.26+ cctgtcactatgcgttctaatggtac 
0.06+ gcgctagatttccaacttaacaaaacg 10.60+ ggtaaatccacctaaaactgtgtggg 
2.03neg gacttgcgaaacaagatgccaaatgcc 11.13+ gaagttagatagcatggagagacg 
1.92+ tggaggcttgcatatggaaaagtgcg 12.64+ gacttaaagtcagaagtaacagctg 
4.20neg ggtataaagaggatttctttatcctcaagatcatg 13.18+ gatctcctcaagtatgattatactgagg 
4,10+ cggaggatggtgttaaataccgc QX13.90+ gaggtgacgtctaaatattttgaatg 
6.08neg caaataatattagaaagaccaaataaagccaattcc 14.69+ caaggtcttgtagcagatatttctgg 
5.90+† gactatggtaaagactcatttgacg 15.25+ aagtgttgctatgaccatgtcatgc 
8.05neg cctggtttagtatactcacatacactacc IB15.60+† ggtgcagcttggtgattttacctttg 
7.97+ cctaatggtgttaggcttatagttcc IB16.40neg† ctataaccttgaaacactgacgtg 
10.10neg gtactaaagactacaggatcataccattg QX16.80neg gaatcagctgtaacacagaatataac 
10.02+ cagttattattggagtttgtgctgaag 16.62+ catgaaagtggctcagcctacaac 
12.08neg gaatcctgatccggagttggacttggc 17.18+ caacatgttttataacacgtgatgaggc 
12.01+ gtggcagcaggtaatcaacctttagg 18.02neg ctgcttgacattgggtactactggattc 
14.12neg ataaaacttggttgttccaataactacagg 18.18+ taacctacctggttgtaatggtgg 
14.05+ gtgtctatcctttctactatgactaataggc 18.71+ gaagagaaatattcgcacactgcc 
16.09neg cacataaagcatcaacagctgcatgag 19.67neg† gtattgacagagttgtgtatactttggc 
QX15.06+ gatgattgcactcgcatagtacctc 19.46+ gtaacagtgtcaattgattaccatagc 
QX18.10neg catagaagaagaatggcatagctttc 19.97+ gatagccaataatggcaatgatgacg 
17.62+† tactcaggcttatgcttgttggaagc IB20.40+† cattgtttatagtgtctcttttgtttgcac 
19.67neg gtattgacagagttgtgtatactttgcc IB21.70neg† gtcacaaattgcccttatgtaagttatgg 
19.46+ gtaacagtgtcaattgattaccatagc IB21.95+† ccagcagtttgtagtttctggtgg 
22.26neg tccatacgcgtttgtatgtactcatctg IB23.60neg† cacgtgcagtgatgtagtaactacc 
IB21.95+ ccagcagtttgtagtttctggtgg QX24.20neg ctacttacactgtttcaattgttttctc 
IB24.07neg gaatcattaaacagactttttaggtctg IB24.70+† gtactcttggtactgaacaagcag 
23.99+ cattatgcctctaatgagtaagtgtgg IB25.60neg† ctcttgaaaagagagcatgaaacaaagagg 
26.24neg† ccaagatacatttccag QX27.20+ cctacatgtctatcgccaggg 
26.02+ gaaaagcgcgaatttatctgagagaagg   
27.83neg catagccaattaaacttaacttaaactaaaatttagctc   
26.49+ gatagccaagatggtatagtgtggg   
Adapt neg gcatctcgagggttgtggc   
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Table	2	Genomic	organization	of	624I	and	Q1	strains.	Strains	belonging	to	the	two	genotypes	show	the	same	genome	organization.	Accessory	genes	4b,	4c	and	6b	have	been	identified	in	the	genome	of	all	the	4	viruses.	
Gene	 Genome	position	gammaCov/AvCoV/Ck/Italy/IP14425/96	 gammaCoV/Ck/Italy/I2022/13	 CK/CH/LDL/97I	 UY/09/CA/01	1a	 433-12288	 432-12290	 433-12291	 432-12254	1ab	 12363-20321	 12365-20323	 12366-20324	 12329-20287	S	 20272-23772	 20274-23774	 20275-23775	 20238-23711	3a	 23772-23945	 23774-23947	 23775-23948	 23738-23911	3b	 23945-24136	 23947-24141	 23938-24142	 23911-24105	E	 24117-24404	 24122-24430	 24123-24431	 24086-24394	M	 24394-25074	 24423-25103	 24424-25104	 24387-25067	4b	 25075-25359	 25104-25388	 25105-25377	 25068-25352	4c	 25280-25450	 25309-25470	 25310-25387	 25273-25434	5a	 25434-25631	 25454-25651	 25466-25663	 25418-25614	5b	 25628-25876	 25648-25896	 25660-25908	 25612-25860	N	 25819-27045	 25839-27068	 25851-27080	 25803-27032	6b	 27054-27278	 27058-27222	 27089-27403	 27041-27265	
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Figure	 1	 Phylogenetic	 tree	 based	 on	 Maximum	 Likelihood	method	 with	 Tamura-Nei	 substitution	 model	 using	 187	representative	complete	IBV	and	TCoV	genomes.	For	easiness	of	representation,	 strains	 considered	 in	 the	 present	 study	 are	marked	in	red.	
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A B 
Figure	 2	 A	 Phylogenetic	 tree	 based	 on	 Maximum	Likelihood	 method	 with	 Kimura-2	 model	 using	 320	 S1	gene	complete	 sequences.	 For	 easiness	of	 representation,	strain	 reported	 in	 the	 present	 study	 and	 closely	 related	strains	 are	marked	 in	 red.	B	 Expanded	 phylogenetic	 tree	based	 on	 Maximum	 Likelihood	 method	 with	 Kimura-2	model	 using	 S1	 complete	 sequences	 closely	 related	 to	gammaCoV/AvCov/Ck/Italy/	IP14425/96.		
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Figure	3 RDP	screenshots	displaying	the	possible	recombination	events	associated	with	CK/CH/LDL/97I	(A),	gammaCoV/Ck/Italy/I2022/13	(B),	gammaCoV/AvCov/Ck/Italy/IP14425/96	(C)	and	UY/09/CA/01	(D).	Each	panel	displays	the	pairwise	identities	among	the	possible	recombinant	and	its	putative	parents.	Crossover	sites	indicated	sharp	changes	in	pairwise	identity	are	indicated	by	arrows.	A	Comparison	among	the	putative	recombinant	CK/CH/LDL/97I	shows	sharp	changes	in	the	pairwise	identity	within	the	1a	gene,	H120	vaccine	strain	FJ888351	has	been	identified	as	putative	parental	strains	for	that	genomic	region.	B	Comparison	among	the	putative	recombinant	gammaCoV/Ck/Italy/I2022/13	shows	sharp	changes	in	the	pairwise	identity	within	the	1a	gene;	strain	gammaCoV/AvCov/Ck/Italy/IP14425/96	has	been	identified	as	major	parental	strain	for	that	region.	C	Comparison	among	the	putative	recombinant	gammaCoV/AvCov/Ck/Italy/IP14425/96	shows	sharp	changes	in	the	pairwise	identity	within	the	1a	gene;	strain	gammaCoV/Ck/Italy/I2022/13	has	been	identified	as	major	parental	strain	for	that	genomic	region.	D	Comparison	among	the	putative	recombinant	UY/09/CA/01	shows	sharp	changes	in	the	pairwise	identity	in	the	last	7kb	of	the	genome;	strain	gammaCoV/Ck/Italy/I2022/13	has	been	identified	as	major	parental	strain	for	that	genomic	region. 
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Figure	 3	 RDP	 cr enshots	 displaying	 the	 possible	 r combination	 events	 associated	 with	 CK/CH/LDL/97I	 (A),	gammaCoV/Ck/Italy/I2022/13	(B),	gammaCoV/AvCov/Ck/Italy/IP14425/96	(C)	and	UY/09/CA/01	(D).	Each	panel	displays	the	pairwise	 identities	 among	the	possible	 recombinant	and	 its	putative	parents.	Crossover	sites	 indicated	sharp	 changes	 in	pairwise	 identity	 are	 indicated	 by	 arrows.	 A	 Comparisons	 among	 the	 putative	 recombinant	 CK/CH/LDL/97I	 shows	 sharp	changes	 in	 the	 airwis 	 identity within	 the	1a	gene,	H120	vaccine	str in	FJ888351	has	been	 identified	 s	putative	parental	strains	for	that	genomic	region.	B	Comparisons	among	the	putativ 	recombinant	gammaCoV/Ck/Italy/I2022/13	shows	sharp	changes	 in	 the	pairwise	 identity	within	 the	 1a	 gene,	 strain	 gammaCoV/AvCov/Ck/Italy/IP14425/96	has	been	 identified	 as	major	 parental	 strain	 for	 that	 region.	 C	 Comparisons	 among	 the	 putative	 recombinant	gammaCoV/AvCov/Ck/Italy/IP14425/96	 shows	 sharp	 changes	 in	 the	 pairwise	 identity	 within	 the	 1a	 gene,	 strain	gammaCoV/Ck/Italy/I2022/13	has	been	identified	as	major	parental	strain	for	that	genomic	region.	D	 Comparisons	among	the	putative	recombinant	UY/09/CA/01	shows	sharp	 changes	 in	 the	pairwise	 identity	 in	 the	 last	 7kb	of	 the	genome,	strain	gammaCoV/Ck/Italy/I2022/13		has	been	identified	as	major	parental	strain	for	that	genomic	region.	
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Figure	 4	 Phylogenetic	 tree	 based	 on	 Maximum	Likelihood	 method	 with	 Tamura-Nei	 substitution	model	using	187	representative	IBV	and	TCoV	1a	gene.	For	 easiness	 of	 representation,	 strains	 considered	 in	the	present	study	are	marked	in	red				
	 94	
											
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	 5	 Phylogenetic	 tree	 based	 on	 Maximum	 Likelihood	method	 with	 Tamura-Nei	 substitution	 model	 using	 187	representative	IBV	and	TCoV	sequences	of	the	last	7kb	of	the	genome.	For	easiness	of	representation,	strains	considered	in	the	present	study	are	marked	in	red						
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Identification	 of	 IBV	 QX	 vaccine	 markers:	 Should	 vaccine	 acceptance	 by	 authorities	
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Abstract		IBV	 genotype	 QX	 causes	 sufficient	 disease	 in	 Europe	 for	 several	 commercial	 companies	 to	have	 started	 developing	 live	 attenuated	 vaccines.	 Here,	 one	 of	 those	 vaccines	 (L1148)	was	fully	consensus	sequenced	alongside	its	progenitor	field	strain	(1148-A)	to	determine	vaccine	markers,	 thereby	 enabling	detection	 on	 farms.	 Twenty-eight	 single	 nucleotide	 substitutions	were	associated	with	the	1148-A	attenuation,	of	which	any	combination	can	identify	vaccine	L1148	in	the	field.	Sixteen	substitutions	resulted	in	amino	acid	coding	changes	of	which	half	were	 in	 spike.	 One	 change	 in	 the	 1b	 gene	 altered	 the	 normally	 highly	 conserved	 final	 5	nucleotides	 of	 the	 transcription	 regulatory	 sequence	 of	 the	 S	 gene,	 common	 to	 all	 IBV	 QX	genes.	 No	 mutations	 can	 currently	 be	 associated	 with	 the	 attenuation	 process.	 Field	vaccination	 strategies	 would	 greatly	 benefit	 by	 such	 comparative	 sequence	 data	 being	mandatorily	 submitted	 to	 regulators	 prior	 to	 vaccine	 release	 following	 a	 successful	registration	process.			
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	1.Introduction		Infectious	Bronchitis	virus	(IBV)	primarily	 infects	domestic	 fowl	and	causes	respiratory	and	other	 diseases	 [1]	 resulting	 in	 serious	 losses	 in	 unprotected	 birds.	 It	 is	 mainly	 controlled	using	 live	 vaccines	 made	 from	 field	 viruses	 isolated	 during	 disease	 outbreaks.	 Most	 IBV	vaccines	are	prepared	by	multiple	passage	of	such	IBV	field	viruses	in	eggs	to	yield	attenuated	strains	which	no	 longer	cause	disease	but	 can	still	 stimulate	a	protective	 immune	response	([2,3]).	There	are	many	IBV	genotypes	and	generally	optimal	protection	relies	on	vaccination	with	the	same	genotype.		Some	genotypes	have	been	continuously	detectable	since	suitable	detection	techniques	were	developed	while	others	have	appeared,	briefly	caused	a	problem,	then	disappeared	([4,5]).	In	general	 such	 transient	 genotypes	 do	 not	 cause	 sufficient	 problem	 to	warrant	 a	 commercial	live	 vaccine	 development.	 However	 other	 genotypes	 have	 caused	 a	 problem	 for	 a	 longer	period	such	as	IBV	793B,	and	led	several	companies	to	prepare	appropriate	vaccines.	IBV	QX	(newly	 classified	 as	 GI-19	 lineage	 [6])	 increasingly	 appears	 to	 fall	 into	 this	 category.	 It	appeared	in	China	and	then	Europe	some	15	years	ago	[7]	and	has	already	caused	sufficient	problems	[8]	for	several	major	European	located	poultry	biological	companies	to	develop	live	vaccines.		Effective	knowledge	of	the	prevalence	and	circulation	of	different	IBV	genotypes	in	any	area	is	not	straightforward.	One	complication	can	be	the	presence	of	the	very	live	vaccines	previously	applied	for	disease	control.	A	recent	example	concerned	IBV	793B	in	an	area	of	 Italy	where	withdrawal	of	IBV	793B	live	vaccine	led	to	the	genotype’s	disappearance;	thereby	suggesting	that,	virulent	IBV	793B,	previously	thought	ubiquitous,	was	largely	absent	[9].	Most	situations	are	not	clear-cut	and	conclusions	become	hampered	by	the	inability	to	distinguish	between	a	genuine	disease-	causing-field-virus	and	the	attenuated	commercial	vaccine	applied	to	protect	birds	 against	 it.	 Fortunately	 molecular	 diagnostic	 developments	 make	 such	 differentiation	relatively	 straightforward,	 but	 only	 if	 the	 field	 strain	 used	 to	 make	 any	 particular	 vaccine	(progenitor)	is	available	to	diagnosticians.	Specifically,	comparison	of	the	full	sequences	of	the	vaccine	 and	 the	 progenitor	 reveals	 the	 changes	 which	 occurred	 in	 the	 largely	 random	attenuation	process,	and	those	changes	are	invariably	unique	to	that	particular	vaccine.	While	for	IBV	little	work	has	been	undertaken	or	published,	for	AMPV,	it	has	been	shown	that	two	
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vaccines	produced	by	passaging	the	identical	progenitor	field	strain,	did	not	contain	any	of	the	same	 attenuation-associated	 mutations	 (manuscript	 in	 preparation).	 Furthermore	 where	AMPV	vaccines	persist	in	the	field	and	mutate	further,	those	mutations	are	never	found	to	be	back-	mutations	to	the	original	progenitor	virus	[10,11].		In	the	current	work	we	fully	consensus	sequenced	the	complete	genomes	of	a	commercial	IBV	QX	 vaccine	 which	 had	 been	 prepared	 by	 80	 chicken-embryo-passages	 of	 its	 virulent	progenitor	1148-A	[12].	We	continue	to	show	how	the	sequence	comparison	can	be	used	to	assist	in	the	assessment	of	IBV	QX	prevalence	on	farms.		2.	Materials	and	methods		2.1.	Viral	RNA	extraction,	RT-PCRs	and	sequencing		Samples	 of	 a	 production	 batch	 of	 vaccine	 strain	 L1148	 and	 an	 aliquot	 of	 its	 egg	 isolated	progenitor	 strain	 1148-A,	 were	 com-	 pared.	 The	 RNA	 of	 both	 viruses	 was	 extracted	 using	Qiamp	 viral	 RNA	minikit	 (Qiagen,	 Hilden,	 Germany)	 following	 the	manufacturer’s	 protocol.	Viral	 RNA	was	 retro-transcribed	 using	 Super	 Script	 III	 enzyme	 (Invitrogen,	 Carlsbad,	 USA)	then	amplified	using	Ranger	enzyme	(Bioline,	London,	UK)	according	to	each	manufacturer’s	instructions.	 Retro-transcription,	 amplification	 and	 sequencing	 used	 primers	 previously	designed	 for	 IBV	 full	 genome	 sequencing	 [13].	 Where	 primers	 did	 not	 work	 due	 to	 QX	sequence	differences,	new	primers	were	designed	based	on	the	newly	determined	sequences	flanking	 those	 genome	 regions	 (Table	 1).	 Sequencing	was	 performed	 by	 Source	 BioScience	(Nottingham,	 UK).	 All	 regions	 were	 sequenced	 twice.	 Where	 vaccine	 and	 progenitor	sequences	 differed,	 the	 locations	 were	 sequenced	 again,	 starting	 with	 a	 new	 retro-transcription	of	the	region.		
2.2.	RT-PCR	of	the	3’	END	of	genome		
The	3’	end	of	the	genome	was	determined	using	a	3’RACE	protocol	previously	described	[14].	Briefly,	RT	was	performed	with	a	primer	containing	20	Ts	followed	by	an	adaptor	sequence	at	its	5’	terminus,	then	amplified	using	2	PCR	primers,	one	within	the	genome	end	and	the	other	matching	the	adaptor	(Table	1).	PCR	products	were	sequenced	towards	the	polyA	tail	using	a	genome	end	primer.		2.3.	Sequences	analysis	and	comparison		
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Chromatograms	 were	 analysed	 using	 the	 program	 Chromas	(http://technelysium.com.au/wp/chromas/)	 and	 sequences	 aligned	 using	 BioEdit	(http://www.mbio.ncsu.edu/bioedit/bioedit.html).	 Open	 Reading	 Frame	 (ORF)	 prediction	was	carried	out	using	ORF-	finder	program	(https://www.ncbi.nlm.nih.gov/orffinder/).		2.4.	Accession	numbers		Sequences	of	IBV	strains	L1148	(QX	vaccine	strain)	and	1148-A	(QX	progenitor	strain)	were	submitted	 to	 the	 GenBank	 database	 and	 were	 assigned	 the	 following	 accession	 numbers:	KY933090	(L1148)	and	KY933089	(1148-A).		3.	Results	and	discussion		A	consensus	sequence	of	both	viruses	was	obtained,	except	for	approximately	the	first	100nt	of	 the	 5’UTRs.	 The	 ORF	 analysis	 predicted	 13	 ORFs	 for	 each,	 resulting	 in	 the	 genome	organization:	 5’UTR-1a-1b-S-3a-3b-E-M-4b-4c-5a-5b-N-6b-3’UTR.	 Transcription	 regulatory	sequences	excluding	that	for	the	polymerase	gene	(TRS-Bs)	were	identified	and	are	reported	in	Table	2.	For	the	S	gene,	a	substitution	was	detected	within	the	normally	highly	conserved	final	5	nucleotide	region	of	the	8	nucleotide	TRS-B,	as	shown	in	Table	2.		Comparison	of	the	two	sequences	showed	28	nucleic	acid	substitutions	between	the	vaccine	strain	and	its	progenitor.	Eleven	nucleic	acid	substitutions	were	located	in	the	1a-1b	genes,	8	in	the	S	gene,	two	changes	each	in	the	5’UTR,	5b	gene	and	3’UTR,	and	one	change	each	in	the	E,	M	 and	5a	 genes	 (Table	3).	Of	 the	28	nucleic	 acids	differences,	 16	 resulted	 in	 amino	 acid	changes,	and	of	the	remainder,	8	were	silent	mutations	and	4	were	in	un-	translated	regions.	Of	15	coding	changes,	7	were	located	in	the	S	gene,	five	in	the	1a-1b	gene	and	one	each	in	the	E,	M	and	5b	genes	(Table	3).		Nucleotide	substitutions	likely	to	affect	protein	structure	and	function	occurred	in	S1	5b	and	Nsp	 13.	 In	 S1,	 amino	 acid	 charge	 alterations	 occurred	 in	 the	 S1	 gene	 corresponding	 to	nucleotide	positions	20,460	(Met->His)	and	21,438	(Glu->Gln),	and	in	the	5b	gene	at	position	25,664	(Asp->Tyr).	 In	Nsp13,	an	aromatic	Pro	was	substituted	by	smaller	and	aliphatic	Leu	corresponding	 to	 nucleotide	 position	 15,693.	 The	 availability	 of	 vaccine	 and	 progenitor	sequences,	 and	 comparison	 of	 those	 sequences	 to	 determine	 vaccine	 markers	 is	 vital	 in	tracking	 IBV	vaccines.	For	QX	L1148	vaccine,	 field	detections	 containing	only	one	of	 the	28	nucleotide	substitutions	arising	from	the	attenuation	process	would	be	highly	 likely	to	have	
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arisen	 from	 that	 vaccine	 having	 been	 applied	 within	 transmissible	 distance.	 Indeed,	 a	commonly	 used	 S1	 diagnostic	 RT-PCR	 [15]	 covers	 the	 mutation	 at	 21,073.	 Sequencing	 of	genome	sections	covering	several	of	the	substitutions	would	make	that	conclusion	irrefutable.	For	simplicity,	sequencing	of	a	region	containing	a	high	density	of	the	changes	would	be	ideal.	The	 region	 of	 S1	 containing	 four	 mutations	 could	 be	 readily	 RT-PCR	 amplified	 and	economically	 sequenced	 using	 primer	 sequences	 provided	 here.	 However	 as	 for	 any	 IBV	genotype,	 recombination	may	have	occurred	hence	only	 for	 those	genome	sections	actually	sequenced	could	vaccine	QX	L1148	origin	be	attributed.		Similar	 to	 our	 previous	 diagnostic	 Avian	 metapneumovirus	 vaccines	 studies	 [16],	 our	research	 facility	 was	 fortunate	 to	 have	 isolated,	 and	 hence	 have	 access	 to,	 the	 IBV	 QX	progenitor	 strain.	 Unfortunately	 vaccine	 progenitors	 or	 their	 sequences	 are	 not	 generally	made	 available	 to	 the	 research	 community	 by	 the	 companies	 producing	 the	 vaccines.	 This	leads	to	an	inability	to	distinguish	vaccine	and	field	virus,	hence	prevents	intelligent	tailoring	of	IBV	vaccine	administration	in	a	disease	situation.	In	our	opinion,	this	is	unacceptable.	This	situation	 also	 means	 that	 vaccines	 can	 become	 wrongly	 implicated	 in	 causing	 a	 disease	problem,	 say	 if	 a	disease	outbreak	becomes	wrongly	 attributed	 to	 a	 suspected	 reversion	 to	virulence	event.	Hence	all	parties	aspiring	to	open	and	informed	vaccination	of	poultry	have	an	interest	in	improving	this	situation.	In	our	view,	vaccine	regulatory	bodies	should	require	that	both	the	vaccine	and	vaccine	progenitor	sequences	are	deter-	mined	and	made	available	at	 the	 time	 of	 vaccine	 registration	 or	 release	 in	 their	 jurisdiction.	 While	 the	 consensus	sequences	presented	in	our	study	relied	on	the	possession	of	oligonucleotides	designed	over	a	considerable	period,	vaccine	producers	could	readily	use	next	generation	sequencing	to	this	end.		A	 further	 potentially	 useful	 aspect	 of	 having	 identified	 mutations	 occurring	 during	 the	attenuation	 process	 is	 that	 they	 could	 seed	 further	 studies	 to	 determine	 which	 were	responsible	 of	 the	 virulence	 loss,	 and	 beyond	 that,	 by	 what	 mechanism	 they	 arose.	 For	example,	the	S	gene	TRS	mutation	may	have	either	up	or	down	regulated	S	gene	transcription	[17],	5b	protein	changes	may	have	altered	visibility	of	the	virus	to	the	host	immune	response	due	 to	 its	 reported	 involvement	 in	 immune	 shut	 off	 [18]	 and	 alterations	 in	 the	 replicase	affecting	pathogenicity	[19]	may	have	all	contributed	to	the	vaccine	phenotype.	The	changes	in	 S	 may	 also	 be	 involved	 in	 attenuation	 but	 there	 remains	 some	 uncertainty	 as	 to	 this	protein’s	role	in	virulence	[20].	Currently	no	role	can	be	attributed	to	any	of	these	mutations	but	further	studies	might	inform	further	and	assist	in	rational	vaccine	design	by	making	use	of	
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the	IBV	reverse	genetics	systems	now	available	
Table	 1.	 Primers	 used	 for	 reverse	 transcription,	 PCR	 and	 sequencing.	 Primer	 names	 generally	 indicate	approximate	binding	 	positions	 in	 the	QX	genome.	Coding	and	anticoding	sense	primers	are	 labeled	+	and	neg	respectively.		
RT	 Sequence	5’-3’	 Sequencing	 Sequence	5’-3’	2.06neg	 tttagtaaaaagaccacc	 0.67+	 cctaaggattacgctgatgcttttgc	4.26neg	 catacttttgcgcatc	 1.26+	 ttcgcaggaacttgtcttgcaagc	6.18neg	 agaaaacctacaccag	 2.52+	 tagaggaatgtcacagcttggtgc	8.18neg	 gtaaagaatgtactaacc	 3.04+	 tacaccaatgtcacagcttggtgc	QX10.20neg	 cacagttgtgtgcactaactcaaag	 3.1+	 ctctcgatgttgtgaatttaccatctgg	12.1neg	 ctccataagaatcctg	 4.8+	 tgattgtgatgttgtgaatttaccatctgg	14.13neg	 taaaacttggttgttcc	 5.32+	 ctattagtcttagggcaatatggg	QX16,15neg	 ggtcaacatactaacctcatctacc	 6.53+	 gttaaacctacagcatatgcttacc	QX18.10neg	 catagaagaagaatggcatagctttc	 7.17+	 aatgctcctccggtagtatggaag	19.73neg	 caaaatgcattactcgc	 QX	8.50	+		 gtgctatacatgtacacaccgctg	22.51neg	 catatcttctttttgacc	 9.26+	 cctgtcactatgcgttctaatggtac	QX24.20neg	 ctacttcacctgtttcaattgttttctc	 QX	9.40neg	 ctaatttatcgggttgaactttctgagc	26.23neg	 accaactttaggtggc	 10.6+	 ggtaaatccacctaaaactgtgtggg	27.89neg	 ttgctctaactctatac	 QX10.90neg	 cagccaagtctctatcaaagattgac	Dta-Adaptneg	 gcatctcgaggcttgtggcttttttttttttttttttttta	 QX11.50+	 gaagcaggcaatcaaatttatgttgac	Dtc-Adaptneg	 gcatctcgaggcttgtggctttttttttttttttttttttc	 11.13+	 gaagttagatagcatggagagacg	Dtg-Adaptneg	 gcatctcgaggcttgtggctttttttttttttttttttttg	 12.64+	 gacttaaagtcagaagtaacagctg		 	 13.18+	 gatctcctcaagtatgattatactgagg	
PCR	 Sequence	5’-3’	 14.69+	 caaggtcttgtagcagatatttctgg	0.06+	 gcgctagatttccaacttaacaaaacg	 15.25+	 aagtgttgctatgaccatgtcatgc	2.03neg	 gacttgcgaaacaagatgccaaatgcc	 16.09neg	 cacataaagcatcaacagctgcatgag	1.92+	 tggaggcttgcatatggaaaagtgcg	 15.99+	 ggcaagcagaagcgtactacagta	4.2neg	 ggtataaagaggatttctttatcctcaagatcatg	 16.62+	 catgaaagtggctcagcctacaac	4.1+	 cggaggatggtgttaaataccgc	 QX16.80neg	 gaatcagctgtaacacagaatataac	6.08neg	 caaataatattagaaagaccaaataaagccaattcc	 17.18+	 caacatgttttataacacgtgatgaggc	5.93+	 gattcttttgatgtgttacgctattgtgcag	 18.18+	 taacctacctggttgtaatggtgg	8.05neg	 cctggtttagtatactcacatacactacc	 18.71+	 gaagagaaatattcgcacactgcc	QX7.80+	 cttccatagcattgtttgcttctag	 19.86+	 tgcacatgtttctgttgctttcagattg	10.02+	 cagttattattggagtttgtgctgaag	 QX19.50+	 agtagccaatgatggcaatgacgatg	12.08-	 gaatcctgatccggagttggacttggc	 QX19.90+	 gcttcagtcggcttggacatgtgg	12.01+	 gtggcagcaggtaatcaacctttagg	 19.97+	 gatagccaataatggcaatgatgacg	14.12-	 ataaaacttggttgttccaataactacagg	 QX20.60+	 ctgcacatgagtgcactgttggtg	QX13.90+	 gaggtgacgtctaaatattttgaatg	 QX21.70neg	 caaaattcgtgcttaattcacctg	QX16.15-	 ggtcaacatactaacctcatctacc	 22.48+	 ccatttcttagtaatgttagcactgg	QX15.06+	 gatgattgcactcgcatagtacctc	 22.99+	 ctctagcattacaacaaattcaagatgttg	QX18.10neg	 catagaagaagaatggcatagctttc	 24.60+	 cttgttgtcttttttcgtatacatgggtag	17.94+	 cgttgtctatgatataggcaaccctaaagg	 25.27+	 gacgtaatatctatcgtatggtgcag	19.67neg	 gtattgacagagttgtgtatactttgcc	 QX25.87+	 ctcaattaagggttttagataggttaattc	QX18.10neg	 catagaagaagaatggcatagctttc	 QX26.88neg	 gacatgtaggtaatcaaactacatgcc	19.46+	 gtaacagtgtcaattgattaccatagc	 QX27.20+	 cctacatgtctatcgccaggg	22.26neg	 tccatacgcgtttgtatgtactcatctg	 	 	QX21.90+	 ggttaatccttgtgaagatgttaatcaac	 	 	QX24.20neg	 ctacttcacctgtttcaattgttttctc	 	 	23.99+	 cattatgcctctaatgagtaagtgtgg	 	 	26.22neg	 aactttaggtggctttggtcctcc	 	 	26.02+	 gaaaagcgcgaatttatctgagagaagg	 	 	27.83neg	 catagccaattaaacttaacttaaactaaaatttagctc	 	 	26.49+	 gatagccaagatggtatagtgtggg	 	 	Adapt	neg	 gcatctcgagggttgtggc	 	 	
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Table	2.	TRS	sequences	of	progenitor	strain	IBV	QX	1148-A	and	QX	vaccine	L1148	showing	showing	the	S	gene	A	to	C	substitution.		Gene	 TRS	start	position	 TRS	sequence	in	progenitor	 TRS	sequence	in	vaccine	S	 20208	 AGG	AACAA	 AGG	ACCAA	3	 23740	 CTG	AACAA	 CTG	AACAA	M	 24326	 CTT	AACAA	 CTT	AACAA	4b	 24800	 CTG	AACAA	 CTG	AACAA	5	 25390	 ACC	AACAA	 ACC	AACAA	N	 25740	 CTT	AACAA	 CTT	AACAA	6b	 26901	 CAA	AACAA	 CAA	AACAA									
Table	3.	Nucleoside	substitutions	arising	during	the	attenuation	of	QX	1148-A	to	yield	vaccine	L-1148.	Shading	denotes	the	16	amino	acid	changes	occurring.				 Genome	region	 Genome	position	 Nucleotide	 Amino	acid		progenitor	 vaccine	 progenitor	 vaccine	5’UTR	 78	 C	 T	 n.c.	 n.c.	5’UTR	 257	 C	 T	 n.c	 n.c.	Nsp	2	 548	 C	 T	 N	 N	Nsp	2	 1970	 C	 T	 F	 F	Nsp	3	 3322	 C	 T	 T	 I	Nsp	3	 4597	 T	 G	 I	 S	Nsp	3	 6209	 C	 T	 C	 C	Nsp	4	 8688	 G	 A	 N	 N	Nsp	8	 10929	 C	 A	 L	 I	Nsp	12	 14440	 C	 T	 V	 V	Nsp	13	 15693	 C	 T	 P	 L	Nsp	14	 17239	 C	 T	 N	 N	Nsp	16	 20212	 A	 C	 E	 D	S1	 20460	 G	 C	 M	 H	S1	 20521	 C	 A	 D	 K	S1	 21073	 C	 T	 T	 I	S1	 21435	 G	 T	 G	 F	S1	 21436	 G	 T	 G	 F	S1	 21438	 G	 C	 E	 Q	S2	 22902	 T	 A	 S	 T	S2	 22921	 C	 T	 S	 L	E	 24281	 G	 T	 A	 S	M	 25048	 A	 C	 E	 A	5a	 25616	 C	 T	 Y	 Y	5b	 25664	 G	 T	 D	 Y	5b	 25831	 C	 T	 N	 N	3’UTR	 27074	 C	 T	 n.c.	 n.c.	3’UTR	 27539	 T	 C	 n.c.	 n.c.	
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Conclusions		 The	 sequencing	 of	 the	 complete	 genome	 of	 IBV	 is	 of	 vital	 importance	 to	 obtain	information	about	the	epidemiology	of	this	virus	and	for	diagnostic	purposes.	 	IBV	is	able	to	mutate	 rapidly	 and	 to	 recombine	 and	 this	 causes	 the	 continuous	 emergence	of	 new	 strains	worldwide.	The	study	of	the	genomic	characteristics	of	the	strains	circulating	is	fundamental	for	the	developing	of	new	controlling	strategies.			 In	recent	times,	different	genotypes	of	apparent	Asian	origin,	such	as	the	Q1	and	the	QX	genotype	 have	 spread	 to	 other	 countries	 and	 continents,	 sometimes	 with	 economic	consequences.	 On	 this	 thesis	 the	 attention	 was	 focused	 on	 the	 characterization	 of	 strains	belonging	to	these	two	genotypes.			 In	 the	 first	 part	 of	 the	 project	 we	 reported,	 for	 the	 first	 time,	 the	 whole	 genome	sequence	of	a	Q1	strain	(gammaCoV/Ck/Italy/I2022/13)	isolated	in	Italy	from	chickens	with	respiratory	signs.	This	genotype,	after	the	first	isolation	in	China	in	the	mid	90’	has	spread	in	many	countries.	In	Italy,	it	was	reported	for	the	first	time	in	2011.	The	phylogenetic	analysis	of	 the	 complete	 genome	 of	 gammaCoV/Ck/Italy/I2022/13	 Q1	 strain	 demonstrated	 that	 it	clusterized	with	a	Chinese	Q1	strain.	Surprisingly,	the	analysis	of	the	S1	gene	revealed	also	a	high	homology	with	an	old	genotype	circulating	 in	 Italy	 from	the	60’,	 the	624I	genotype.	 In	order	 to	 clarify	 the	 genetic	 correlation	 between	 624I	 genotype	 and	 Q1	 genotype	 we	sequenced	 and	 analysed	 the	 complete	 genome	 of	 a	 624I	 strain	 isolated	 in	 Italy	 in	 1996	(gammaCov/Ck/Italy/IP14425/96).	The	basal	location	of	the	624I	strain	in	both	phylogenetic	trees,	 constructed	on	 the	complete	genome	sequence	and	on	 the	S1	gene,	 strongly	 suggests	that	 this	 genotype	 has	 played	 an	 important	 role	 in	 the	 emerge	 and	 in	 the	 evolution	 of	 Q1	genotype	and	supports	the	hypothesis	that	elects	624I	genotype	as	Q1	ancestor.	The	findings	reported	 in	 this	 study	 strongly	 suggest	 that	 624I	 genotype	 was	 introduced	 in	 China	somewhere	in	the	past,	there	evolved	into	Q1	genotype,	before	its	reintroduction	in	Italy.			 In	 the	 second	part	of	 the	project	we	 sequenced	and	 compared	a	 commercial	 vaccine	strain	of	QX	genotype	and	its	progenitor	strain.	The	QX	genotype	was	isolated	in	China	about	15	years	ago	and	then	spread	worldwide	becoming	one	of	the	major	genotype	circulating,	this	epidemiological	situation	has	prompted	the	production	of	homologous	vaccines.	In	this	study	the	 sequencing	 of	 the	QX	 vaccine	 strain	 L1148,	widely	 used	 in	 the	 field,	 and	 its	 progenitor	strain	1148-A	led	to	the	identification	of	28	markers	in	the	vaccine	sequence.	The	sequencing	of	 the	 region	 of	 the	 S1	 gene	 containing	 four	 vaccine	 markers	 could	 be	 an	 efficacious	 and	economic	 method	 for	 the	 irrefutable	 identification	 of	 this	 vaccine	 in	 the	 field.	 A	 further	
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potentially	 useful	 aspect	 of	 having	 identified	 mutations	 occurring	 during	 the	 attenuation	process	 is	 that	 they	 could	 seed	 further	 studies	 to	determine	which	were	 responsible	of	 the	virulence	loss,	and	beyond	that,	by	what	mechanism	they	arose.		In	 conclusion,	 it	 is	 important	 to	 remark	 the	 importance	 of	 performing	 complete	 genome	sequencing	of	viruses	and	 the	urgency	of	 an	 increase	 sequence	data	availability	 that,	 in	 the	future,	 with	 the	 increasing	 use	 of	 sequencing	 techniques,	 might	 be	 more	 achievable	 and	economic.					 	
